
<html lang="en"     class="pb-page"  data-request-id="1d96a036-804e-4c05-ac5b-3333b98c206c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.5b01998;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists" /></meta><meta name="dc.Creator" content="Dilip K.  Tosh" /></meta><meta name="dc.Creator" content="Antonella  Ciancetta" /></meta><meta name="dc.Creator" content="Eugene  Warnick" /></meta><meta name="dc.Creator" content="Robert  O’Connor" /></meta><meta name="dc.Creator" content="Zhoumou  Chen" /></meta><meta name="dc.Creator" content="Elizabeth  Gizewski" /></meta><meta name="dc.Creator" content="Steven  Crane" /></meta><meta name="dc.Creator" content="Zhan-Guo  Gao" /></meta><meta name="dc.Creator" content="John A.  Auchampach" /></meta><meta name="dc.Creator" content="Daniela  Salvemini" /></meta><meta name="dc.Creator" content="Kenneth A.  Jacobson" /></meta><meta name="dc.Description" content="Purine (N)-methanocarba-5′-N-alkyluronamidoriboside A3 adenosine receptor (A3AR) agonists lacking an exocyclic amine resulted from an unexpected reaction during a Sonogashira coupling and subsequen..." /></meta><meta name="Description" content="Purine (N)-methanocarba-5′-N-alkyluronamidoriboside A3 adenosine receptor (A3AR) agonists lacking an exocyclic amine resulted from an unexpected reaction during a Sonogashira coupling and subsequen..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 18, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01998" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01998" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01998" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01998" /></link>
        
    
    

<title>Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01998" /></meta><meta property="og:title" content="Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0013.jpeg" /></meta><meta property="og:description" content="Purine (N)-methanocarba-5′-N-alkyluronamidoriboside A3 adenosine receptor (A3AR) agonists lacking an exocyclic amine resulted from an unexpected reaction during a Sonogashira coupling and subsequent aminolysis. Because the initial C6-Me and C6-styryl derivatives had unexpectedly high A3AR affinity, other rigid nucleoside analogues lacking an exocyclic amine were prepared. Of these, the C6-Me-(2-phenylethynyl) and C2-(5-chlorothienylethynyl) analogues were particularly potent, with human A3AR Ki values of 6 and 42 nM, respectively. Additionally, the C2-(5-chlorothienyl)-6-H analogue was potent and selective at A3AR (MRS7220, Ki 60 nM) and also completely reversed mouse sciatic nerve mechanoallodynia (in vivo, 3 μmol/kg, po). The lack of a C6 H-bond donor while maintaining A3AR affinity and efficacy could be rationalized by homology modeling and docking of these hypermodified nucleosides. The modeling suggests that a suitable combination of stabilizing features can partially compensate for the lack of an exocyclic amine, an otherwise important contributor to recognition in the A3AR binding site." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01998"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01998">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01998&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01998&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01998&amp;href=/doi/10.1021/acs.jmedchem.5b01998" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3249-3263</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01995" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b02029" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Purine (<i>N</i>)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A<sub>3</sub> Adenosine Receptor Agonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dilip+K.++Tosh">Dilip K. Tosh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonella++Ciancetta">Antonella Ciancetta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eugene++Warnick">Eugene Warnick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++O%E2%80%99Connor">Robert O’Connor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhoumou++Chen">Zhoumou Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Gizewski">Elizabeth Gizewski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Crane">Steven Crane</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhan-Guo++Gao">Zhan-Guo Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.++Auchampach">John A. Auchampach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Salvemini">Daniela Salvemini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+A.++Jacobson">Kenneth A. Jacobson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 8A, Room B1A-19, Bethesda, Maryland 20892-0810, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri 63104, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 301-496-9024. Fax: 301-496-8422. E-mail: <a href="/cdn-cgi/l/email-protection#98f3f9f2f9fbf7faebd8f0fdf4f1e0b6f6f1f0b6fff7ee"><span class="__cf_email__" data-cfemail="98f3f9f2f9fbf7faebd8f0fdf4f1e0b6f6f1f0b6fff7ee">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01998&amp;href=/doi/10.1021%2Facs.jmedchem.5b01998" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3249–3263</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 18, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 December 2015</li><li><span class="item_label"><b>Published</b> online</span>18 February 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01998" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01998</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01998"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1292</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01998" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dilip&quot;,&quot;last_name&quot;:&quot;K. Tosh&quot;},{&quot;first_name&quot;:&quot;Antonella&quot;,&quot;last_name&quot;:&quot;Ciancetta&quot;},{&quot;first_name&quot;:&quot;Eugene&quot;,&quot;last_name&quot;:&quot;Warnick&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;O’Connor&quot;},{&quot;first_name&quot;:&quot;Zhoumou&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Gizewski&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Crane&quot;},{&quot;first_name&quot;:&quot;Zhan-Guo&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. Auchampach&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Salvemini&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;A. Jacobson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;3249-3263&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01998&quot;},&quot;abstract&quot;:&quot;Purine (N)-methanocarba-5′-N-alkyluronamidoriboside A3 adenosine receptor (A3AR) agonists lacking an exocyclic amine resulted from an unexpected reaction during a Sonogashira coupling and subsequent aminolysis. Because the initial C6-Me and C6-styryl derivatives had unexpectedly high A3AR affinity, other rigid nucleoside analogues lacking an exocyclic amine were prepared. Of these, the C6-Me-(2-phenylethynyl) and C2-(5-chlorothienylethynyl) analogues were particularly potent, with human A3AR Ki values of 6 and 42 nM, respectively. Additionally, the C2-(5-chlorothienyl)-6-H analogue was potent and selective at A3AR (MRS7220, Ki 60 nM) and also completely reversed mouse sciatic nerve mechanoallodynia (in vivo, 3 μmol/kg, po). The lack of a C6 H-bond donor while maintaining A3AR affinity and efficacy could be rationalized by homology modeling and docking of these hypermodified nucleosides. The modeling suggests that a suitable combination of stabilizing features can partially compensate for the lack of an exocyc&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01998&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01998" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01998&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01998" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01998&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01998" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01998&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01998&amp;href=/doi/10.1021/acs.jmedchem.5b01998" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01998" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01998" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01998%26sid%3Dliteratum%253Aachs%26pmid%3D26890707%26genre%3Darticle%26aulast%3DTosh%26date%3D2016%26atitle%3DPurine%2B%2528N%2529-Methanocarba%2BNucleoside%2BDerivatives%2BLacking%2Ban%2BExocyclic%2BAmine%2Bas%2BSelective%2BA3%2BAdenosine%2BReceptor%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D7%26spage%3D3249%26epage%3D3263%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/jmcmar.2016.59.issue-7/20160414-01/jmcmar.2016.59.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Purine (<i>N</i>)-methanocarba-5′-<i>N</i>-alkyluronamidoriboside A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR) agonists lacking an exocyclic amine resulted from an unexpected reaction during a Sonogashira coupling and subsequent aminolysis. Because the initial C6-Me and C6-styryl derivatives had unexpectedly high A<sub>3</sub>AR affinity, other rigid nucleoside analogues lacking an exocyclic amine were prepared. Of these, the C6-Me-(2-phenylethynyl) and C2-(5-chlorothienylethynyl) analogues were particularly potent, with human A<sub>3</sub>AR <i>K</i><sub>i</sub> values of 6 and 42 nM, respectively. Additionally, the C2-(5-chlorothienyl)-6-H analogue was potent and selective at A<sub>3</sub>AR (MRS7220, <i>K</i><sub>i</sub> 60 nM) and also completely reversed mouse sciatic nerve mechanoallodynia (in vivo, 3 μmol/kg, po). The lack of a C6 H-bond donor while maintaining A<sub>3</sub>AR affinity and efficacy could be rationalized by homology modeling and docking of these hypermodified nucleosides. The modeling suggests that a suitable combination of stabilizing features can partially compensate for the lack of an exocyclic amine, an otherwise important contributor to recognition in the A<sub>3</sub>AR binding site.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There is an expanding effort to develop selective adenosine receptor (AR) agonists and antagonists for clinical use in inflammation, pain, ischemia, cancer, and other conditions.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Generally, insight into ligand affinity for the four ARs (A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub>) has come from screening, mutagenesis and structure-based studies,<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4-7)</a> with the latter currently relying on homology with the known X-ray structures of ligand-bound A<sub>2A</sub>ARs.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> Structure-based optimization of known ligands and the discovery of novel chemotypes for the ARs have also been reported.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In general, these studies suggest that recognition of AR pharmacophores, especially as applied to adenosine derivatives, depends on a set of interactions with typically conserved amino acid residues. For example, the adenine ring engages in aromatic π–π stacking with a conserved Phe residue in EL2 (168 in the human (h) A<sub>3</sub>AR), and the 5′-<i>N</i>-alkyluronamide of potent AR agonists such as <b>1</b> (nonselective) typically H-bonds with a conserved Thr/Ser 3.36 (using standard notation<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a>) in transmembrane helix (TM) 3. The N<sup>6</sup> hydrogen, as H-bond donor, and N<sup>7</sup>, as H-bond acceptor, form a bidentate coordination with Asn (6.55). This latter interaction is the reason that 7-deaza adenosine derivatives are nearly inactive as AR agonists.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> The removal of H-bonding groups on the adenosine pharmacophore that interacts through these conserved recognition points often reduces agonist potency and/or efficacy across the four AR subtypes.</div><div class="NLM_p">Although changes to the primary pharmacophore may disrupt binding completely, subtle changes in these conserved drug–receptor interactions can lead to subtype specificity. For example, substituting the ribose oxygen for sulfur reduced A<sub>1</sub> and increased A<sub>2A</sub>AR affinity of 2-chloroadenosine.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Conversely, replacing the flexible ribose conformation by a rigid Northern (<i>N</i>)-methanocarba moiety decreased A<sub>2A</sub> and increased A<sub>1</sub> and A<sub>3</sub> AR affinity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Similarly, <i>N</i><sup>6</sup>-3-halobenzyl and 5′-<i>N</i>-methyluronamide moieties, along with combinations thereof, are particularly important for enhancing A<sub>3</sub>AR selectivity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> There are also derivatives lacking an exocyclic NH, such as C6-phenylpurine (nonriboside) derivatives that bind to the A<sub>1</sub>AR as antagonists<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and various purine-9-riboside derivatives that bind to the A<sub>3</sub>AR.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> For example, the <i>N</i><sup>6</sup>-dimethyl <b>2</b> and inosine <b>3</b> analogues of the nonselective, potent agonist 5′-<i>N</i>-ethylcarboxamidoadenosine <b>1</b> maintain moderate A<sub>3</sub>AR binding affinity (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). Among nucleosides having a ring-constrained (<i>N</i>)-methanocarba (bicyclo[3.1.0]hexane) modification that maintains an A<sub>3</sub>AR-preferred conformation, several inosines, <b>4</b>, <b>5</b>, and thioinosine <b>6</b> derivatives show moderate binding affinity.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> Thus, compounds <b>2</b> and <b>6</b> lack a H-bond donor at the C6 position yet have μM A<sub>3</sub>AR binding affinity.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Reported Examples of C6-Modified Ribose-Containing (<b>1</b>–<b>3</b>)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and (<i>N</i>)-Methanocarba (<b>4</b>–<b>6</b>) Nucleosides<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> as AR Ligands<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>The binding <i>K</i><sub>i</sub> values (μM) at the rat (r) A<sub>3</sub>AR or hA<sub>3</sub>AR are shown in parentheses. Values for <b>4</b> and <b>6</b> were measured for the present study using the same methods as in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></p></figure><div class="NLM_p last">Here, we considered whether other analogues lacking the H-bond donor at N<sup>6</sup> behave as potent A<sub>3</sub>AR-selective agonists. Using structural modification of known A<sub>3</sub>AR agonists and assays for binding, function, and in vivo efficacy, we characterize such motifs. Also, we use molecular modeling based on an agonist-bound A<sub>2A</sub>AR crystal structure to explore the binding of this redefined pharmacophore. The presence of other stabilizing interactions in these hypermodifed analogues appears to compensate for the lack of an exocyclic NH. We show that this new variety of ligands not only enlarges the class of high affinity and specific A<sub>3</sub>AR ligands, which is highly desirable clinically but also gives new insight into the specificity attributes of the A<sub>3</sub>AR pharmacophore.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21327" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21327" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemical Synthesis</h3><div class="NLM_p">The opportunity to explore the structure–activity relationship (SAR) of C6-methylated and other C6-alkylated adenosine derivatives arose from a side reaction and an unanticipated fragmentation product that occurred during the attempted reaction of a 6-chloro-2-iodo intermediate <b>28</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The attempted Sonogashira coupling of <b>28</b> was sought as an alternate route to synthesize C2-arylethynyl (<i>N</i>)-methanocarba nucleosides, e.g., 6-amino derivatives <b>7</b>–<b>10</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), which we reported previously to be highly specific A<sub>3</sub>AR agonists.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> During the Sonogashira reaction of compound <b>28</b> with phenylacetylene, instead of the desired monosubstituted product <b>30</b>, only disubstituted product <b>31a</b> was obtained. To convert the 5′-ester group of compound <b>31a</b> to an amide derivative, it was stirred with 40% methylamine solution in methanol at room temperature overnight. It was interesting to observe that a hydroamination reaction<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> had occurred at the C6-phenylacetylene group in addition to amidation to give compound <b>32a</b>. We have never observed a similar hydroamination product when a phenylacetylene group is present at the C2 position.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> The structure of this product <b>32a</b> was thoroughly characterized by various NMR studies (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf" class="ext-link">Figures S3–S5, Tables S1–S3</a>, Supporting Information (SI)). Similar products were also observed during a reaction of compound <b>28</b> with 2-chloro-phenylacetylene and 4-<i>t</i>-butyl-phenylacetylene followed by amination to give the C2-aminostyryl derivatives <b>32b</b> and <b>32c</b>. To prove chemically that the hydroamination reaction occurred exclusively at the C6 phenylacetylene group, compound <b>34</b> was synthesized by a Sonogashira reaction of 2,6-dichloro derivative <b>33</b> with phenylacetylene (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Aminolysis of compound <b>34</b> with methylamine solution provided compound <b>11a</b>. Attempted removal of the isopropylidene group of <b>32a</b> with 10% TFA in methanol at 70 °C provided a hydrolyzed enol derivative <b>12</b> and the unexpected fragmented product <b>15</b>. Enamines are known to be hydrolyzed to ketones under acidic conditions.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Both products were extensively characterized by various NMR studies, and also a plausible mechanism for the formation of fragmented 6-Me product <b>15</b> is presented in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf" class="ext-link">Scheme S1</a> (SI). We propose that under acidic conditions, methanol may attack the protonated keto tautomer equivalent of the enol group followed by a fragmentation that leaves a 6-Me group on the purine base. Similarly, hydrolysis of <b>32b</b>–<b>c</b> and <b>11a</b> provided enol derivatives <b>13</b>, <b>14</b>, and <b>11b</b>. However, only a C6 fragmented product, e.g., <b>17</b>, was observed in the hydrolysis reaction of 4-<i>t</i>-Bu-phenylethynyl derivative <b>32c</b>. No fragmentation products were detected upon hydrolysis of 2-chlorophenylethynyl <b>32b</b> and 2-chloro <b>11a</b> derivatives.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Attempted Synthesis of 6-Chloro (<i>N</i>)-Methanocarba Intermediate <b>30</b> as a Possible Precursor of Selective A<sub>3</sub>AR Agonists and the Redirected Route to A<sub>3</sub>AR Agonist Series Containing at the C6 Position Either a Substituted Styryl <b>12</b>–<b>14</b> or a Methyl Group <b>15</b>, <b>17</b> (Affinities in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, rt; (ii) 40% MeNH<sub>2</sub>, MeOH, rt; (iii) 10% TFA, MeOH, 70 °C.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Application of the Redirected Route from <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> to the Preparation of C6-Substituted 2-Cl (<i>N</i>)-Methanocarba Derivative <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Although many 2-Cl derivatives are potent A<sub>3</sub>AR agonists,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> this compound only weakly bound to the receptor (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). (i) phenylacetylene, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, rt; (ii) 40% MeNH<sub>2</sub>, MeOH, rt; (iii) 10% TFA, MeOH, 70 °C.</p></p></figure><div class="NLM_p">C6-Me derivatives (<b>16</b>, <b>18</b>, and <b>19</b>) having different C2-arylethynyl groups were synthesized by an alternate route, which preinstalled a 6-Me group on the nucleobase (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The nucleobase intermediate 2-iodo-6-methyl purine <b>55</b> was prepared from a 9-protected 2-amino-6-methyl purine <b>52</b> as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf" class="ext-link">Scheme S2</a> (SI). Similarly, C6-H derivatives were prepared from an intermediate 6-iodopurine (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). However, it was observed that during attempted conversion of 5′-ester <b>39</b> to an amide, MeNH<sub>2</sub> also replaced the iodo group at C2 position to give compound <b>40</b>, which upon acid hydrolysis provided compound <b>23</b>. To avoid this side reaction at the C2 position, a Sonogashira coupling was first performed on compound <b>39</b> with different arylalkynes to give <b>41a</b>–<b>c</b>. Amidation of esters <b>41a</b> and <b>41b</b> with a methylamine solution followed by acid hydrolysis yielded C6-H derivatives <b>20</b> and <b>21</b>, respectively. In contrast, the same reactions for the pyrazine derivative <b>41c</b> yielded a hydroamination product <b>43</b>, which upon acid hydrolysis gave the enol derivative <b>24</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of C6-CH<sub>3</sub> (<i>N</i>)-Methanocarba Derivatives <b>16</b>, <b>18</b>, and <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2-iodo-6-methyl purine <b>54</b>, Ph<sub>3</sub>P, DIAD, THF, rt; (ii) 40% MeNH<sub>2</sub>, MeOH, rt; (iii) aryl alkynes, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF; (iv) 10% TFA, MeOH, H<sub>2</sub>O, 70 °C.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of C6-H (<i>N</i>)-Methanocarba Derivatives <b>20</b>, <b>21</b>, <b>23</b>, and <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2-iodo-purine, Ph<sub>3</sub>P, DIAD, THF, rt; (ii) 40% MeNH<sub>2</sub>, MeOH, rt; (iii) 10% TFA, MeOH, H<sub>2</sub>O, 70 °C; (iv) aryl alkynes, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF.</p></p></figure><div class="NLM_p">For comparison, we also prepared one C6-methoxy (<i>N</i>)-methanocarba nucleoside <b>22</b>, based on inosine, containing an extended C2 substituent. In the first route, we have synthesized a C6-OMe derivative <b>44</b>; however, the attempted conversion of the ester to an amide by treatment of <b>44</b> with methylamine solution gave a C6-NHMe substituted derivative <b>45</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). To avoid this side reaction, an alternate route featuring oxidation of a 5′-CH<sub>2</sub>OH and MeNH<sub>2</sub> coupling was designed (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). Compound <b>46</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> was converted to C6-OMe derivative <b>47</b>, which upon TBDPS deprotection and PDC oxidation gave the acid derivative <b>49</b>. Coupling of MeNH<sub>2</sub> with compound <b>49</b> in the presence of HATU gave the desired precursor <b>50</b>, with no detectable C6-NHMe side products. Sonogashira coupling of compound <b>50</b> with 2-chloro-5-ethynylthiophene followed by acid hydrolysis afforded the C6-OMe derivative <b>22</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Unproductive Synthetic Route to (<i>N</i>)-Methanocarba-inosine Derivative <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) MeONa, MeOH, rt; rt; (ii) 40% MeNH<sub>2</sub>, MeOH, rt.</p></p></figure><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0011.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of (<i>N</i>)-Methanocarba-inosine Derivative <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) MeONa, MeOH, rt; (ii) TBAF, THF, rt; (iii) PDC, DMF, 40 °C; (iv) MeNH<sub>2</sub>, HATU, DIPEA, DMF; (v) 2-chloro-5-ethynylthiophene, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF; (vi) Dowex50, MeOH, H<sub>2</sub>O, 70 °C.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Pharmacological Activity</h3><div class="NLM_p"><a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> lists the AR affinities for the various synthesized purine nucleoside analogues lacking a C6-exocyclic amino group and their related <i>N</i><sup>6</sup>-substituted adenosine derivatives. Standard radioligand (<b>25</b>–<b>27</b>) binding assays were performed on human (h)A<sub>1</sub>, A<sub>2A</sub>, and A<sub>3</sub> ARs using reported methods,<a onclick="showRef(event, 'ref7 ref20'); return false;" href="javascript:void(0);" class="ref ref7 ref20">(7, 20)</a> and IC<sub>50</sub> values were transformed to <i>K</i><sub>i</sub> as described.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> The fortuitously synthesized initial C6-methyl derivative <b>15</b> had unexpectedly high binding at the hA<sub>3</sub>AR (<i>K</i><sub>i</sub> 6.01 nM). This motivated us to explore other accessible C6-alkyl or alkenyl derivatives containing either a 2-Cl (<b>11b</b>) or 2-arylethynyl (<b>15</b>–<b>19</b>) group. None of these compounds bound significantly to the hA<sub>1</sub> or A<sub>2A</sub> ARs and were therefore selective for the A<sub>3</sub> AR. The 2-chloro analogue <b>11b</b> bound only weakly to the hA<sub>3</sub>AR (<i>K</i><sub>i</sub> 1.14 μM). Many other 2-chloro nucleosides are known to have potent A<sub>3</sub>AR agonist activity,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> which suggests that the presence of a rigid extension at the C2 position, e.g., the 6-styryl derivatives <b>12</b> and <b>13</b>, enhances binding to the A<sub>3</sub>AR in this series lacking an exocyclic NH.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and Binding Affinities at Three ARs of Reference Compounds (<b>7</b>–<b>10</b>)<a onclick="showRef(event, 'ref23 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref26">(23, 26)</a> and Newly Synthesized Nucleoside Derivatives (<b>11</b>–<b>24</b>)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0012.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Binding<a onclick="showRef(event, 'ref7 ref20 ref32'); return false;" href="javascript:void(0);" class="ref ref7 ref20 ref32">(7, 20, 32)</a> in membranes prepared from CHO or HEK293 (hA<sub>2A</sub>AR and mA<sub>3</sub>AR) cells stably expressing one of three hAR subtypes. The binding affinity for hA<sub>1</sub>, A<sub>2A</sub>, and A<sub>3</sub>ARs was expressed as <i>K</i><sub>i</sub> values (<i>n</i> = 3–4) measured using agonist radioligands [<sup>3</sup>H]<i>N</i><sup>6</sup>-<i>R</i>-phenylisopropyladenosine <b>25</b>, [<sup>3</sup>H]2-[<i>p</i>-(2-carboxyethyl)phenyl-ethylamino]-5′-<i>N</i>-ethylcarboxamido-adenosine <b>26</b>, or [<sup>125</sup>I]<i>N</i><sup>6</sup>-(4-amino-3-iodobenzyl)adenosine-5′-<i>N</i>-methyl-uronamide <b>27</b>, respectively. A percent in italics refers to inhibition of binding at 10 μM. Nonspecific binding was determined using adenosine-5′-<i>N</i>-methyluronamide <b>1</b> (10 μM at hARs, 100 μM at mA<sub>3</sub>AR). The concentrations of radioligands and their <i>K</i><sub>D</sub> values at the corresponding hARs in parentheses used to calculate <i>K</i><sub>i</sub> values of competing ligands were all in nM: <b>25</b>, 1.0 (1.5); <b>26</b>, 10 (16.2); <b>27</b>, 0.2 (1.22).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Data from Tosh et al.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a></p></div></div><div></div></div><div class="NLM_p">A C2 modified, 5-chlorothienylethynyl substituent was associated with higher affinity in C6-modified analogues than most other aryl groups except an unsubstituted phenyl, as in <b>15</b>. The 5-chlorothienylethynyl group in C6-Me (<b>19</b>) and C6-H (<b>21</b>) analogues produced <i>K</i><sub>i</sub> values of 42 and 60 nM, respectively, and were both highly A<sub>3</sub>AR selective, with hA<sub>1</sub> and A<sub>2A</sub>ARs <i>K</i><sub>i</sub> values extrapolated to ≫10 μM. Other aryl groups, specifically substituted phenyl rings, did not achieve such high affinity. The rank order of decreasing hA<sub>3</sub>AR affinity was: <b>15</b> > <b>19</b> > <b>16</b> > <b>17</b> ≥ <b>18</b>. The least potent C6-Me analogues, compounds <b>17</b> (<i>K</i><sub>i</sub> 305 nM, hA<sub>3</sub>AR) and <b>18</b> (<i>K</i><sub>i</sub> 343 nM) contained a bulky <i>p</i>-<i>t</i>-Bu-phenyl group or a pyrazine group, respectively. The disubstituted 6-styryl derivatives <b>12</b>–<b>14</b> were of intermediate affinity at the hA<sub>3</sub>AR, ranging from <i>K</i><sub>i</sub> ∼ 80–500 nM. It is interesting that the 4-<i>t</i>-Bu group was highly detrimental to hA<sub>3</sub>AR affinity in the case of C6-Me but not with a larger C6 substituent.</div><div class="NLM_p">Selected nucleosides were tested in a binding assay at the mouse (m) A<sub>3</sub>AR expressed in HEK293 cells using reported methods.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The <i>K</i><sub>i</sub> values of <b>12</b> and <b>15</b> were 136 ± 9 and 158 ± 10 nM, respectively, which suggested that human vs mouse species differences are greater for the C6-methyl analogue than with a larger group at that position. Other analogues were weaker in binding at the mA<sub>3</sub>AR, with <i>K</i><sub>i</sub> values: <b>19</b>, 722 ± 35, and <b>21</b>, 396 ± 29 nM.</div><div class="NLM_p">Selected high affinity ligands (<b>15</b>, <b>19</b>, and <b>21</b>) were examined in a functional activity at hA<sub>3</sub>AR, e.g., the ability to inhibit production of cyclic AMP<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> via the hA<sub>3</sub>AR expressed in CHO cells. All three compounds activated the hA<sub>3</sub>AR as full agonists with a similar rank order of potency as in the binding results; the EC<sub>50</sub> values (nM) were: <b>15</b>, 3.16 ± 0.72; <b>19</b>, 12.5 ± 2.8; <b>21</b>, 26.9 ± 8.4 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). Compounds <b>12</b> and <b>15</b> were also tested in a functional assay at the mA<sub>3</sub>AR expressed in HEK293 cells, e.g., the ability to inhibit production of cyclic AMP. <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B shows that these compounds were also full agonists for this receptor, with efficacy comparable to the reference compound 2-chloro-<i>N</i><sup>6</sup>-(3-iodobenzyl)-5′-<i>N</i>-methylcarboxamidoadenosine <b>55</b>. Both <b>12</b> and <b>15</b> were quite potent in activating the mA<sub>3</sub>AR, with EC<sub>50</sub> values of 4.86 and 20.2 nM, respectively.</div><figure id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Functional agonism at the hA<sub>3</sub>AR (A) and the mA<sub>3</sub>AR (B) of nucleosides lacking an exocyclic NH, which remain selective A<sub>3</sub>AR ligands. (A) Compounds <b>15</b>, <b>19</b>, and <b>21</b> proved to be potent, full agonists at the hA<sub>3</sub>AR (% values relative to inhibition of forskolin-stimulated cyclic AMP accumulation by adenosine-5′-<i>N</i>-methyluronamide <b>1</b> at 10 μM). Compounds <b>12</b> (B) and <b>15</b> (C) in an assay of inhibition of forskolin-stimulated cyclic AMP accumulation with HEK293 cells expressing the mA<sub>3</sub>AR, as described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Concentration–effect curves with reference full agonist 2-chloro-<i>N</i><sup>6</sup>-(3-iodobenzyl)-5′-<i>N</i>-methylcarboxamidoadenosine <b>55</b> are included. Data are the mean ± SEM, <i>n</i> = 4–7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the potent in vitro A<sub>3</sub>AR activity of these congeners, selected compounds were tested in vivo using previously reported methods<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> for the ability to reduce chronic neuropathic pain following oral administration in the mouse chronic constriction injury (CCI) model<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). 2-Phenylethynyl analogues <b>12</b> and <b>15</b>, differing in the nature of the C6 group, were efficacious in reducing pain at the point of peak pain, day 7, although neither reached 100% reversal of the pain and the duration of action was less than that observed for the corresponding C6-NHMe analogue, i.e., <b>9</b>.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The 2-(5-chlorothienyl)ethynyl compounds <b>19</b> and <b>21</b> were also compared in the mouse CCI model. Here, the 6-H analogue <b>21</b> was clearly more efficacious and longer lasting (at least 5 h) than the corresponding 6-CH<sub>3</sub> analogue <b>19</b> and other compounds tested in vivo. The absence of a C6 substitution in <b>21</b> evidently contributes to its prolonged activity in vivo. The absence of an exocyclic amine slightly improved the physicochemical parameter tPSA, which might be related to the increased in vivo efficacy. The tPSA value of <b>21</b> is 110 Å<sup>2</sup>, compared to 122 Å<sup>2</sup> for compound <b>10</b>, suggesting better drug-like qualities and bioavailability. On the other hand, the cLogP of <b>21</b> is 1.27, compared to 2.17 for <b>10</b>, which may be advantageous for solubility.</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time course of protection hind paw mechanoallodynia of the sciatic nerve in the CCI mouse model (po administration on day 7, 3 μmol/kg). The vehicle was 10% DMSO in 0.5% methylcellulose, which when administered alone had no effect on PWT. There was no effect on the contralateral paw. (A) CCI results (<i>n</i> = 3) for compounds <b>12</b> (●) and <b>15</b> (■). Data are the mean ± SEM. For comparison, compound <b>8</b> at the same dose provided 100% and 23.7 ± 10.8% protection against mechanoallodynia in the same model at 1 and 3 h, respectively.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (B) CCI results (<i>n</i> = 2) for compounds <b>19</b> (●) and <b>21</b> (■).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Off-target activities of compounds <b>15</b>, <b>19</b>, and <b>21</b> were evaluated at various receptors by the Psychoactive Drug Screening Program (PDSP).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Results (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf" class="ext-link">SI</a>) indicated only a few off-target interactions in the μM range. Compound <b>15</b> showed no significant binding inhibition at the diverse receptors, but at 10 μM it enhanced human dopamine transporter (hDAT) binding of [<sup>3</sup>H]methyl (1<i>R</i>,2<i>S</i>,3<i>S</i>)-3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate by roughly 200% (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf" class="ext-link">Figure S1</a>, SI), similar to other (<i>N</i>)-methanocarba-adenosine derivatives.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> This unusual activity of this chemical series was shown by Janowsky et al.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> to correlate with an allosteric enhancement of the affinity of the tropane radioligand binding to DAT. Compound <b>19</b> showed only one such off-target interaction (<i>K</i><sub>i</sub> at δ opioid receptor 5.8 μM, 68% inhibition), and compound <b>21</b> showed no off-target interactions.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Molecular Modeling</h3><div class="NLM_p">Docking simulations were carried out to explore the environment of receptor-bound C6 substituted purine nucleosides. Selected compounds (<i>K</i><sub>i</sub> < 100 nM) were docked into the putative TM binding site of a previously reported homology model of the hA<sub>3</sub>AR,<a onclick="showRef(event, 'ref7 ref32'); return false;" href="javascript:void(0);" class="ref ref7 ref32">(7, 32)</a> based on a hybrid A<sub>2A</sub>AR-β<sub>2</sub> adrenergic receptor template.</div><div class="NLM_p">The docking poses were selected by taking into account optimal interaction geometries with the residues surrounding the binding site and by inspecting electrostatic and van der Waals contributions of computed per residue interaction scores, denoted IS<sub>ele</sub> and IS<sub>vdW</sub>, respectively. The “interaction score maps” (ISMs) arising from the latter analysis (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf" class="ext-link">Figure S2</a> (SI)) identify a common binding mode for derivatives <b>15</b>, <b>16</b>, <b>19</b>, and <b>21</b>, involving residues located mainly in TM3, extracellular loop (EL) 2, TM6, and TM7. On the other side, the C6-styryl derivatives <b>12</b> and <b>14</b> interact with residues belonging to EL2, EL3, and TM7, thus implying that their placement in the binding site is shifted toward the extracellular side of the receptor (data not shown).</div><div class="NLM_p">As an example of the binding mode exhibited by the majority of the considered purine nucleosides, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> shows the docking pose of compound <b>15</b> (<i>K</i><sub>i</sub> = 6.0 nM). The ligand resides in the upper region of the TM bundle (see also SI, <a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_004.avi" class="ext-link">Video S1</a>) with the C2 terminal cyclic group pointing toward the extracellular environment, and this mode features several interactions typical for AR agonists. The planar bicyclic core establishes an aromatic π–π stacking interaction with Phe168 (EL2), whereas the purine N7 engages the side chain of Asn250 (6.55) acting as H-bond donor. A tight hydrogen bond network with Thr94 (3.36), Ser271 (7.42), and His272 (7.43) anchors the methanocarba region of the compound in the binding pocket. In addition to these conserved recognition points, the ISMs (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf" class="ext-link">Figure S2B</a> (SI)) report several other residues involved in favorable contacts with the ligand, including Leu91 (3.32), Ile92 (3.33), Val169 (EL2), Trp243 (6.48), Leu246 (6.51), and Ile268 (7.31).</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hypothetical binding mode of C6-methyl (<i>N</i>)-methanocarba derivative <b>15</b> (orange carbon atoms, ball and stick representation), a potent and selective agonist, obtained after docking simulations at the hA<sub>3</sub>AR. Side chains of residues important for ligand recognition are reported as sticks (gray carbon atoms). H-bonds are pictured as green solid lines, whereas π–π stacking interactions as cyan dashed lines with the centroids of the aromatic rings displayed as cyan spheres. Nonpolar hydrogen atoms are omitted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Previously, removal of the exocyclic NH of adenosine derivatives was not considered a feasible approach to the design of new, selective AR agonists. In an early, pioneering SAR paper by Bruns,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> purine-9-riboside <b>56</b> (nebularine) and 6-methylpurine-9-riboside (structures not shown) were described as weak AR agonists at 1 mM with only 15% and 6%, respectively, of the efficacy of 10 μM adenosine at a receptor in fibroblasts that was later identified as the human A<sub>2B</sub>AR. <b>56</b> was 40-fold less potent than adenosine in activation of the canine coronary artery A<sub>2A</sub>AR, and the exocyclic NH was deemed essential for AR activation.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Compound <b>56</b> is also a weak inhibitor of adenosine deaminase; however, we are not concerned about that off-target activity with respect to the potent A<sub>3</sub>AR agonists in this study because 5′-<i>N</i>-alkyluronamido and other modifications of adenosine preclude interaction with that enzyme.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> Purine-9-riboside analogues lacking an exocyclic amine have also been explored as anticancer and anti-infective agents through activities unrelated to ARs.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(37, 38)</a> We did not prepare the corresponding hypermodified 9-ribosides for direct comparison with (<i>N</i>)-methanocarba analogues in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_p">Many adenosine derivatives containing a monosubstituted N<sup>6</sup> group, in combination with other substitutions, have been reported as potent A<sub>3</sub>AR agonists.<a onclick="showRef(event, 'ref7 ref38'); return false;" href="javascript:void(0);" class="ref ref7 ref38">(7, 36)</a> We revisited these two previously rejected modifications of adenosine for AR agonists, C6-H and C6-Me, using highly optimized A<sub>3</sub>AR agonists as lead structures. In this compound series, the loss of the exocyclic NH still preserved moderate affinity and high selectivity for the A<sub>3</sub>AR. Moreover, these purine analogues maintained an ability to fully activate the G<sub>i</sub>-coupled human and mouse A<sub>3</sub>ARs and to protect against neuropathic pain in the mouse, a characteristic A<sub>3</sub>AR effect.</div><div class="NLM_p">The correlation of activation of the A<sub>3</sub>AR with relief from chronic neuropathic pain has been established in various rodent models.<a onclick="showRef(event, 'ref3 ref28'); return false;" href="javascript:void(0);" class="ref ref3 ref28">(3, 28)</a> Selected compounds evaluated in functional assays and in the CCI pain model in mice had A<sub>3</sub>AR selectively and activity comparable to nucleosides containing an exocyclic amine. Activation of the A<sub>1</sub>AR is also known to reduce neuropathic pain,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> but except for two relatively weak analogues, 6-Me <b>16</b> and 6-MeO <b>22</b>, these derivatives have no appreciable affinity for the A<sub>1</sub>AR. Therefore, we conclude that the antinociceptive activity of orally administered <b>12</b>, <b>15</b>, <b>19</b>, and <b>21</b> was due to activation of the A<sub>3</sub>AR, with <b>21</b> completely reversing mechanoallodynia of the mouse sciatic nerve. With both peripheral and central mechanisms contributing to the antinociceptive effects,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> a novel class of AR agonists that lacks the exocyclic amine might have different patterns of distribution in vivo including conceivably greater entry into the brain due to the loss of an H-bonding group, which could affect the net protection against pain. Thus, these modifications might serve as a means of improving the bioavailability in A<sub>3</sub>AR agonists by altering physicochemical properties.</div><div class="NLM_p">With the elucidation of the structures of antagonist-bound and agonist-bound A<sub>2A</sub> adenosine receptors (ARs),<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> the design of selective AR ligands is increasingly structure-based.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> The fact that otherwise optimized nucleoside analogues lacking the exocyclic NH remain efficacious in activating the A<sub>3</sub>AR can be analyzed structurally. Homology modeling of the A<sub>3</sub>AR and other GPCRs based on a closely related templates is a useful component in the design of novel ligands.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Our homology model of the A<sub>3</sub>AR based on the X-ray structure of an agonist-bound A<sub>2A</sub>AR has aided in understanding the recognition of nucleoside agonists at this subtype.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Previously, the exocyclic amine (specifically an NH group) was considered an important recognition element for nucleosides binding to ARs in general, as it H-bonds to the conserved Asn (6.55). We have discovered that other structural features of the ligand can partially compensate for the lack of this important contributor and also increase A<sub>3</sub>AR specificity.</div><div class="NLM_p">The C6-truncated or C6-methyl or styryl compounds prepared in this study display a wide range of A<sub>3</sub>AR affinities. Certain 6-methyl analogues were particularly potent, with <i>K</i><sub>i</sub> values of 6 nM (<b>15</b>) to ∼50 nM (<b>19</b>, <b>21</b>), and other 6-methyl analogues bound in the μM range. Unsubstituted phenyl and 5-chlorothienylethynyl groups at the C2 position appeared to promote higher A<sub>3</sub>AR affinity compared to other aryl groups. The loss of energetic stabilization provided by binding of an exocyclic NH of conventional A<sub>3</sub>AR agonists can be compensated by other groups at different locations on the nucleoside, such as the extended C2 substituent, the rigid bicyclic ring, or the 5′-methylamide. All of these groups contribute to A<sub>3</sub>AR affinity and selectivity and help to anchor the ligand. For example, the C2 extended analogue <b>12</b> was 15-fold more potent at the hA<sub>3</sub>AR than the corresponding C2–Cl derivative <b>11b</b>. The inspection of the ligand−receptor interactions suggests that the above-mentioned groups are engaged in hydrophobic contacts with several residues (mainly leucine side chains located in TM3 and TM7) surrounding the binding cavity. These ancillary interactions ensure an optimal orientation of the hydrogen-bonding groups toward the conserved recognition points. From the present set of ligands, we have no evidence that selective A<sub>1</sub>AR or A<sub>2A</sub>AR agonists lacking an exocyclic NH can be designed.</div><div class="NLM_p last">It was already observed that H-bonding groups located on the ribose moiety are more closely related to the activation of the A<sub>3</sub>AR, i.e., the “message” portion of the molecule, and the adenine constitutes the “address” portion of the nucleoside.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The present findings reinforce that generalized division of function in that full agonism is observed in the absence of the NH.</div></div><div id="dec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74324" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74324" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, this study is the first demonstration that removal of an H-bond donor group at C6 of purine nucleosides is still compatible with binding and activation of an AR subtype. This set of novel A<sub>3</sub>AR agonists arose from an unexpected series of reactions on the adenosine precursors that left a methyl or styryl group at the C6 position of adenine. After we discovered the biological utility of such truncated purine derivatives, we found synthetic approaches to enlarge the SAR beyond the accidental analogues. It is surprising that the adenine 6-NH group, which is traditionally considered essential for the recognition of nucleosides at the various ARs, is not universally essential. Importantly, these hypermodified nucleosides have lower polar surface area than the equivalent adenine analogues, which should be advantageous for bioavailability. Moreover, the C6-truncated and C6-C compounds are selective agonists of the A<sub>3</sub>AR that display considerable in vivo activity against chronic neuropathic pain in a mouse model.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Materials and Instrumentation</h3><div class="NLM_p last">All reagents and solvents were purchased from Sigma-Aldrich (St. Louis, MO). Routine <sup>1</sup>H NMR spectra were obtained at 298 K with a Bruker AVIII 400 MHz or AV 500 MHz spectrometer using CDCl<sub>3</sub>, CD<sub>3</sub>OD, and DMSO as solvents. Reported chemical shifts (δ, ppm) are referenced to tetramethylsilane (0.00) for CDCl<sub>3</sub>, methanol (3.30) for CD<sub>3</sub>OD, and water (3.30) for DMSO, unless otherwise noted. Confirmation of the product structures was obtained by mass spectrometry and standard 1D and 2D NMR methods including COSY, TOCSY, HSQC, and HMBC. TLC analysis was carried out on glass sheets precoated with silica gel F254 (0.2 mm) from Aldrich. The purity of final nucleoside derivatives was checked using a Hewlett–Packard 1100 HPLC equipped with a Zorbax SB-Aq 5 μm analytical column (50 mm × 4.6 mm; Agilent Technologies Inc., Palo Alto, CA). Mobile phase: linear gradient solvent system, 5 mM TBAP (tetrabutylammonium dihydrogen phosphate)-CH<sub>3</sub>CN from 80:20 to 0:100 in 13 min; the flow rate was 0.5 mL/min. Peaks were detected by UV absorption with a diode array detector at 230, 254, and 280 nm. All derivatives tested for biological activity showed >95% purity by HPLC analysis (detection at 254 nm). Low-resolution mass spectrometry was performed with a JEOL SX102 spectrometer with 6 kV Xe atoms following desorption from a glycerol matrix or on an Agilent LC/MS 1100 MSD, with a Waters (Milford, MA) Atlantis C18 column. High resolution mass spectroscopic (HRMS) measurements were performed on a proteomics optimized Q-TOF-2 (Micromass-Waters) using external calibration with polyalanine, unless noted. Observed mass accuracies are those expected based on known performance of the instrument as well as trends in masses of standard compounds observed at intervals during the series of measurements. Reported masses are observed masses uncorrected for this time-dependent drift in mass accuracy. All of the monosubsituted alkyne intermediates were purchased from Sigma-Aldrich (St. Louis, MO), Small Molecules, Inc. (Hoboken, NJ), Anichem (North Brunswick, NJ), PharmaBlock, Inc. (Sunnyvale, CA), Frontier Scientific (Logan, UT), and Tractus (Perrineville, NJ). tPSA and cLogP were calculated using ChemDraw Professional V. 15.0 (PerkinElmer, Boston, MA).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemical Synthesis</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-Chloro-6-((<i>Z</i>)-2-(methylamino)-2-phenylvinyl)-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>11a</b>)</h4><div class="NLM_p last">Methylamine solution (40%, 2 mL) was added to a solution of compound <b>34</b> (24.5 mg, 0.051 mmol) in methanol (2.5 mL) and the mixture stirred at room temperature for 24 h. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 40:1) to give the compound <b>11a</b> (16 mg, 65%) as a yellowish syrup. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) (δH, H-multiplicity, <i>J</i> Hz, H-integral) (9.97, br s, 1H), (7.78, s, 1H), (7.46, s, 5H), (6.94, d 4.4, 1H), (5.76, s, 1H), (5.70, d 6.8, 1H), (4.83–4.80, m, 2H), (3.01, d 5.2, 3H), (2.95, d 4.8, 1H), (2.08–2.04, m, 1H), (1.72–1.68, m, 1H), (1.57, s, 3H), (1.34–1.30, m, 4H). HRMS calculated for C<sub>25</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub>Cl (M + H)<sup>+</sup>, 495.1906; found, 495.1907.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-Chloro-6-((<i>Z</i>)-2-hydroxy-2-phenylvinyl)-9<i>H</i>-purin-9-yl)-2,3-dihydroxy-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>11b</b>)</h4><div class="NLM_p last">A solution of compound <b>11a</b> (10 mg, 0.02 mmol) in methanol (2 mL) and 10% trifluoromethanesulfonic acid (1.5 mL) was heated at 70 °C overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 25:1) to give the compound <b>11b</b> (6.8 mg, 77%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.43, s, 1H), (7.98, dd 7.2:1.6, 2H), (7.52–7.50, m, 3H), (6.87, s, 1H), (5.13, d 6.4, 1H), (4.93, s, 1H), (4.08, d 6.8, 1H), (2.90, s, 3H), (2.14–2.11, m, 1H), (1.85, t 4.8, 1H), (1.43–1.39, m, 1H). HRMS calculated for C<sub>21</sub>H<sub>21</sub>N<sub>5</sub>O<sub>4</sub>Cl (M + H)<sup>+</sup>, 442.1277; found, 442.1279.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-2,3-Dihydroxy-4-(6-((<i>Z</i>)-2-hydroxy-2-phenylvinyl)-2-(phenylethynyl)-9<i>H</i>-purin-9-yl)-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>12</b>)</h4><div class="NLM_p">A solution of compound <b>32a</b> (58 mg, 0.103 mmol) in methanol (5 mL) and 10% trifluoromethanesulfonic acid (3.5 mL) was heated at 70 °C overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 30:1) to give the compound <b>12</b> (31 mg, 59%) as a colorless syrup. Column was further eluted with (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 15:1) to give the C6-methyl compound <b>15</b> (6.2 mg, 15%) as colorless syrup. NMR (CD<sub>3</sub>OD, 500 MHz) (δH:δC, H-multiplicity, <i>J</i> Hz, H-integral).</div><div id="sec4_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Compound <b>12</b></h5><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD, 500 MHz)  (1.42:15.5, ddd 9.1:4.9:1.7, 1H), (1.89:15.5, t 5.0, 1H), (2.16:28.9, ddd 9.1:4.7:1.5, 1H), (2.85:27.2, s, 3H), (4.12:77.9, dt 6.6:1.3, 1H), (5.0:64.1, s, 1H), (5.12:73.4, dd 6.6:1.3, 1H), (7.4–7.5:129.9, 130.1, 131.4, 132.4, m, 6H), (7.72:133.6, m, 2H), (8.0:127.6, m, 2H), (8.43:144.6, s, 1H); δCq 40.1, 87.4, 89.3, 122.5, 127.6, 137.4, 143.4, 149.7, 156.1, 157.8, 174.9. HRMS calculated for C<sub>29</sub>H<sub>26</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 508.1985; found, 508.1991.</div></div><div id="sec4_2_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Compound <b>15</b></h5><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD, 500 MHz) (1.40:15.5, ddd 9.1:5.1:1.7, 1H), (1.87:15.5, t 5.1, 1H), (2.14:28.8, ddd 9.1:4.8:1.4, 1H), (2.82:19.3, s, 3H), (2.84:27.3, s, 3H), (4.10:77.9, dt 6.6:1.1, 1H), (4.99:64.2, s, 1H), (5.14:73.5, dd 6.6:1.3, 1H), (7.43–7.49:130.0, 131.1, m, 3H), (7.68:133.5, ∼ dd 7.8:1.6, 2H), (8.5:146.5, s, 1H); δCq 39.9, 87.7, 89.3, 123.0, 147.2, 151.8, 160.8, 175.0. HRMS calculated for C<sub>22</sub>H<sub>22</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 404.1723; found, 404.1719.</div></div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(6-((<i>Z</i>)-2-(2-Chlorophenyl)-2-hydroxyvinyl)-2-(2-chlorophenyl)ethynyl)-9<i>H</i>-purin-9-yl)-2,3-dihydroxy-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>13</b>)</h4><div class="NLM_p last">A solution of compound <b>32b</b> (33 mg, 0.052 mmol) in methanol (3 mL) and 10% trifluoromethanesulfonic acid (2.5 mL) was heated at 70 °C overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 25:1) to give the compound <b>13</b> (22 mg, 75%) as a colorless syrup and no C6-methyl product was identified in this reaction. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.43, s, 1H), (7.79, d 6.0, 1H), (7.67, d 6.8, 1H), (7.60, d 7.2, 1H), (7.53–7.49, m, 2H), (7.48–7.42, m, 3H), (6.47, s, 1H), (5.13, d 5.6, 1H), (5.00, s, 1H), (4.13, d 6.4, 1H), (2.84, s, 3H), (2.18–2.14, m, 1H), (1.88, t 5.2, 1H), (1.44–1.40, m, 1H). HRMS calculated for C<sub>29</sub>H<sub>24</sub>N<sub>5</sub>O<sub>4</sub>Cl<sub>2</sub> (M + H)<sup>+</sup>, 576.1205; found, 576.1208.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(6-((Z)-2-(4-(<i>tert</i>-Butyl)phenyl)-2-hydroxyvinyl)-2-(4-(<i>tert</i>-butyl) phenyl)ethynyl)-9<i>H</i>-purin-9-yl)-2,3-dihydroxy-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>14</b>)</h4><div class="NLM_p">A solution of compound <b>32c</b> (24 mg, 0.035 mmol) in methanol (2.5 mL) and 10% trifluoromethanesulfonic acid (2.5 mL) was heated at 70 °C overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 30:1) to give the compound <b>14</b> (12 mg, 55%) as a colorless syrup. Column was further eluted with (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 15:1) to give the C6-methyl compound <b>1</b>7 (2.8 mg, 17%) as colorless syrup.</div><div id="sec4_2_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Compound <b>14</b></h5><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.36, s, 1H), (7.92, d 8.8, 1H), (7.63, d 8.8, 1H), (7.55–7.52, m, 4H), (6.75, s, 1H), (5.10, d 6.6, 1H), (4.95, s, 1H), (4.11, d 6.8, 1H), (2.85, s, 3H), (2.17–2.13, m, 1H), (1.88, t 5.2, 1H), (1.38, s, 18H). HRMS calculated for C<sub>37</sub>H<sub>42</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 620.3237; found, 620.3232.</div></div><div id="sec4_2_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> Compound <b>17</b></h5><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.51, s, 1H), (7.62, d 8.4, 1H), (7.52, d 8.4, 1H), (5.15, d 6.4, 1H), (5.00, s, 1H), (4.11, d 6.8, 1H), (2.86, s, 3H), (2.83, s, 3H), (2.16–2.13, m, 1H), (1.88, t 5.2, 1H), (1.44–1.40, m, 1H), (1.37, s, 9H). HRMS calculated for C<sub>26</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 460.2349; found, 460.2341.</div></div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((3,4-Difluorophenyl)ethynyl)-6-methyl-9<i>H</i>-purin-9-yl)-2,3-dihydroxy-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>16</b>)</h4><div class="NLM_p last">A solution of compound <b>38a</b> (20 mg, 0.041 mmol) in methanol (2 mL) and 10% trifluoromethanesulfonic acid (2 mL) was heated at 70 °C for 5 h. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 20:1) to give the compound <b>16</b> (16 mg, 89%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.52, s, 1H), (7.64–7.61, m, 1H), (7.55–7.50, m, 1H), (7.43–7.36, m, 1H), (5.14, d 6.8, 1H), (5.00, s, 1H), (4.11, d 5.6, 1H), (2.84, s, 3H), (2.83, s, 3H), (2.16–2.12, m, 1H), (1.88, t 5.2, 1H), (1.43–1.39, m, 1H). HRMS calculated for C<sub>22</sub>H<sub>20</sub>N<sub>5</sub>O<sub>3</sub>F<sub>2</sub> (M + H)<sup>+</sup>, 440.1534; found, 440.1530.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-2,3-Dihydroxy-<i>N</i>-methyl-4-(6-methyl-2-(pyrazin-2-ylethynyl)-9<i>H</i>-purin-9-yl)bicyclo[3.1.0]hexane-1-carboxamide (<b>18</b>)</h4><div class="NLM_p last">Compound <b>18</b> (91%) was prepared from compound <b>38b</b> following the same method as for compound <b>16</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.95, s, 1H), (8.71, d 2.4, 1H), (8.66, d 2.4, 1H), (8.57, s, 1H), (5.20, d 6.8, 1H), (5.01, s, 1H), (4.13, d 5.6, 1H), (2.86, s, 3H), (2.85, s, 3H), (2.16–2.12, m, 1H), (1.86, t 5.2, 1H), (1.44–1.40, m, 1H). HRMS calculated for C<sub>20</sub>H<sub>20</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 406.1628; found, 406.1621.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-methyl-9<i>H</i>-purin-9-yl)-2,3-dihydroxy-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>19</b>)</h4><div class="NLM_p last">Compound <b>19</b> (93%) was prepared from compound <b>38c</b> following the same method as for compound <b>16</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.52, s, 1H), (7.36, d 4.0, 1H), (7.05, d 4.0, 1H), (5.12, d 6.4, 1H), (4.99, s, 1H), (4.10, d 5.6, 1H), (2.88, s, 3H), (2.81, s, 3H), (2.16–2.12, m, 1H), (1.87, t 5.2, 1H), (1.43–1.39, m, 1H). HRMS calculated for C<sub>20</sub>H<sub>19</sub>N<sub>5</sub>O<sub>3</sub>ClS (M + H)<sup>+</sup>, 444.0897; found, 444.0899.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((3,4-Difluorophenyl)ethynyl)-9<i>H</i>-purin-9-yl)-2,3-dihydroxy-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>20</b>)</h4><div class="NLM_p last">A solution of compound <b>42a</b> (25 mg, 0.053 mmol) in methanol (3 mL) and 10% trifluoromethanesulfonic acid (2.5 mL) was heated at 70 °C for 5 h. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 20:1) to give the compound <b>20</b> (19 mg, 85%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (9.10, s, 1H), (8.60, s, 1H), (7.64, t 8.4, 1H), (7.54–7.51, m, 1H), (7.43–7.36, m, 1H), (5.15, d 6.4, 1H), (5.03, s, 1H), (4.12, d 6.4, 1H), (2.84, s, 3H), (2.17–2.14, m, 1H), (1.89, t 5.2, 1H), (1.44–1.40, m, 1H). HRMS calculated for C<sub>21</sub>H<sub>18</sub>N<sub>5</sub>O<sub>3</sub>F<sub>2</sub> (M + H)<sup>+</sup>, 426.1378; found, 426.1385.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-9<i>H</i>-purin-9-yl)-2,3-dihydroxy-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>21</b>)</h4><div class="NLM_p last">Compound <b>21</b> (83%) was prepared from compound <b>42b</b> following the same method for compound <b>20</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (9.09, s, 1H), (8.59, s, 1H), (7.38, d 4.0, 1H), (7.05, d 4.0, 1H), (5.13, d 6.4, 1H), (5.02, s, 1H), (4.11, d 6.4, 1H), (2.88, s, 3H), (2.17–2.14, m, 1H), (1.88, t 4.8, 1H), (1.44–1.40, m, 1H). HRMS calculated for C<sub>19</sub>H<sub>17</sub>N<sub>5</sub>O<sub>3</sub>SCl (M + H)<sup>+</sup>, 430.0741; found, 430.0734.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-methoxy-9<i>H</i>-purin-9-yl)-2,3-dihydroxy-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>22</b>)</h4><div class="NLM_p last">Dowex 50 (H<sup>+</sup> form, 18 mg) was added to a solution of compound <b>51</b> (18 mg, 0.036 mmol) in MeOH (1 mL)-water (0.6 mL) and the mixture heated at 70 °C for 2.5 h. Reaction mixture was filtered, the filtrate was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 25:1) to give the compound <b>22</b> (14 mg, 88%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.34, s, 1H), (7.35, d 4.0, 1H), (7.04, d 4.0, 1H), (5.09, d 6.2, 1H), (4.96, s, 1H), (4.21, s, 3H), (4.07, d 7.4 Hz 1H), (2.87, s, 3H), (2.15–2.11, m, 1H), (1.87, t 5.2, 1H), (1.42–1.38, m, 1H). HRMS calculated for C<sub>20</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H)<sup>+</sup>, 460.0846; found, 460.0852.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-2,3-Dihydroxy-<i>N</i>-methyl-4-(2-(methylamino)-9<i>H</i>-purin-9-yl)bicycle[3.1.0]hexane-1-carboxamide (<b>23</b>)</h4><div class="NLM_p last">A solution of compound <b>40</b> (145 mg, 0.40 mmol) in methanol (4 mL) and 10% trifluoromethanesulfonic acid (4 mL) was heated at 70 °C for 5 h. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 8:1) to give the compound <b>23</b> (106 mg, 83%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.61, s, 1H), (8.16, s, 1H), (5.18, d 6.8, 1H), (4.8, s, 1H), (4.15, d 6.2, 1H), (2.99, s, 3H), (2.83, s, 3H), (2.13–2.10, m, 1H), (1.78, d 5.2, 1H), (1.38–1.34, m, 1H). HRMS calculated for C<sub>14</sub>H<sub>19</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 319.1513; found, 319.1511.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-2,3-Dihydroxy-4-(2-((<i>Z</i>)-2-hydroxy-2-(pyrazin-2-yl)vinyl)-9<i>H</i>-purin-9-yl)-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> (72%) was prepared from compound <b>43</b> following the same method for compound <b>20</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.12, d 1.2, 1H), (9.08, s, 1H), (8.68, d 2.4, 1H), (8.62, d 2.4, 1H), (8.46, s, 1H), (7.01, s, 1H), (5.26, d 6.4, 1H), (4.98, s, 1H), (4.13, d 6.4, 1H), (3.0, s, 3H), (2.16–2.13, m, 1H), (1.85, t 5.2, 1H), (1.44–1.40, m, 1H). HRMS calculated for C<sub>19</sub>H<sub>20</sub>N<sub>7</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 410.1577; found, 410.1576.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2,6-Bis(phenylethynyl)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>31a</b>)</h4><div class="NLM_p last">PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (28 mg, 0.4 mmol), CuI (3.8 mg, 0.02 mmol), phenylacetylene (0.13 mL, 1.2 mmol), and triethylamine (0.28 mL, 2.0 mmol) was added to a solution of compound <b>28</b> (101 mg, 0.2 mmol) in anhydrous DMF (4 mL) and the mixture stirred at room temperature overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (hexane:ethyl acetate = 1:1) to give the compound <b>31a</b> (91.8 mg, 84.2%) as a brownish glassy solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) (8.14, s, 1H), (7.71–7.75, m, 4H), (7.44–7.41, m, 6H), (5.95, d 7.2, 1H), (5.08, s, 1H), (4.81, d 7.2, 1H), (4.25–4.22, m, 2H), (2.32–2.29, m, 1H), (1.82–1.78, m, 1H), (1.64–1.60, m, 4H), (1.33, s, 3H), (1.22, t 7.2, 3H). HRMS calculated for C<sub>33</sub>H<sub>29</sub>N<sub>4</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 545.2189; found, 545.2197.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2,6-Bis((2-chlorophenyl)ethynyl)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>31b</b>)</h4><div class="NLM_p last">Compound <b>31b</b> (82%) was prepared from compound <b>28</b> following the same method for compound <b>31a</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.65, s, 1H), (7.91–7.56, m, 2H), (7.53–7.51, m, 2H), (7.50–7.40, m, 4H), (5.98, d 7.2, 1H), (5.18, s, 1H), (5.01, d 7.2, 1H), (4.21–4.10, m, 2H), (2.43–2.39, m, 1H), (1.74–1.70, m, 1H), (1.60–1.56, m, 4H), (1.31, s, 3H), (1.15, t 7.2, 3H). HRMS calculated for C<sub>33</sub>H<sub>27</sub>N<sub>4</sub>O<sub>4</sub>Cl<sub>2</sub> (M + H)<sup>+</sup>, 613.1409; found, 613.1400.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2,6-Bis((4-(<i>tert</i>-butyl)phenyl)ethynyl)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>31c</b>)</h4><div class="NLM_p last">Compound <b>31c</b> (85%) was prepared from compound <b>28</b> following the same method for compound <b>31a</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.61, s, 1H), (7.72, dd 11.2:2.8, 4H), (7.54, dd 11.2:2.8, 4H), (5.97, d 6.8, 1H), (5.16, s, 1H), (4.96, d 7.2, 1H), (4.27–4.17, m, 2H), (2.43–2.39, m, 1H), (1.75–1.71, m, 1H), (1.60–1.56, m, 4H), (1.38, s, 18H), (1.32, s, 3H), (1.18, d 7.2, 3H). HRMS calculated for C<sub>41</sub>H<sub>45</sub>N<sub>4</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 657.3441; found, 657.3446.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-<i>N</i>,2,2-Trimethyl-5-(6-((<i>Z</i>)-2-(methylamino)-2-phenylvinyl)-2-(phenylethynyl)-9<i>H</i>-purin-9-yl)tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>32a</b>)</h4><div class="NLM_p last">Methylamine solution (40%, 5 mL) was added to a solution of compound <b>31a</b> (97 mg, 0.173 mmol) in methanol (6 mL) and the mixture stirred at room temperature overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 40:1) to give the compound <b>32a</b> (67.4 mg, 68%) as a yellowish syrup. NMR (CD<sub>3</sub>OD, δC:49.2), (500 MHz) (δH:δC, H- multiplicity, <i>J</i> Hz, H-integral) (1.30:24.7, s, 3H), (1.42:17.7, t 5.5, 1H), (1.54:26.5, s, 3H), (1.54:17.7, ddd, 1H), (2.18:36.9, ddd 9.4:5.5:1.5, 1H), (2.76:27.5, s, 3H), (2.97:32.2, s, 3H), (4.89:90.7, ddd 7.1:1.7:0.4, 1H), (4.95:61.9, s, 1H), (5.67:89.3, s, 1H), (5.81:83.1, dd 7.1:1.1, 1H), (7.43–7.51:129.4, 129.8, 130.0, 130.6, 130.7, m, 8H), (7.69–7.73:133.6, m, 2H), (8.22:143.4, s, 1H); NH in CDCl<sub>3</sub> (7.38, q), (10.25, q); δCq 42.8, 85.6, 90.4, 114.0, 123.6, 128.0, 138.2, 146.8, 149.4, 158.6, 164.7, 174.4. HRMS calculated for C<sub>33</sub>H<sub>33</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 561.2614; found, 561.2612.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(6-((<i>Z</i>)-2-(2-Chlorophenyl)-2-(methylamino)vinyl)-2-((2-chloro phenyl)ethynyl)-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta [1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>32b</b>)</h4><div class="NLM_p last">Compound <b>32b</b> (71%) was prepared from compound <b>31b</b> following the same method for compound <b>32a</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) (10.41, br s, 1H), (7.86, s, 1H), (7.72, d 6.0, 1H), (7.53, d 6.8, 1H), (7.48, d 6.0, 1H), (7.42–7.38, m, 5H), (5.83, d 6.8, 1H), (5.69, s, 1H), (4.91, t 7.2, 1H), (4.86, s, 1H), (2.91, d 5.2, 3H), (2.83, d 4.8, 3H), (2.04–1.97, m, 1H), (1.72–1.69, m, 1H), (1.58, s, 3H), (1.32–1.24, m, 4H). HRMS calculated for C<sub>33</sub>H<sub>31</sub>N<sub>6</sub>O<sub>3</sub>Cl<sub>2</sub> (M + H)<sup>+</sup>, 629.1829; found, 629.1835.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(6-((<i>Z</i>)-2-(4-(<i>tert</i>-Butyl)phenyl)-2-(methylamino)vinyl)-2-(4-(<i>tert</i>-butyl)phenyl)ethynyl)-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclo-propa[3,4]cyclopenta [1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>32c</b>)</h4><div class="NLM_p last">Compound <b>32c</b> (70%) was prepared from compound <b>31c</b> following the same method for compound <b>32a</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) (10.30, br s, 1H), (7.84, s, 1H), (7.62, d 8.4, 2H), (7.47–7.44, m, 8H), (5.82, d 7.2, 1H), (5.80, s, 1H), (4.89, d 6.0, 1H), (4.85, s, 1H), (3.04, d 5.2, 3H), (2.86, d 4.8, 3H), (2.01–1.97, m, 1H), (1.72–1.68, m, 1H), (1.58, s, 3H), (1.37, s, 18H), (1.31–1.24, m, 4H). HRMS calculated for C<sub>41</sub>H<sub>49</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 673.3866; found, 673.3876.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-Chloro-6-(phenylethynyl)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>34</b>)</h4><div class="NLM_p last">PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (13.8 mg, 0.02 mmol), CuI (1.9 mg, 0.01 mmol), phenylacetylene (64 μL, 0.58 mmol), and triethylamine (0.13 mL, 0.98 mmol) was added to a solution of compound <b>33</b> (40.6 mg, 0.098 mmol) in anhydrous DMF (1.5 mL) and the mixture stirred at room temperature overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (hexane:ethyl acetate = 2:1) to give the compound <b>34</b> (40.4 mg, 86%) as a colorless glassy syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.59, s, 1H), (7.80, d 8.0, 2H), (7.53–7.50, m, 3H), (5.88, d 7.2, 1H), (5.13, s, 1H) (4.28–4.25, m, 2H), (2.40–2.36, m, 1H), (1.73–1.70, m, 1H), (1.59–1.55, m, 4H), (1.34, t 7.2, 3H), (1.30, s, 3H). HRMS calculated for C<sub>25</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub>Cl (M + H)<sup>+</sup>, 479.1481; found, 479.1482.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-Iodo-6-methyl-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>36</b>)</h4><div class="NLM_p last">DIAD (0.23 mL, 1.2 mmol) was added to a solution of triphenylphosphine (0.326 g, 1.242 mmol) and 2-iodo-6-methylpurine <b>54</b> (0.234 g, 0.9 mmol) in dry THF (4 mL) at 0 °C, and after addition it was stirred at room temperature for 10 min. A solution of compound <b>35</b> (0.145 g, 0.6 mmol) in THF (2 mL) was added to the reaction mixture and stirred overnight at room temperature. Solvent was evaporated, and the residue was purified on flash silica gel column chromatography (hexane:ethyl acetate = 1:1) to give the compound <b>36</b> (0.243 g, 84%) as a colorless foamy solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.36, s, 1H), (5.85, d 6.4, 1H), (5.06, s, 1H), (4.88, d 6.8, 1H), (4.34–4.29, m, 2H), (2.74, s, 3H), (2.32–2.28, m, 1H), (1.68–1.64, m, 1H), (1.55–1.53, m, 4H), (1.34, t 7.2, 3H), (1.29, s, 3H). HRMS calculated for C<sub>18</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>I (M + H)<sup>+</sup>, 485.0686; found, 485.0684.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-Iodo-6-methyl-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>37</b>)</h4><div class="NLM_p last">Methylamine solution (40%, 5 mL) was added to a solution of compound <b>36</b> (288 mg, 0.595 mmol) in methanol (5 mL) and the mixture stirred at room temperature for 24 h. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 35:1) to give the compound <b>37</b> (184 mg, 66%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.38, s, 1H), (5.75, d 7.2, 1H), (5.05, s, 1H), (4.90, d 6.8, 1H), (2.91, s, 3H), (2.74, s, 3H), (2.21–2.17, m, 1H), (1.55–1.51, m, 4H), (1.43, t 5.2, 1H), (1.30, s, 3H). HRMS calculated for C<sub>17</sub>H<sub>21</sub>N<sub>5</sub>O<sub>3</sub>I (M + H)<sup>+</sup>, 470.0689; found, 470.0694.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-((3,4-Difluorophenyl)ethynyl)-6-methyl-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>38a</b>)</h4><div class="NLM_p last">PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (6.37 mg, 0.01 mmol), (CuI (1 mg, 0.005 mmol), (3,4-difluoro-phenylacetylene (32 μL, 0.27 mmol), and triethylamine (63 μL, 0.45 mmol) was added to a solution of compound <b>37</b> (21 mg, 0.045 mmol) in anhydrous DMF (1.2 mL), and stirred at room temperature overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (hexane:ethyl acetate = 1:1) to give the compound <b>38a</b> (20 mg, 92%) as a yellowish syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.54, s, 1H), (7.75–7.70, m, 1H), (7.61–7.57, m, 1H), (7.43–7.37, m, 1H), (5.86, d 6.8, 1H), (5.13, s, 1H), (4.93, d 7.2, 1H), (2.83, s, 3H), (2.78, s, 3H), (2.24–2.19, m, 1H), (1.58–1.55, m, 4H), (1.47, t 5.2, 1H), (1.31, s, 3H). HRMS calculated for C<sub>25</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>F<sub>2</sub> (M + H)<sup>+</sup>, 480.1847; found, 480.1849.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-<i>N</i>,2,2-Trimethyl-5-(6-methyl-2-(pyrazin-2-ylethynyl)-9<i>H</i>-purin-9-yl)tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>38b</b>)</h4><div class="NLM_p last">Compound <b>38b</b> (86%) was prepared from compound <b>37</b> following the same method for compound <b>38a</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (9.01, d 1.2, 1H), (8.73–8.72, m, 1H), (8.68, d 2.4, 1H), (8.57, s, 1H), (5.93, d 7.2, 1H), (5.14, s, 1H), (4.97, d 7.2, 1H), (2.84, s, 3H), (2.80, s, 3H), (2.23–2.17, m, 1H), (1.61–1.56, m, 4H), (1.47, t 5.2, 1H), (1.32, s, 3H). HRMS calculated for C<sub>23</sub>H<sub>24</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 446.1941; found, 446.1942.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-methyl-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>38c</b>)</h4><div class="NLM_p last">Compound <b>38c</b> (89%) was prepared from compound <b>37</b> following the same method for compound <b>38a</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.53, s, 1H), (7.43, d 4.0, 1H), (7.06, d 4.0, 1H), (5.84, d 7.2, 1H), (5.1, s, 1H), (4.92, d 6.8, 1H), (2.83, s, 3H), (2.81, s, 3H), (2.22–2.18, m, 1H), (1.59–1.56, m, 4H), (1.46, d 5.2, 1H), (1.34, s, 3H). HRMS calculated for C<sub>23</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub>ClS (M + H)<sup>+</sup>, 484.1210; found, 484.1204.</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-Iodo-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>39</b>)</h4><div class="NLM_p last">DIAD (0.196 mL, 1.0 mmol) was added to a solution of triphenylphosphine (0.261 g, 1.0 mmol) and 2-iodo-purine (0.184 g, 0.75 mmol) in dry THF (4 mL) at 0 °C, and after addition it was stirred at room temperature for 10 min. A solution of compound <b>35</b> (0.121 g, 0.5 mmol) in THF (2 mL) was added to the reaction mixture and stirred overnight at room temperature. Solvent was evaporated, and the residue was purified on flash silica gel column chromatography (hexane:ethyl acetate = 2:1) to give the compound <b>39</b> (0.181 g, 72%) as a colorless foamy solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.83, s, 1H), (8.44, s, 1H), (5.85, d 7.2, 1H), (5.09, s, 1H), (4.89, d 7.2, 1H), (4.36–4.30, m, 2H), (2.35–2.31, m, 1H), (1.69–1.65, m, 1H), (1.56–1.54, m, 4H), (1.34, t 7.2, 3H), (1.29, s, 3H). HRMS calculated for C<sub>17</sub>H<sub>20</sub>N<sub>4</sub>O<sub>4</sub>I (M + H)<sup>+</sup>, 471.0524; found, 471.0523.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-<i>N</i>,2,2-Trimethyl-5-(2-(methylamino)-9<i>H</i>-purin-9-yl)tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>40</b>)</h4><div class="NLM_p last">Methylamine solution (40%, 4 mL) was added to a solution of compound <b>39</b> (460 mg, 0.97 mmol) in methanol (4 mL) and the mixture stirred at room temperature for 24 h. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 30:1) to give the compound <b>40</b> (224 mg, 64%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.56, s, 1H), (8.05, s, 1H), (5.80, d 7.2, 1H), (4.96–4.94, m, 2H), (2.96, s, 3H), (2.77, s, 3H), (2.25–2.22, m, 1H), (1.55, s, 3H), (1.52–1.48, m, 1H), (1.42, t 5.2, 1H), (1.31, s, 3H). HRMS calculated for C<sub>17</sub>H<sub>23</sub>N<sub>6</sub>O<sub>3</sub> (M + H<sup>+</sup>, 359.2002; found, 359.2001.</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-((3,4-Difluorophenyl)ethynyl)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>41a</b>)</h4><div class="NLM_p last">Compound <b>41a</b> (84%) was prepared from compound <b>39</b> following the same method for compound <b>38a</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (9.08, s, 1H), (8.59, s, 1H), (7.76–7.21, m, 1H), (7.68–7.57, m, 3H), (7.44–7.37, m, 1H), (5.96, d 7.2, 1H), (5.17, s, 1H), (4.90, d 7.2, 1H), (4.25–4.14, m, 2H), (2.41–2.37, m, 1H), (1.76–1.73, m, 1H), (1.61, t 5.6, 1H), (1.56, s, 3H), (1.30, s, 3H), (1.18, t 6.8, 3H). HRMS calculated for C<sub>25</sub>H<sub>23</sub>N<sub>4</sub>O<sub>4</sub>F<sub>2</sub> (M + H)<sup>+</sup>, 481.1687; found, 481.1689.</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-((5-Chlorothiophen-2-yl)ethynyl)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>41b</b>)</h4><div class="NLM_p last">Compound <b>41b</b> (87%) was prepared from compound <b>39</b> following the same method for compound <b>38a</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (9.07, s, 1H), (8.58, s, 1H), (7.54, d 4.0, 1H), (7.05, d 4.0, 1H), (5.93, d 7.2, 1H), (5.16, s, 1H), (4.91, d 7.2, 1H), (4.30–4.20, m, 2H), (2.40–2.36, m, 1H), (1.76–1.72, m, 1H), (1.59, t 5.2, 1H), (1.55, s, 3H), (1.29, s, 3H), (1.23, t 7.2, 3H). HRMS calculated for C<sub>23</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>SCl (M + H)<sup>+</sup>, 485.1050; found, 485.1042.</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-2,2-Dimethyl-5-(2-(pyrazin-2-ylethynyl)-9<i>H</i>-purin-9-yl)tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>41c</b>)</h4><div class="NLM_p last">Compound <b>41c</b> (82%) was prepared from compound <b>39</b> following the same method for compound <b>38a</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (9.14, s, 1H), (9.06, s, 1H), (8.71, d 6.8, 1H), (8.66, d 2.8, 1H), (8.62, s, 1H), (5.97, d 7.2, 1H), (5.18, s, 1H), (4.92, d 7.2, 1H), (4.28–4.22, m, 2H), (2.42–2.38, m, 1H), (1.76–1.72, m, 1H), (1.59, t 5.2, 1H), (1.56, s, 3H), (1.30, s, 3H), (1.20, t 7.2, 3H). HRMS calculated for C<sub>23</sub>H<sub>23</sub>N<sub>6</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 447.1781; found, 447.1775.</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-((3,4-Difluorophenyl)ethynyl)-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>42a</b>)</h4><div class="NLM_p last">Compound <b>42a</b> (68%) was prepared from compound <b>39</b> following the same method for compound <b>37</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (9.10, s, 1H), (8.60, s, 1H), (7.75–7.70, m, 1H), (7.61–7.58, m, 1H), (7.43–7.37, m, 1H), (5.87, d 7.2, 1H), (5.16, s, 1H), (4.94, d 6.4, 1H), (2.78, s, 3H), (2.26–2.22, m, 1H), (1.60–1.57, m, 4H), (1.49, t 5.2, 1H), (1.32, s, 3H). HRMS calculated for C<sub>24</sub>H<sub>22</sub>N<sub>5</sub>O<sub>3</sub>F<sub>2</sub> (M + H)<sup>+</sup>, 466.1691; found, 466.1689.</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-((5-Chlorothiophen-2-yl)ethynyl)-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>42b</b>)</h4><div class="NLM_p last">Compound <b>42b</b> (66%) was prepared from compound <b>39</b> following the same method for compound <b>37</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (9.08, s, 1H), (8.60, s, 1H), (7.44, d 4.0, 1H), (7.06, d 4.0, 1H), (5.85, d 7.2, 1H), (5.15, s, 1H), (4.93, d 7.2, 1H), (2.84, s, 3H), (2.25–2.21, m, 1H), (1.60–1.57, m, 4H), (1.48, t 5.2, 1H), (1.31, s, 3H). HRMS calculated for C<sub>22</sub>H<sub>21</sub>N<sub>5</sub>O<sub>3</sub>SCl (M + H)<sup>+</sup>, 470.1054; found, 470.1047.</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-N,2,2-Trimethyl-5-(2-((<i>Z</i>)-2-(methylamino)-2-(pyrazin-2-yl)vinyl)-9<i>H</i>-purin-9-yl)tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>43</b>)</h4><div class="NLM_p last">Methylamine solution (40%, 1.5 mL) was added to a solution of compound <b>41c</b> (21 mg, 0.044 mmol) in methanol (2 mL) and the mixture stirred at room temperature for 24 h. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 25:1) to give the compound <b>43</b> (12.8 mg, 62%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.98, s, 1H), (8.91, d 1.6, 1H), (8.73, s, 1H), (8.68, d 2.4, 1H), (8.36, s, 1H), (5.75, d 7.2, 1H), (5.59, s, 1H), (5.07, s, 1H), (4.92, d 7.2, 1H), (2.92, s, 3H), (2.71, d 2.8, 3H), (2.34–2.28, m, 1H), (1.62–1.56, m, 4H), (1.47, d 5.2, 1H), (1.29, s, 3H). HRMS calculated for C<sub>23</sub>H<sub>27</sub>N<sub>8</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 463.2206; found, 463.2208.</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Methyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-Iodo-6-methoxy-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>44</b>)</h4><div class="NLM_p last">Sodium methoxide (24 mg, 0.44 mmol) was added to a solution of compound <b>28</b> (45 mg, 0.09 mmol) in methanol (2 mL) and the mixture stirred at room temperature overnight. The reaction mixture was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (hexane:ethyl acetate = 1:1) to give the compound <b>44</b> (11 mg, 25%) as a colorless powder. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.21, s, 1H), (5.85, d 6.8, 1H), (5.04, s, 1H), (4.88, d 6.8, 1H), (4.15, s, 3H), (3.85, s, 3H), (2.31–2.27, m, 1H), (1.68–1.65, m, 1H), (1.57–1.51, m, 4H), (<b>1.29</b>, m, 3H). HRMS calculated for C<sub>17</sub>H<sub>20</sub>N<sub>4</sub>O<sub>5</sub>I (M + H)<sup>+</sup>, 487.0478; found, 487.0482.</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-Iodo-6-(methylamino)-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>45</b>)</h4><div class="NLM_p last">40% Methylamine solution (0.5 mL) was added to a solution of compound <b>44</b> (11 mg, 0.022 mmol) in methanol (0.5 mL) and the mixture stirred at room temperature overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 35:1) to give the compound <b>45</b> (7.4 mg, 68%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (7.95, s, 1H), (5.72, d 7.2, 1H), (4.93, s, 1H), (4.84, d 7.2, 1H), (3.05, br s, 3H), (2.90, s, 3H), (2.15–2.11, m, 1H), (1.54–1.49, m, 4H), (1.39, t 5.2, 1H), (1.30, s, 3H). HRMS calculated for C<sub>17</sub>H<sub>22</sub>N<sub>6</sub>O<sub>3</sub>I (M + H)<sup>+</sup>, 485.0798; found, 485.0798.</div></div><div id="sec4_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 9-(3a<i>R</i>,3b<i>R</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-3b-(((<i>tert</i>-Butyldiphenylsilyl)oxy)methyl)-2,2-dimethylhexahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxol-5-yl)-2-iodo-6-methoxy-9<i>H</i>-purine (<b>47</b>)</h4><div class="NLM_p last">Sodium methoxide (77.8 mg, 1.44 mmol) was added to a solution of compound <b>46</b> (202 mg, 0.28 mmol) in methanol (5 mL) and the mixture stirred at room temperature for 1.5 h. The reaction mixture was evaporated under vacuum, and the residue was partitioned with ethyl acetate and water. Combined organic layer was dried, filtered, and evaporated, and the residue was purified on flash silica gel column chromatography (hexane:ethyl acetate = 2:1) to give the compound <b>47</b> (192 mg, 96%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.26, s, 1H), (7.67–7.59, m, 4H), (7.40–7.23, m, 6H), (5.28, d 6.8, 1H), (4.97, s, 1H), (4.78, d 6.8, 1H), (4.16, s, 3H), (4.14, d 10.8, 1H), (4.02, d 10.8, 1H), (1.57–1.53, m, 4H), (1.25, s, 3H), (1.10–1.05, m, 11H). HRMS calculated for C<sub>32</sub>H<sub>38</sub>N<sub>4</sub>O<sub>4</sub>SiI (M + H)<sup>+</sup>, 697.1707; found, 697.1710.</div></div><div id="sec4_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> ((3a<i>R</i>,3b<i>R</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-Iodo-6-methoxy-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxol-3b(3a<i>H</i>)-yl)methanol (<b>48</b>)</h4><div class="NLM_p last">Tetrabutylammonium fluoride (0.41 mL, 1 M solution in THF) was added to a solution of compound <b>47</b> (192 mg, 0.27 mmol) in dry THF (4 mL) and the mixture stirred at room temperature for 1 h. Solvent was evaporated, and residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 30:1) to give the compound <b>48</b> (115 mg, 91%) as a syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.38, s, 1H), (5.35, d 7.2, 1H), (5.02, s, 1H), (4.75, d 6.8, 1H), (4.16, s, 3H), (3.92, d 11.6, 1H), (3.79, d 11.6, 1H), (1.70–1.66, m, 1H), (1.53, s, 3H), (1.27, s, 3H), (1.15, t 5.2, 1H), (1.03–0.99, m, 1H). HRMS calculated for C<sub>16</sub>H<sub>20</sub>N<sub>4</sub>O<sub>4</sub>I (M + H)<sup>+</sup>, 459.0529; found, 459.0526.</div></div><div id="sec4_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-Iodo-6-methoxy-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylic Acid (<b>49</b>)</h4><div class="NLM_p last">PDC (567 mg, 1.5 mmol) was added to a solution of compound <b>48</b> (115 mg, 0.25 mmol) in dry DMF (2 mL) and the mixture heated at 40 °C overnight. After completion of starting material, water (10 mL) was added into the reaction mixture and extracted with ethyl acetate (3 × 10 mL). Combined organic layer was washed with brine (15 mL), dried, filtered, and evaporated, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 20:1) to give the compound <b>49</b> (91 mg, 72%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.20, s, 1H), (5.85, d 7.2, 1H), (5.04, s, 1H), (4.85, d 6.8, 1H), (4.15, s, 3H), (2.28–2.24, m, 1H), (1.70–1.66, m, 1H), (1.54–1.52, m, 4H), (1.29, s, 3H). HRMS calculated for C<sub>16</sub>H<sub>18</sub>N<sub>4</sub>O<sub>5</sub>I (M + H)<sup>+</sup>, 474.0322; found, 474.0321.</div></div><div id="sec4_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-Iodo-6-methoxy-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>50</b>)</h4><div class="NLM_p last">MeNH<sub>2</sub> (53 μL, 2 M solution in THF) and DIPEA (22 μL, 0.12 mmol) were added to a solution of compound <b>49</b> (46 mg, 0.09 mmol) and HATU (48.15 mg, 0.12 mmol) in dry DMF (1.5 mL). The reaction mixture was stirred at room temperature overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 60:1) to give the compound <b>50</b> (31 mg, 67%) as a colorless powder. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.22, s, 1H), (5.75, d 7.2, 1H), (5.02, s, 1H), (4.87, d 6.8, 1H), (4.15, s, 3H), (2.90, d 3.6, 3H)), (2.20–2.15, m, 1H), (1.55–1.51, m, 4H), (1.42, t 5.2, 1H), (1.31, s, 3H). HRMS calculated for C<sub>17</sub>H<sub>21</sub>N<sub>5</sub>O<sub>4</sub>I (M + H)<sup>+</sup>, 486.0638; found, 486.0644.</div></div><div id="sec4_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-methoxy-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>51</b>)</h4><div class="NLM_p last">PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (8.96 mg, 0.01 mmol), (CuI (1 mg, 0.006 mmol), (2-chloro-5-ethynylthiophene (54.6 mg, 0.38 mmol), and triethylamine (90 μL, 0.45 mmol) was added to a solution of compound <b>50</b> (31 mg, 0.063 mmol) in anhydrous DMF (1.2 mL) and stirred at room temperature overnight. Solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 40:1) to give the compound <b>51</b> (24 mg, 77%) as a yellowish syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.37, s, 1H), (7.42, d 4.0, 1H), (7.05, d 4.0, 1H), (5.82, d 6.4, 1H), (5.09, s, 1H), (4.90, d 7.0, 1H), (4.20, s, 3H), (2.82, d 4.4, 3H), (2.21–2.17, m, 1H), (1.58–1.55, m, 4H), (1.45, t 5.2, 1H), (1.31, s, 3H). HRMS calculated for C<sub>23</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H)<sup>+</sup>, 500.1159; found, 500.1150.</div></div><div id="sec4_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-Iodo-9-(4-methoxybenzyl)-6-methyl-9<i>H</i>-purine (<b>53</b>)</h4><div class="NLM_p last">CuI (558 mg, 3.04 mmol), iodine (704 mg, 2.77 mmol), CH<sub>2</sub>I<sub>2</sub> (2.23 mL, 27.7 mmol), and isoamyl nitrite (1.12 mL, 8.33 mmol) were added to a solution of compound <b>52</b> (747 mg, 2.77 mmol) in dry THF (30 mL) and refluxed at 80 °C for 1.5 h. Water was added into the reaction mixture, and the aqueous layer was extracted with ethyl acetate. The combined organic layer was washed with saturated sodium bisulfite solution followed by brine, dried, filtered, and evaporated under vacuum. The residue was purified on flash silica gel column chromatography (hexane:ethyl acetate = 2:1) to give the compound <b>53</b> (736 mg, 58%) as a colorless powder. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.35, s, 1H), (8.34, d 8.8, 2H), (6.91, d 8.8, 2H), (4.87, s, 2H), (3.78, s, 3H), (2.73, s, 3H). HRMS calculated for C<sub>14</sub>H<sub>14</sub>N<sub>4</sub>OI (M + H)<sup>+</sup>, 460.0846; found, 460.0852.</div></div><div id="sec4_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-Iodo-6-methyl-9<i>H</i>-purine (<b>54</b>)</h4><div class="NLM_p last">A solution of compound <b>53</b> (1.00 g, 2.17 mmol) in TFA (14 mL)–CH<sub>2</sub>l<sub>2</sub> (2 mL) was heated at 50 °C overnight. Solvent was evaporated, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 30:1) to give the compound <b>54</b> (519 mg, 92%) as a colorless powder. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) (8.40, s, 1H), (2.75, s, 3H). HRMS calculated for C<sub>6</sub>H<sub>6</sub>N<sub>4</sub>I (M + H)<sup>+</sup>, 260.9637; found, 260.9628.</div></div><div id="sec4_2_42_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Human AR Binding and A<sub>3</sub>AR Activation</h4><div class="NLM_p last">Radioligand binding was performed as described (footnote a of <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and agonism at the hA<sub>3</sub>AR was measured as described<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> in CHO cells expressing the hA<sub>3</sub>AR.</div></div><div id="sec4_2_42_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Mouse A<sub>3</sub>AR Binding and Activation</h4><div class="NLM_p last">Binding of agonist radioligand (<b>27</b>) at the mA<sub>3</sub>AR was performed as described,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and agonism at the mA<sub>3</sub>AR was measured as described<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> in HEK293 cells expressing the mA<sub>3</sub>AR.</div></div><div id="sec4_2_42_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Chronic Neuropathic Pain Model</h4><div class="NLM_p last">As in our previous reports,<a onclick="showRef(event, 'ref6 ref32'); return false;" href="javascript:void(0);" class="ref ref6 ref32">(6, 32)</a> adenosine agonists were dissolved in vehicle and administered by oral gavage (po, 3 μmol/kg, ∼ 0.2 mL, <i>n</i> = 3) to mice (Harlan, Indianapolis, IN, USA); on day 7, the time peak pain was reached following ligation of the sciatic nerve, as described by Bennett and colleagues.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The vehicle consisted of 10% DMSO in 0.5% methylcellulose, diluted from a 5 mM stock solution in DMSO). Methylcellulose (lot no. 021M0067 V) was obtained from Sigma Viscosity 400 cP and prepared in sterile distilled water (UPS). The PWT (g) of the ipsilateral hind paw was measured as a function of time following drug administration. This time course allowed the assessment of duration of action and indirectly indicated sufficient bioavailability when protection was observed. All in vivo experiments were performed by methods described<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and in accordance with the International Association for the Study of Pain and the National Institutes of Health guidelines on laboratory animal welfare and the recommendations by Saint Louis University Institutional Animal Care and Use Committee. All experiments were conducted with the experimenters blinded to treatment conditions.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Molecular Modeling</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> hA<sub>3</sub>AR Homology Model</h4><div class="NLM_p last">In this study, we used a previously published hA<sub>3</sub>AR homology model<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> based upon a hybrid template structure and built by means of the homology modeling tool implemented in the MOE suite.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In particular, the agonist-bound hA<sub>2A</sub>AR crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAK">3QAK</a>)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> was selected as a template for the entire A<sub>3</sub>AR structure except for the extracellular terminus of TM2 (residues from Val63 to Ser73) and EL1 (residues from Leu74 to Tyr81). The X-ray structure of the hβ<sub>2</sub> adrenergic receptor in complex with the Gs protein (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SN6">3SN6</a>),<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> after superimposition with the hA<sub>2A</sub>AR crystal structure, was set as template for the extracellular terminus of TM2. No structural templates were used to model the EL1. Details of the modeling procedure have been previously described.<a onclick="showRef(event, 'ref7 ref32'); return false;" href="javascript:void(0);" class="ref ref7 ref32">(7, 32)</a></div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Molecular Docking of (<i>N</i>)-Methanocarba C6 Substituted Purine Nucleoside Derivatives</h4><div class="NLM_p last">The ligands were built with the build panel implemented in the Schrödinger suite and prepared for docking with LigPrep.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> Molecular docking of the ligands at the hA<sub>3</sub>AR model was performed by means of the Glide<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> package part of the Schrödinger suite. The docking site was defined centering a 20 Å × 20 Å × 20 Å box on key residues of the hA<sub>3</sub>AR binding pocket, namely Phe168 (EL2), Asn250 (6.55), Trp243 (6.48), and His272 (7.43). Docking of ligands was carried out in the rigid binding site using the XP (extra precision) procedure with post-docking refinement of the obtained poses. The top ranked conformations of each ligand were subjected to visual inspection and analysis of protein–ligand interactions to select the final binding pose.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Analysis of Ligand–Receptor Interactions</h4><div class="NLM_p last">Per residue electrostatic and van der Waals interaction scores (hereby denoted as IS<sub>ele</sub> and IS<sub>vdW</sub>, respectively) were computed as implemented in Glide.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> By means of in-house bash scripts and Gnuplot 4.6, the scores were converted into heat-like maps (interaction scores maps, ISMs), highlighting key residues involved in the binding along with a quantitative estimate of the occurring interaction scores reported in kcal/mol and rendered with a color code (the more intense and blue/green-shifted the color, the better the interaction).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01998">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01998" class="ext-link">10.1021/acs.jmedchem.5b01998</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">NMR analysis and mass spectra of selected synthesized compounds, results of PDSP screening, and supplementary chemical schemes (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Video related to <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_004.avi" class="ext-link">AVI</a>)</p></li><li><p class="inline">3D coordinates of the modeled hA<sub>3</sub>AR complex with <b>15</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_005.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">3D coordinates of the modeled hA<sub>3</sub>AR complex with <b>21</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_006.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf">jm5b01998_si_001.pdf (4.7 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_002.csv">jm5b01998_si_002.csv (1.92 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_004.avi">jm5b01998_si_004.avi (6.38 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_005.pdb">jm5b01998_si_005.pdb (188.45 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_006.pdb">jm5b01998_si_006.pdb (188.37 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01998" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth A. Jacobson</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Bioorganic Chemistry, National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes
of Health, Building 8A,
Room B1A-19, Bethesda, Maryland 20892-0810, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dfb4beb5bebcb0bdac9fb7bab3b6a7f1b1b6b7f1b8b0a9"><span class="__cf_email__" data-cfemail="18737972797b777a6b58707d74716036767170367f776e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dilip K. Tosh</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Bioorganic Chemistry, National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes
of Health, Building 8A,
Room B1A-19, Bethesda, Maryland 20892-0810, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonella Ciancetta</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Bioorganic Chemistry, National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes
of Health, Building 8A,
Room B1A-19, Bethesda, Maryland 20892-0810, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugene Warnick</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Bioorganic Chemistry, National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes
of Health, Building 8A,
Room B1A-19, Bethesda, Maryland 20892-0810, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert O’Connor</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Bioorganic Chemistry, National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes
of Health, Building 8A,
Room B1A-19, Bethesda, Maryland 20892-0810, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhoumou Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri 63104, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Gizewski</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin  53226, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Crane</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Bioorganic Chemistry, National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes
of Health, Building 8A,
Room B1A-19, Bethesda, Maryland 20892-0810, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhan-Guo Gao</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Bioorganic Chemistry, National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes
of Health, Building 8A,
Room B1A-19, Bethesda, Maryland 20892-0810, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. Auchampach</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin  53226, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Salvemini</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri 63104, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1622e5267-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77820" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77820" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the NIH Intramural Research Program (NIDDK, ZIA DK031117-28); National Cancer Institute (R01CA169519) and National Heart Lung Institute (R01HL077707 and R01HL111392) for support and John Lloyd and Noel Whittaker (NIDDK) for mass spectral determinations. We thank Dr. Bryan L. Roth (University of North Carolina at Chapel Hill) and National Institute of Mental Health’s Psychoactive Drug Screening Program (contract no. HHSN-271-2008-00025-C) for screening data.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i74" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i74"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i75" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i75"> Abbreviations Used</h2><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">adenosine receptor</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">adenosine 3′,5′-cyclic monophosphate</p></td></tr><tr><td class="NLM_term">CCI</td><td class="NLM_def"><p class="first last">chronic constriction injury</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle Medium</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">EL</td><td class="NLM_def"><p class="first last">extracellular loop</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HMBC</td><td class="NLM_def"><p class="first last">heteronuclear multiple bond correlation</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high resolution mass spectroscopy</p></td></tr><tr><td class="NLM_term">IS<sub>ele</sub></td><td class="NLM_def"><p class="first last">per residue interaction score, electrostatic</p></td></tr><tr><td class="NLM_term">IS<sub>vdW</sub></td><td class="NLM_def"><p class="first last">per residue interaction score, van der Waals</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PDC</td><td class="NLM_def"><p class="first last">pyridinium dichromate</p></td></tr><tr><td class="NLM_term">PDSP</td><td class="NLM_def"><p class="first last">Psychoactive Drug Screening Program</p></td></tr><tr><td class="NLM_term">PWT</td><td class="NLM_def"><p class="first last">paw withdrawal threshold</p></td></tr><tr><td class="NLM_term">RMS</td><td class="NLM_def"><p class="first last">root-mean-square</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–affinity relationship</p></td></tr><tr><td class="NLM_term">TBAP</td><td class="NLM_def"><p class="first last">tetrabutylammonium dihydrogen phosphate</p></td></tr><tr><td class="NLM_term">TBDPS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldiphenylsilyl</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane helix</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53774" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53774" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor: History and perspectives</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span><span class="refDoi"> DOI: 10.1124/pr.113.008540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1124%2Fpr.113.008540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=25387804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=74-102&author=P.+A.+Boreaauthor=K.+Varaniauthor=F.+Vincenziauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Merighiauthor=S.+Gessi&title=The+A3+adenosine+receptor%3A+History+and+perspectives&doi=10.1124%2Fpr.113.008540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor: history and perspectives</span></div><div class="casAuthors">Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Merighi, Stefania; Gessi, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-102, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  By general consensus, the omnipresent purine nucleoside adenosine is considered a major regulator of local tissue function, esp. when energy supply fails to meet cellular energy demand.  Adenosine mediation involves activation of a family of four G protein-coupled adenosine receptors (ARs): A1, A2A, A2B, and A3.  The A3 adenosine receptor (A3AR) is the only adenosine subtype to be overexpressed in inflammatory and cancer cells, thus making it a potential target for therapy.  Originally isolated as an orphan receptor, A3AR presented a twofold nature under different pathophysiol. conditions: it appeared to be protective/harmful under ischemic conditions, pro/anti-inflammatory, and pro/antitumoral depending on the systems investigated.  Until recently, the greatest and most intriguing challenge has been to understand whether, and in which cases, selective A3 agonists or antagonists would be the best choice.  Today, the choice has been made and A3AR agonists are now under clin. development for some disorders including rheumatoid arthritis, psoriasis, glaucoma, and hepatocellular carcinoma.  More specifically, the interest and relevance of these new agents derives from clin. data demonstrating that A3AR agonists are both effective and safe.  Thus, it will become apparent in the present review that purine scientists do seem to be getting closer to their goal: the incorporation of adenosine ligands into drugs with the ability to save lives and improve human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNTebUcia2x7Vg90H21EOLACvtfcHk0ljJ3aokpSxmMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D&md5=152673d44c951624ccb2ef090ffc670c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.113.008540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.113.008540%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DGessi%26aufirst%3DS.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%253A%2520History%2520and%2520perspectives%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26spage%3D74%26epage%3D102%26doi%3D10.1124%2Fpr.113.008540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Stoilov, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licheva, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihaylova, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitblat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrov, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimbova, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pispati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurman- Balbir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagaria, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oparanov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpaz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farbstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Therapeutic effect of oral CF101 in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled Phase II study</span> <span class="citation_source-journal">Immunome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">087</span><span class="refDoi"> DOI: 10.4172/1745-7580.1000087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.4172%2F1745-7580.1000087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=087&author=R.+M.+Stoilovauthor=R.+N.+Lichevaauthor=M.+K.+Mihaylovaauthor=T.+Reitblatauthor=E.+A.+Dimitrovauthor=K.+M.+Shimbovaauthor=G.+Bhatiaauthor=A.+Pispatiauthor=A.+Gurman-+Balbirauthor=B.+R.+Bagariaauthor=B.+A.+Oparanovauthor=S.+Fishmanauthor=Z.+Harpazauthor=M.+Farbsteinauthor=S.+Cohenauthor=D.+Bristolauthor=M.+H.+Silvermanauthor=P.+Fishman&title=Therapeutic+effect+of+oral+CF101+in+patients+with+rheumatoid+arthritis%3A+A+randomized%2C+double-blind%2C+placebo-controlled+Phase+II+study&doi=10.4172%2F1745-7580.1000087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4172%2F1745-7580.1000087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F1745-7580.1000087%26sid%3Dliteratum%253Aachs%26aulast%3DStoilov%26aufirst%3DR.%2BM.%26aulast%3DLicheva%26aufirst%3DR.%2BN.%26aulast%3DMihaylova%26aufirst%3DM.%2BK.%26aulast%3DReitblat%26aufirst%3DT.%26aulast%3DDimitrov%26aufirst%3DE.%2BA.%26aulast%3DShimbova%26aufirst%3DK.%2BM.%26aulast%3DBhatia%26aufirst%3DG.%26aulast%3DPispati%26aufirst%3DA.%26aulast%3DGurman-%2BBalbir%26aufirst%3DA.%26aulast%3DBagaria%26aufirst%3DB.%2BR.%26aulast%3DOparanov%26aufirst%3DB.%2BA.%26aulast%3DFishman%26aufirst%3DS.%26aulast%3DHarpaz%26aufirst%3DZ.%26aulast%3DFarbstein%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DBristol%26aufirst%3DD.%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DTherapeutic%2520effect%2520of%2520oral%2520CF101%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%253A%2520A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520Phase%2520II%2520study%26jtitle%3DImmunome%2520Res.%26date%3D2014%26volume%3D11%26spage%3D087%26doi%3D10.4172%2F1745-7580.1000087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Little, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons-Liguori, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luongo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maione, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickenson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">Endogenous adenosine A<sub>3</sub> receptor activation selectively alleviates persistent pain states</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1093/brain/awu330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1093%2Fbrain%2Fawu330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=25414036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A280%3ADC%252BC2M3pvFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2015&pages=28-35&author=J.+W.+Littleauthor=A.+Fordauthor=A.+M.+Symons-Liguoriauthor=Z.+Chenauthor=K.+Janesauthor=T.+Doyleauthor=J.+Xieauthor=L.+Luongoauthor=D.+K.+Toshauthor=S.+Maioneauthor=K.+Bannisterauthor=A.+Dickensonauthor=T.+W.+Vanderahauthor=F.+Porrecaauthor=K.+A.+Jacobsonauthor=D.+Salvemini&title=Endogenous+adenosine+A3+receptor+activation+selectively+alleviates+persistent+pain+states&doi=10.1093%2Fbrain%2Fawu330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states</span></div><div class="casAuthors">Little Joshua W; Ford Amanda; Chen Zhoumou; Janes Kali; Doyle Timothy; Salvemini Daniela; Symons-Liguori Ashley M; Xie Jennifer; Vanderah Todd W; Porreca Frank; Luongo Livio; Maione Sabatino; Tosh Dillip K; Jacobson Kenneth A; Bannister Kirsty; Dickenson Anthony H</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">Pt 1</span>),
    <span class="NLM_cas:pages">28-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic pain is a global burden that promotes disability and unnecessary suffering.  To date, efficacious treatment of chronic pain has not been achieved.  Thus, new therapeutic targets are needed.  Here, we demonstrate that increasing endogenous adenosine levels through selective adenosine kinase inhibition produces powerful analgesic effects in rodent models of experimental neuropathic pain through the A3 adenosine receptor (A3AR, now known as ADORA3) signalling pathway.  Similar results were obtained by the administration of a novel and highly selective A3AR agonist.  These effects were prevented by blockade of spinal and supraspinal A3AR, lost in A3AR knock-out mice, and independent of opioid and endocannabinoid mechanisms.  A3AR activation also relieved non-evoked spontaneous pain behaviours without promoting analgesic tolerance or inherent reward.  Further examination revealed that A3AR activation reduced spinal cord pain processing by decreasing the excitability of spinal wide dynamic range neurons and producing supraspinal inhibition of spinal nociception through activation of serotonergic and noradrenergic bulbospinal circuits.  Critically, engaging the A3AR mechanism did not alter nociceptive thresholds in non-neuropathy animals and therefore produced selective alleviation of persistent neuropathic pain states.  These studies reveal A3AR activation by adenosine as an endogenous anti-nociceptive pathway and support the development of A3AR agonists as novel therapeutics to treat chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTV_nDN4yfcy0Q0lWbKiCflfW6udTcc2eav-PDQkSK777ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3pvFersw%253D%253D&md5=85411b662ffef21c0fc58f0549845716</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawu330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawu330%26sid%3Dliteratum%253Aachs%26aulast%3DLittle%26aufirst%3DJ.%2BW.%26aulast%3DFord%26aufirst%3DA.%26aulast%3DSymons-Liguori%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJanes%26aufirst%3DK.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DBannister%26aufirst%3DK.%26aulast%3DDickenson%26aufirst%3DA.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DEndogenous%2520adenosine%2520A3%2520receptor%2520activation%2520selectively%2520alleviates%2520persistent%2520pain%2520states%26jtitle%3DBrain%26date%3D2015%26volume%3D138%26spage%3D28%26epage%3D35%26doi%3D10.1093%2Fbrain%2Fawu330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doré, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurrell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhukov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span> </span><span class="NLM_article-title">Discovery of 1,2,4-triazine derivatives as adenosine A<sub>2A</sub> antagonists using structure based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1898</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span><span class="refDoi"> DOI: 10.1021/jm201376w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201376w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1898-1903&author=M.+Congreveauthor=S.+P.+Andrewsauthor=A.+S.+Dor%C3%A9author=K.+Hollensteinauthor=E.+Hurrellauthor=C.+J.+Langmeadauthor=J.+S.+Masonauthor=I.+W.+Ngauthor=B.+Tehanauthor=A.+Zhukovauthor=M.+P.+Weirauthor=F.+H.+Marshall&title=Discovery+of+1%2C2%2C4-triazine+derivatives+as+adenosine+A2A+antagonists+using+structure+based+drug+design&doi=10.1021%2Fjm201376w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design</span></div><div class="casAuthors">Congreve, Miles; Andrews, Stephen P.; Dore, Andrew S.; Hollenstein, Kaspar; Hurrell, Edward; Langmead, Christopher J.; Mason, Jonathan S.; Ng, Irene W.; Tehan, Benjamin; Zhukov, Andrei; Weir, Malcolm; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1898-1903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, ligand efficient, selective, and orally efficacious 1,2,4-triazine derivs. have been identified using structure based drug design approaches as antagonists of the adenosine A2A receptor.  The X-ray crystal structures of compds. 4e and 4g (I) bound to the GPCR illustrate that the mols. bind deeply inside the orthosteric binding cavity.  In vivo pharmacokinetic and efficacy data for compd. 4k are presented, demonstrating the potential of this series of compds. for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpddydZvtRPv7Vg90H21EOLACvtfcHk0lhzteQnZ88cdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D&md5=71d76db8a22bf82f11d3632d2917e155</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm201376w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201376w%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3DHurrell%26aufirst%3DE.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DNg%26aufirst%3DI.%2BW.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DWeir%26aufirst%3DM.%2BP.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DDiscovery%2520of%25201%252C2%252C4-triazine%2520derivatives%2520as%2520adenosine%2520A2A%2520antagonists%2520using%2520structure%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1898%26epage%3D1903%26doi%3D10.1021%2Fjm201376w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heitman, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegal, G.</span><span> </span><span class="NLM_article-title">Fragment screening of GPCRs using biophysical methods: identification of ligands of the adenosine A<sub>2A</sub> Receptor with novel biological activity</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2064</span><span class="NLM_x">–</span> <span class="NLM_lpage">2073</span><span class="refDoi"> DOI: 10.1021/cb300436c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300436c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWhtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=2064-2073&author=D.+Chenauthor=J.+C.+Erreyauthor=L.+H.+Heitmanauthor=F.+H.+Marshallauthor=A.+P.+IJzermanauthor=G.+Siegal&title=Fragment+screening+of+GPCRs+using+biophysical+methods%3A+identification+of+ligands+of+the+adenosine+A2A+Receptor+with+novel+biological+activity&doi=10.1021%2Fcb300436c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment Screening of GPCRs Using Biophysical Methods: Identification of Ligands of the Adenosine A2A Receptor with Novel Biological Activity</span></div><div class="casAuthors">Chen, Dan; Errey, James C.; Heitman, Laura H.; Marshall, Fiona H.; IJzerman, Adriaan P.; Siegal, Gregg</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2064-2073</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery (FBDD) has proven a powerful method to develop novel drugs with excellent oral bioavailability against challenging pharmaceutical targets such as protein-protein interaction targets.  Very recently the underlying biophys. techniques have begun to be successfully applied to membrane proteins.  Here we show that novel, ligand efficient small mols. with a variety of biol. activities can be found by screening a small fragment library using thermostabilized (StaR) G protein-coupled receptors (GPCRs) and target immobilized NMR screening (TINS).  Detergent-solubilized StaR adenosine A2A receptor was immobilized with retention of functionality, and a screen of 531 fragments was performed.  Hits from the screen were thoroughly characterized for biochem. activity using the wild-type receptor.  Both orthosteric and allosteric modulatory activity has been demonstrated in biochem. validation assays.  Allosteric activity was confirmed in cell-based functional assays.  The validated fragment hits make excellent starting points for a subsequent hit-to-lead elaboration program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1XViW7Pwl9bVg90H21EOLACvtfcHk0lgKmn-JHxGbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWhtbbL&md5=100b470e43c452b4fef8b9cf1637cfcd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fcb300436c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300436c%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DSiegal%26aufirst%3DG.%26atitle%3DFragment%2520screening%2520of%2520GPCRs%2520using%2520biophysical%2520methods%253A%2520identification%2520of%2520ligands%2520of%2520the%2520adenosine%2520A2A%2520Receptor%2520with%2520novel%2520biological%2520activity%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D2064%26epage%3D2073%26doi%3D10.1021%2Fcb300436c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">In vivo phenotypic screening for treating chronic neuropathic pain: Modification of C2-arylethynyl group of conformationally constrained A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9901</span><span class="NLM_x">–</span> <span class="NLM_lpage">9914</span><span class="refDoi"> DOI: 10.1021/jm501021n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501021n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9901-9914&author=D.+K.+Toshauthor=A.+Finleyauthor=S.+Paolettaauthor=S.+M.+Mossauthor=Z.+G.+Gaoauthor=E.+Gizewskiauthor=J.+Auchampachauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=In+vivo+phenotypic+screening+for+treating+chronic+neuropathic+pain%3A+Modification+of+C2-arylethynyl+group+of+conformationally+constrained+A3+adenosine+receptor+agonists&doi=10.1021%2Fjm501021n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Phenotypic Screening for Treating Chronic Neuropathic Pain: Modification of C2-Arylethynyl Group of Conformationally Constrained A3 Adenosine Receptor Agonists</span></div><div class="casAuthors">Tosh, Dilip K.; Finley, Amanda; Paoletta, Silvia; Moss, Steven M.; Gao, Zhan-Guo; Gizewski, Elizabeth T.; Auchampach, John A.; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9901-9914</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(N)-Methanocarba adenosine 5'-methyluronamides contg. 2-arylethynyl groups were synthesized as A3 adenosine receptor (AR) agonists and screened in vivo (po) for redn. of neuropathic pain.  A small N6-Me group maintained binding affinity, with human > mouse A3AR and MW < 500 and other favorable physicochem. properties.  Emax (maximal efficacy in a mouse chronic constriction injury pain model) of previously characterized A3AR agonist, 2-(3,4-difluorophenylethynyl)-N6-(3-chlorobenzyl) deriv. 6a, MRS5698, was surpassed.  More efficacious analogs (in vivo) contained the following C2-arylethynyl groups: pyrazin-2-yl 23 (binding Ki, hA3AR, nM 1.8), fur-2-yl 27 (0.6), thien-2-yl 32 (0.6) and its 5-chloro 33, MRS5980 (0.7) and 5-bromo 34 (0.4) equiv., and physiol. unstable ferrocene 36, MRS5979 (2.7). 33 and 36 displayed particularly long in vivo duration (>3 h).  Selected analogs were docked to an A3AR homol. model to explore the environment of receptor-bound C2 and N6 groups.  Various analogs bound with μM affinity at off-target biogenic amine (M2, 5HT2A, β3, 5HT2B, 5HT2C, and α2C) or other receptors.  Thus, we have expanded the structural range of orally active A3AR agonists for chronic pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQCo4JjAXTTLVg90H21EOLACvtfcHk0lgKmn-JHxGbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrjF&md5=d9f3f36c4c107a289cef7f4deb9b70ce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm501021n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501021n%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DFinley%26aufirst%3DA.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DMoss%26aufirst%3DS.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DIn%2520vivo%2520phenotypic%2520screening%2520for%2520treating%2520chronic%2520neuropathic%2520pain%253A%2520Modification%2520of%2520C2-arylethynyl%2520group%2520of%2520conformationally%2520constrained%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9901%26epage%3D9914%26doi%3D10.1021%2Fjm501021n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure-guided design of A<sub>3</sub> adenosine receptor-selective nucleosides: Combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4847</span><span class="NLM_x">–</span> <span class="NLM_lpage">4860</span><span class="refDoi"> DOI: 10.1021/jm300396n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300396n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4847-4860&author=D.+K.+Toshauthor=F.+Deflorianauthor=K.+Phanauthor=Z.+G.+Gaoauthor=T.+C.+Wanauthor=E.+Gizewskiauthor=J.+A.+Auchampachauthor=K.+A.+Jacobson&title=Structure-guided+design+of+A3+adenosine+receptor-selective+nucleosides%3A+Combination+of+2-arylethynyl+and+bicyclo%5B3.1.0%5Dhexane+substitutions&doi=10.1021%2Fjm300396n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of A3 Adenosine Receptor-Selective Nucleosides: Combination of 2-Arylethynyl and Bicyclo[3.1.0]hexane Substitutions</span></div><div class="casAuthors">Tosh, Dilip K.; Deflorian, Francesca; Phan, Khai; Gao, Zhan-Guo; Wan, Tina C.; Gizewski, Elizabeth; Auchampach, John A.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4847-4860</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(N)-Methanocarba adenosine 5'-methyluronamides contg. known A3 AR (adenosine receptor)-enhancing modifications, i.e., 2-(arylethynyl)adenine and N6-Me or N6-(3-substituted-benzyl), were nanomolar full agonists of human (h) A3AR and highly selective (Ki ∼0.6 nM, N6-Me 2-(halophenylethynyl) analogs).  Combined 2-arylethynyl-N6-3-chlorobenzyl substitutions preserved A3AR affinity/selectivity in the (N)-methanocarba series (e.g., 3,4-difluoro full agonist MRS5698, Ki 3 nM, human and mouse A3) better than that for ribosides.  Polyarom. 2-ethynyl N6-3-chlorobenzyl analogs, such as potent linearly extended 2-p-biphenylethynyl MRS5679 (Ki hA3 3.1 nM; A1, A2A, inactive) and fluorescent 1-pyrene adduct MRS5704 (Ki hA3 68.3 nM), were conformationally rigid; receptor docking identified a large, mainly hydrophobic binding region.  The vicinity of receptor-bound C2 groups was probed by homol. modeling based on recent x-ray structure of an agonist-bound A2AAR, with a predicted helical rearrangement requiring an agonist-specific outward displacement of TM2 resembling opsin.  Thus, the x-ray structure of related A2AAR is useful in guiding the design of new A3AR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMpTThMrry7bVg90H21EOLACvtfcHk0lgKmn-JHxGbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFygu74%253D&md5=e01c27247742c9d20ee7ff753a2de88c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm300396n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300396n%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DWan%26aufirst%3DT.%2BC.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-guided%2520design%2520of%2520A3%2520adenosine%2520receptor-selective%2520nucleosides%253A%2520Combination%2520of%25202-arylethynyl%2520and%2520bicyclo%255B3.1.0%255Dhexane%2520substitutions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4847%26epage%3D4860%26doi%3D10.1021%2Fjm300396n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chubukov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heitman, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structural basis for allosteric regulation of GPCRs by sodium ions</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span><span class="refDoi"> DOI: 10.1126/science.1219218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1126%2Fscience.1219218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=22798613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVKqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2012&pages=232-236&author=W.+Liuauthor=E.+Chunauthor=A.+A.+Thompsonauthor=P.+Chubukovauthor=F.+Xuauthor=V.+Katritchauthor=G.+W.+Hanauthor=C.+B.+Rothauthor=L.+H.+Heitmanauthor=A.+P.+IJzermanauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structural+basis+for+allosteric+regulation+of+GPCRs+by+sodium+ions&doi=10.1126%2Fscience.1219218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions</span></div><div class="casAuthors">Liu, Wei; Chun, Eugene; Thompson, Aaron A.; Chubukov, Pavel; Xu, Fei; Katritch, Vsevolod; Han, Gye Won; Roth, Christopher B.; Heitman, Laura H.; IJzerman, Adriaan P.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">6091</span>),
    <span class="NLM_cas:pages">232-236</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Pharmacol. responses of G protein-coupled receptors (GPCRs) can be fine-tuned by allosteric modulators.  Structural studies of such effects have been limited due to the medium resoln. of GPCR structures.  We reengineered the human A2A adenosine receptor by replacing its third intracellular loop with apocytochrome b562RIL and solved the structure at 1.8 angstrom resoln.  The high-resoln. structure allowed us to identify 57 ordered water mols. inside the receptor comprising three major clusters.  The central cluster harbors a putative sodium ion bound to the highly conserved aspartate residue Asp2.50.  Addnl., two cholesterols stabilize the conformation of helix VI, and one of 23 ordered lipids intercalates inside the ligand-binding pocket.  These high-resoln. details shed light on the potential role of structured water mols., sodium ions, and lipids/cholesterol in GPCR stabilization and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvcjQimGnIMLVg90H21EOLACvtfcHk0lgarRF6d6E5Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVKqtbs%253D&md5=782b2235b76ef77b11b6456f8e4485e1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1219218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1219218%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DChubukov%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DRoth%26aufirst%3DC.%2BB.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520basis%2520for%2520allosteric%2520regulation%2520of%2520GPCRs%2520by%2520sodium%2520ions%26jtitle%3DScience%26date%3D2012%26volume%3D337%26spage%3D232%26epage%3D236%26doi%3D10.1126%2Fscience.1219218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R.</span><span> </span><span class="NLM_article-title">Agonist bound structure of the human adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1126/science.1202793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1126%2Fscience.1202793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=21393508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFWjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2011&pages=322-327&author=F.+Xuauthor=H.+Wuauthor=V.+Katritchauthor=G.+W.+Hanauthor=K.+A.+Jacobsonauthor=Z.+G.+Gaoauthor=V.+Cherezovauthor=R.+Stevens&title=Agonist+bound+structure+of+the+human+adenosine+A2A+receptor&doi=10.1126%2Fscience.1202793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of an Agonist-Bound Human A2A Adenosine Receptor</span></div><div class="casAuthors">Xu, Fei; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Jacobson, Kenneth A.; Gao, Zhan-Guo; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">6027</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Activation of G protein-coupled receptors upon agonist binding is a crit. step in the signaling cascade for this family of cell surface proteins.  We report the crystal structure of the A2A adenosine receptor (A2AAR) bound to an agonist UK-432097 at 2.7 angstrom resoln.  Relative to inactive, antagonist-bound A2AAR, the agonist-bound structure displays an outward tilt and rotation of the cytoplasmic half of helix VI, a movement of helix V, and an axial shift of helix III, resembling the changes assocd. with the active-state opsin structure.  Addnl., a seesaw movement of helix VII and a shift of extracellular loop 3 are likely specific to A2AAR and its ligand.  The results define the mol. UK-432097 as a "conformationally selective agonist" capable of receptor stabilization in a specific active-state configuration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMkD1ni9m9GrVg90H21EOLACvtfcHk0lgarRF6d6E5Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFWjt7s%253D&md5=b1e074f38f45c95d4cc3b40378b24923</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1202793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1202793%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%26atitle%3DAgonist%2520bound%2520structure%2520of%2520the%2520human%2520adenosine%2520A2A%2520receptor%26jtitle%3DScience%26date%3D2011%26volume%3D332%26spage%3D322%26epage%3D327%26doi%3D10.1126%2Fscience.1202793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lebon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, C. G.</span><span> </span><span class="NLM_article-title">Agonist-bound adenosine A<sub>2A</sub> receptor structures reveal common features of GPCR activation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">474</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span><span class="refDoi"> DOI: 10.1038/nature10136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1038%2Fnature10136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=21593763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFyqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=474&publication_year=2011&pages=521-525&author=G.+Lebonauthor=T.+Warneauthor=P.+C.+Edwardsauthor=K.+Bennettauthor=C.+J.+Langmeadauthor=A.+G.+Leslieauthor=C.+G.+Tate&title=Agonist-bound+adenosine+A2A+receptor+structures+reveal+common+features+of+GPCR+activation&doi=10.1038%2Fnature10136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation</span></div><div class="casAuthors">Lebon, Guillaume; Warne, Tony; Edwards, Patricia C.; Bennett, Kirstie; Langmead, Christopher J.; Leslie, Andrew G. W.; Tate, Christopher G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">474</span>
        (<span class="NLM_cas:issue">7352</span>),
    <span class="NLM_cas:pages">521-525</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adenosine receptors and β-adrenoceptors are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins on binding the agonists adenosine or noradrenaline, resp.  GPCRs have similar structures consisting of seven transmembrane helixes that contain well-conserved sequence motifs, indicating that they are probably activated by a common mechanism.  Recent structures of β-adrenoceptors highlight residues in transmembrane region 5 that initially bind specifically to agonists rather than to antagonists, indicating that these residues have an important role in agonist-induced activation of receptors.  Here we present two crystal structures of the thermostabilized human adenosine A2A receptor (A2AR-GL31) bound to its endogenous agonist adenosine and the synthetic agonist NECA.  The structures represent an intermediate conformation between the inactive and active states, because they share all the features of GPCRs that are thought to be in a fully activated state, except that the cytoplasmic end of transmembrane helix 6 partially occludes the G-protein-binding site.  The adenine substituent of the agonists binds in a similar fashion to the chem. related region of the inverse agonist ZM241385 (ref. 8).  Both agonists contain a ribose group, not found in ZM241385, which extends deep into the ligand-binding pocket where it makes polar interactions with conserved residues in H7 (Ser 2777.42 and His 2787.43; superscripts refer to Ballesteros-Weinstein numbering) and non-polar interactions with residues in H3.  In contrast, the inverse agonist ZM241385 does not interact with any of these residues and comparison with the agonist-bound structures indicates that ZM241385 sterically prevents the conformational change in H5 and therefore it acts as an inverse agonist.  Comparison of the agonist-bound structures of A2AR with the agonist-bound structures of β-adrenoceptors indicates that the contraction of the ligand-binding pocket caused by the inward motion of helixes 3, 5 and 7 may be a common feature in the activation of all GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1rCKkCsE9CrVg90H21EOLACvtfcHk0lgarRF6d6E5Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFyqsrg%253D&md5=1b8161216b878db48ad33d7e8e007dc7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature10136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10136%26sid%3Dliteratum%253Aachs%26aulast%3DLebon%26aufirst%3DG.%26aulast%3DWarne%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DBennett%26aufirst%3DK.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DTate%26aufirst%3DC.%2BG.%26atitle%3DAgonist-bound%2520adenosine%2520A2A%2520receptor%2520structures%2520reveal%2520common%2520features%2520of%2520GPCR%2520activation%26jtitle%3DNature%26date%3D2011%26volume%3D474%26spage%3D521%26epage%3D525%26doi%3D10.1038%2Fnature10136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaakola, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span> </span><span class="NLM_article-title">Structure-based discovery of novel chemotypes for adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1799</span><span class="NLM_x">–</span> <span class="NLM_lpage">1809</span><span class="refDoi"> DOI: 10.1021/jm901647p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901647p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlKqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1799-1809&author=V.+Katritchauthor=V.+P.+Jaakolaauthor=J.+R.+Laneauthor=J.+Linauthor=A.+P.+IJzermanauthor=M.+Yeagerauthor=I.+Kufarevaauthor=R.+C.+Stevensauthor=R.+Abagyan&title=Structure-based+discovery+of+novel+chemotypes+for+adenosine+A2A+receptor+antagonists&doi=10.1021%2Fjm901647p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Novel Chemotypes for Adenosine A2A Receptor Antagonists</span></div><div class="casAuthors">Katritch, Vsevolod; Jaakola, Veli-Pekka; Lane, J. Robert; Lin, Judy; IJzerman, Adriaan P.; Yeager, Mark; Kufareva, Irina; Stevens, Raymond C.; Abagyan, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1799-1809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent progress in crystallog. of G-protein coupled receptors opens an unprecedented venue for structure-based GPCR drug discovery.  To test efficiency of the structure-based approach, we performed mol. docking and virtual ligand screening (VLS) of more than 4 million com. available "drug-like" and "lead-like" compds. against the A2AAR 2.6 Å resoln. crystal structure.  Out of 56 high ranking compds. tested in A2AAR binding assays, 23 showed affinities under 10 μM, 11 of those had sub-μM affinities and two compds. had affinities under 60 nM.  The identified hits represent at least 9 different chem. scaffolds and are characterized by very high ligand efficiency (0.3-0.5 kcal/mol per heavy atom).  Significant A2AAR antagonist activities were confirmed for 10 out of 13 ligands tested in functional assays.  High success rate, novelty, and diversity of the chem. scaffolds and strong ligand efficiency of the A2AAR antagonists identified in this study suggest practical applicability of receptor-based VLS in GPCR drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX-YAwoEVzEbVg90H21EOLACvtfcHk0lhWl2n3jaN0bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlKqsw%253D%253D&md5=5a54df43f6edd20d83e7e5942e2f9811</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm901647p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901647p%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DJaakola%26aufirst%3DV.%2BP.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DYeager%26aufirst%3DM.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DStructure-based%2520discovery%2520of%2520novel%2520chemotypes%2520for%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1799%26epage%3D1809%26doi%3D10.1021%2Fjm901647p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Integrated methods for the construction of three dimensional models and computational probing of structure-function relationships in G-protein coupled receptors</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1016/S1043-9471(05)80049-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=366-428&author=J.+A.+Ballesterosauthor=H.+Weinstein&title=Integrated+methods+for+the+construction+of+three+dimensional+models+and+computational+probing+of+structure-function+relationships+in+G-protein+coupled+receptors&doi=10.1016%2FS1043-9471%2805%2980049-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span></div><div class="casAuthors">Ballesteros, Juan A.; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">366-428</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review, with 135 refs., on approaches that can be used to resolve the apparent ambiguities that burden the pharmacol. testing of G protein-coupled receptor (GPCR) models, based on the integration of structural information about the receptor, about mutants, and about the changes induced by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfENoRspqa7LVg90H21EOLACvtfcHk0lhWl2n3jaN0bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D&md5=d3f99e9d07cea245a770f3f099bc8cc7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three%2520dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure-function%2520relationships%2520in%2520G-protein%2520coupled%2520receptors%26jtitle%3DMethods%2520Neurosci.%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428%26doi%3D10.1016%2FS1043-9471%2805%2980049-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bruns, R. F.</span><span> </span><span class="NLM_article-title">Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists</span> <span class="citation_source-journal">Can. J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1139/y80-110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1139%2Fy80-110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=6253037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADyaL3cXls1Sqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1980&pages=673-691&author=R.+F.+Bruns&title=Adenosine+receptor+activation+in+human+fibroblasts%3A+nucleoside+agonists+and+antagonists&doi=10.1139%2Fy80-110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor activation in human fibroblasts:  nucleoside agonists and antagonists</span></div><div class="casAuthors">Bruns, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">673-91</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    </div><div class="casAbstract">Adenosine  [58-61-7] (ED50 15 μM) causes a 50-fold increase in intracellular cyclic AMP in the VA13 human fibroblast line.  A total of 128 nucleosides was tested as agonists and antagonists.  Eight classes of compds. were found: full agonists (14 compds.), weak agonists (20), high-efficacy partial agonists (16), low-efficacy partial agonists (7), competitive inhibitors (11), noncompetitive inhibitors (3), partial agonist - noncompetitive inhibitors (3), and inactive compds. (54).  The noncompetitive inhibitors antagonized the responses to adenosine, isoproterenol, and prostaglandin E1 and thus may have been adenylate cyclase inhibitors.  The most potent noncompetitive inhibitor, 2',5'-dideoxyadenosine  [6698-26-6] was a partial inhibitor, reducing the response to isoproterenol by only 77% even at very high concns.  The most potent agonists, partial agonists, and pure antagonists had apparent affinities of about 5 μM.  Although all positions were important for affinity at the adenosine receptor, only the 3'- and 5'-positions and to a much lesser extent the 6- and 8-positions had an effect on efficacy.  The receptor tolerated bulky groups at the 6-position of adenosine, had an Et-sized pocket near the 5'-position, and had little bulk tolerance towards modifications at other positions.  Among the full agonists, only one 5'-deriv. and one 2-position deriv. had higher apparent affinity than adenosine.  Studies with conformationally restricted agonists and antagonists showed that adenosine must be in the anti conformation in order to bind to the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKRAqZBkQJY7Vg90H21EOLACvtfcHk0lhWl2n3jaN0bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXls1Sqtb4%253D&md5=1851e7bb2c11b84bddafc934515169fb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1139%2Fy80-110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fy80-110%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26atitle%3DAdenosine%2520receptor%2520activation%2520in%2520human%2520fibroblasts%253A%2520nucleoside%2520agonists%2520and%2520antagonists%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D1980%26volume%3D58%26spage%3D673%26epage%3D691%26doi%3D10.1139%2Fy80-110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span><span class="refDoi"> DOI: 10.2174/138161208784480081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.2174%2F138161208784480081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=18537675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1525-1552&author=G.+Cristalliauthor=C.+Lambertucciauthor=G.+Marucciauthor=R.+Volpiniauthor=D.+Dal+Ben&title=A2A+adenosine+receptor+and+its+modulators%3A+overview+on+a+druggable+GPCR+and+on+structure-activity+relationship+analysis+and+binding+requirements+of+agonists+and+antagonists&doi=10.2174%2F138161208784480081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists</span></div><div class="casAuthors">Cristalli, G.; Lambertucci, C.; Marucci, G.; Volpini, R.; Dal Ben, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1525-1552</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the biol. effects of adenosine, the development of potent and selective agonists and antagonists of adenosine receptors has been the subject of medicinal chem. research for several decades, even if their clin. evaluation has been discontinued.  Main problems include side effects due to the ubiquity of the receptors and the possibility of side effects, or to low brain penetration (in particular for the targeting of CNS diseases), short half-life of compds., lack of effects.  Furthermore, species differences in the affinity of ligands make difficult preclin. testing in animal models.  Nevertheless, adenosine receptors continue to represent promising drug targets.  A2A receptor has proved to be a promising pharmacol. target for small synthetic ligands, and while A2A agonists are undergoing clin. trials for myocardial perfusion imaging and as anti-inflammatory agents, A2A antagonists represent an attractive field of research to discover new drugs for the treatment of neurodegenerative disorders, such as Parkinson's disease.  Furthermore, the information coming from bioinformatics and mol. modeling studies for the A2A receptor has made easier the understanding of ligand-target interaction and the rational design of agonists and antagonists for this subtype.  The aim of this review is to show an overview of the most significant steps and progresses in developing A2A adenosine receptor agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLD7b3gsaCZrVg90H21EOLACvtfcHk0lhcTiUsA7JPxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D&md5=3b8c004d9a1fbff02c0a0ee1b476fcea</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F138161208784480081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208784480081%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DDal%2BBen%26aufirst%3DD.%26atitle%3DA2A%2520adenosine%2520receptor%2520and%2520its%2520modulators%253A%2520overview%2520on%2520a%2520druggable%2520GPCR%2520and%2520on%2520structure-activity%2520relationship%2520analysis%2520and%2520binding%2520requirements%2520of%2520agonists%2520and%2520antagonists%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D1525%26epage%3D1552%26doi%3D10.2174%2F138161208784480081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Siddiqi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esker, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, J. A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneller, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span> </span><span class="NLM_article-title">Search for new purine- and ribose- modified adenosine analogues as selective agonists and antagonists at adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1174</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span><span class="refDoi"> DOI: 10.1021/jm00007a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00007a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1174-1188&author=S.+M.+Siddiqiauthor=K.+A.+Jacobsonauthor=J.+L.+Eskerauthor=M.+E.+Olahauthor=X.-D.+Jiauthor=N.+Melmanauthor=K.+N.+Tiwariauthor=J.+A.+Secristauthor=S.+W.+Schnellerauthor=G.+Cristalliauthor=G.+L.+Stilesauthor=C.+R.+Johnsonauthor=A.+P.+IJzerman&title=Search+for+new+purine-+and+ribose-+modified+adenosine+analogues+as+selective+agonists+and+antagonists+at+adenosine+receptors&doi=10.1021%2Fjm00007a014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00007a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00007a014%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqi%26aufirst%3DS.%2BM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DEsker%26aufirst%3DJ.%2BL.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DJi%26aufirst%3DX.-D.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DTiwari%26aufirst%3DK.%2BN.%26aulast%3DSecrist%26aufirst%3DJ.%2BA.%26aulast%3DSchneller%26aufirst%3DS.%2BW.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJohnson%26aufirst%3DC.%2BR.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26atitle%3DSearch%2520for%2520new%2520purine-%2520and%2520ribose-%2520modified%2520adenosine%2520analogues%2520as%2520selective%2520agonists%2520and%2520antagonists%2520at%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1174%26epage%3D1188%26doi%3D10.1021%2Fjm00007a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chang, L. C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanjersberg, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe Künzel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder-Krieger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span> </span><span class="NLM_article-title">2,6-Disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2861</span><span class="NLM_x">–</span> <span class="NLM_lpage">2867</span><span class="refDoi"> DOI: 10.1021/jm050640i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050640i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVajtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2861-2867&author=L.+C.+W.+Changauthor=R.+F.+Spanjersbergauthor=J.+K.+von+Frijtag+Drabbe+K%C3%BCnzelauthor=T.+Mulder-Kriegerauthor=J.+Brusseeauthor=A.+P.+IJzerman&title=2%2C6-Disubstituted+and+2%2C6%2C8-trisubstituted+purines+as+adenosine+receptor+antagonists&doi=10.1021%2Fjm050640i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">2,6-Disubstituted and 2,6,8-Trisubstituted Purines as Adenosine Receptor Antagonists</span></div><div class="casAuthors">Chang, Lisa C. W.; Spanjersberg, Ronald F.; Von Kuenzel, Jacobien K.; Mulder-Krieger, Thea; Brussee, Johannes; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2861-2867</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Purines have long been exploited as adenosine receptor antagonists.  The substitution pattern about the purine ring has been well investigated, and certain criteria have become almost a prerequisite for good affinity at the adenosine A1 receptor.  The adaptation of the pharmacophore and the initial series of pyrimidines developed in an earlier publication resulted in a series of purines with an entirely new substitution pattern.  One compd. in particular, 8-cyclopentyl-2,6-diphenylpurine (31, LUF 5962) has been shown to be very promising with an affinity of 0.29 nM at the human adenosine A1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgkii9-PAkabVg90H21EOLACvtfcHk0lhcTiUsA7JPxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVajtLc%253D&md5=f13f0250833a4575bdd74a5f26a51e26</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm050640i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050640i%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%2BC.%2BW.%26aulast%3DSpanjersberg%26aufirst%3DR.%2BF.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BK%25C3%25BCnzel%26aufirst%3DJ.%2BK.%26aulast%3DMulder-Krieger%26aufirst%3DT.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26atitle%3D2%252C6-Disubstituted%2520and%25202%252C6%252C8-trisubstituted%2520purines%2520as%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2861%26epage%3D2867%26doi%3D10.1021%2Fjm050640i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">van Galen, P. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Bergen, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">A binding site model and structure-activity relationships for the rat A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=1101-1111&author=P.+J.+M.+van+Galenauthor=A.+H.+van+Bergenauthor=C.+Gallo-Rodriguezauthor=N.+Melmanauthor=M.+E.+Olahauthor=A.+P.+IJzermanauthor=G.+L.+Stilesauthor=K.+A.+Jacobson&title=A+binding+site+model+and+structure-activity+relationships+for+the+rat+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BGalen%26aufirst%3DP.%2BJ.%2BM.%26aulast%3Dvan%2BBergen%26aufirst%3DA.%2BH.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA%2520binding%2520site%2520model%2520and%2520structure-activity%2520relationships%2520for%2520the%2520rat%2520A3%2520adenosine%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D1101%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ravi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltysiak, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2295</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span><span class="refDoi"> DOI: 10.1016/S0960-894X(01)00450-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2FS0960-894X%2801%2900450-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=2295-2300&author=G.+Raviauthor=K.+Leeauthor=X.+D.+Jiauthor=H.+S.+Kimauthor=K.+A.+Soltysiakauthor=V.+E.+Marquezauthor=K.+A.+Jacobson&title=Synthesis+and+purine+receptor+affinity+of+6-oxopurine+nucleosides+and+nucleotides+containing+%28N%29-methanocarba-pseudoribose+rings&doi=10.1016%2FS0960-894X%2801%2900450-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900450-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900450-4%26sid%3Dliteratum%253Aachs%26aulast%3DRavi%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DSoltysiak%26aufirst%3DK.%2BA.%26aulast%3DMarquez%26aufirst%3DV.%2BE.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520purine%2520receptor%2520affinity%2520of%25206-oxopurine%2520nucleosides%2520and%2520nucleotides%2520containing%2520%2528N%2529-methanocarba-pseudoribose%2520rings%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D2295%26epage%3D2300%26doi%3D10.1016%2FS0960-894X%2801%2900450-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis using ring closure metathesis and effect on nucleoside transport of a (N)-methanocarba <i>S</i>-(4-nitrobenzyl)thioinosine derivative</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1021/ol006999c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol006999c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=597-599&author=K.+Leeauthor=C.+Cassauthor=K.+A.+Jacobson&title=Synthesis+using+ring+closure+metathesis+and+effect+on+nucleoside+transport+of+a+%28N%29-methanocarba+S-%284-nitrobenzyl%29thioinosine+derivative&doi=10.1021%2Fol006999c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fol006999c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006999c%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DCass%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520using%2520ring%2520closure%2520metathesis%2520and%2520effect%2520on%2520nucleoside%2520transport%2520of%2520a%2520%2528N%2529-methanocarba%2520S-%25284-nitrobenzyl%2529thioinosine%2520derivative%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26spage%3D597%26epage%3D599%26doi%3D10.1021%2Fol006999c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure-guided design of A<sub>3</sub> adenosine receptor-selective nucleosides: Combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7580</span><span class="NLM_x">–</span> <span class="NLM_lpage">7592</span><span class="refDoi"> DOI: 10.1021/jm900426g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900426g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7580-7592&author=D.+K.+Toshauthor=M.+Chinnauthor=A.+A.+Ivanovauthor=A.+M.+Klutzauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=Structure-guided+design+of+A3+adenosine+receptor-selective+nucleosides%3A+Combination+of+2-arylethynyl+and+bicyclo%5B3.1.0%5Dhexane+substitutions&doi=10.1021%2Fjm900426g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm900426g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900426g%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DChinn%26aufirst%3DM.%26aulast%3DIvanov%26aufirst%3DA.%2BA.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-guided%2520design%2520of%2520A3%2520adenosine%2520receptor-selective%2520nucleosides%253A%2520Combination%2520of%25202-arylethynyl%2520and%2520bicyclo%255B3.1.0%255Dhexane%2520substitutions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7580%26epage%3D7592%26doi%3D10.1021%2Fjm900426g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Joshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, A. K.</span><span> </span><span class="NLM_article-title">Base-mediated selective synthesis of diversely substituted <i>N</i>-heterocyclic enamines and enaminones by the hydroamination of alkynes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">5633</span><span class="NLM_x">–</span> <span class="NLM_lpage">5645</span><span class="refDoi"> DOI: 10.1021/jo300782n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo300782n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslGjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=5633-5645&author=M.+Joshiauthor=M.+Patelauthor=R.+Tiwariauthor=A.+K.+Verma&title=Base-mediated+selective+synthesis+of+diversely+substituted+N-heterocyclic+enamines+and+enaminones+by+the+hydroamination+of+alkynes&doi=10.1021%2Fjo300782n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Base-Mediated Selective Synthesis of Diversely Substituted N-Heterocyclic Enamines and Enaminones by the Hydroamination of Alkynes</span></div><div class="casAuthors">Joshi, Megha; Patel, Monika; Tiwari, Rakesh; Verma, Akhilesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5633-5645</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Regio- and stereoselective alkynylation of various N-heterocycles using potassium and cesium salts in DMSO is described.  Terminal alkynes and internal alkynes provided the kinetically stable Z-enamines in good to excellent yields using KOH at 120 °C.  E.g., in presence of KOH in DMSO, alkynylation of pyrrole by 4-EtC6H4C≡CH gave 82% (Z)-I.  Addn. of heterocyclic amines to 1,3- and 1,4-diethynylbenzene provided a mixt. of E/Z isomers with KOH; however, with Cs2CO3 Z-isomers were obtained by the hydroamination at one triple bond.  This methodol. also provides an easy and novel access for the synthesis of enaminones.  The detailed work also supports the formation of the cis-isomer by preferential addn. of o-haloarylalkynes followed by intramol. C2 arylation in the copper-catalyzed tandem synthesis of indolo and pyrrolo[2,1-a]isoquinolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0e2DuhUB1e7Vg90H21EOLACvtfcHk0likxbLyYMX5yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslGjs78%253D&md5=1235fbc7459a052acd70c63b798ed5b2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjo300782n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo300782n%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DVerma%26aufirst%3DA.%2BK.%26atitle%3DBase-mediated%2520selective%2520synthesis%2520of%2520diversely%2520substituted%2520N-heterocyclic%2520enamines%2520and%2520enaminones%2520by%2520the%2520hydroamination%2520of%2520alkynes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2012%26volume%3D77%26spage%3D5633%26epage%3D5645%26doi%3D10.1021%2Fjo300782n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Muller, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultzsch, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foubelo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, M.</span><span> </span><span class="NLM_article-title">Hydroamination: Direct addition of amines to alkenes and alkynes</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">3795</span><span class="NLM_x">–</span> <span class="NLM_lpage">3892</span><span class="refDoi"> DOI: 10.1021/cr0306788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0306788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A280%3ADC%252BD1crptleisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=3795-3892&author=T.+E.+Mullerauthor=K.+C.+Hultzschauthor=M.+Yusauthor=F.+Foubeloauthor=M.+Tada&title=Hydroamination%3A+Direct+addition+of+amines+to+alkenes+and+alkynes&doi=10.1021%2Fcr0306788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroamination: direct addition of amines to alkenes and alkynes</span></div><div class="casAuthors">Muller Thomas E; Hultzsch Kai C; Yus Miguel; Foubelo Francisco; Tada Mizuki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3795-892</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSV453Tu8yN5ntlzo9xastyfW6udTcc2eZlUvf6TYXg57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crptleisg%253D%253D&md5=56894f42f4e5b51472b69eecddb81b89</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fcr0306788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0306788%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DT.%2BE.%26aulast%3DHultzsch%26aufirst%3DK.%2BC.%26aulast%3DYus%26aufirst%3DM.%26aulast%3DFoubelo%26aufirst%3DF.%26aulast%3DTada%26aufirst%3DM.%26atitle%3DHydroamination%253A%2520Direct%2520addition%2520of%2520amines%2520to%2520alkenes%2520and%2520alkynes%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D3795%26epage%3D3892%26doi%3D10.1021%2Fcr0306788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Severin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doye, S.</span><span> </span><span class="NLM_article-title">The catalytic hydroamination of alkynes</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1407</span><span class="refDoi"> DOI: 10.1039/b600981f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1039%2Fb600981f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=17660874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1ygtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=1407&author=R.+Severinauthor=S.+Doye&title=The+catalytic+hydroamination+of+alkynes&doi=10.1039%2Fb600981f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">The catalytic hydroamination of alkynes</span></div><div class="casAuthors">Severin, Rene; Doye, Sven</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1407-1420</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The review focus on recent developments in intermol. hydroamination of alkynes and developments in catalysts that appeared in the literature between the end of 2002 and Oct. 31, 2006.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLf6UnNZGoU7Vg90H21EOLACvtfcHk0lj51J4tC8E_Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1ygtbw%253D&md5=451aee5c9a59c6ba8aa25f7fc39bac5b</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1039%2Fb600981f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb600981f%26sid%3Dliteratum%253Aachs%26aulast%3DSeverin%26aufirst%3DR.%26aulast%3DDoye%26aufirst%3DS.%26atitle%3DThe%2520catalytic%2520hydroamination%2520of%2520alkynes%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2007%26volume%3D36%26spage%3D1407%26doi%3D10.1039%2Fb600981f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maas, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamhuis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynberg, H.</span><span> </span><span class="NLM_article-title"><a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a>Mechanism of enamine reactions. IV. The hydrolysis of tertiary enamines in acidic medium</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1111</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span><span class="refDoi"> DOI: 10.1021/jo01279a056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01279a056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1965&pages=1111-1115&author=W.+Maasauthor=M.+J.+Janssenauthor=E.+J.+Stamhuisauthor=H.+Wynberg&title=%281%29Mechanism+of+enamine+reactions.+IV.+The+hydrolysis+of+tertiary+enamines+in+acidic+medium&doi=10.1021%2Fjo01279a056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fjo01279a056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01279a056%26sid%3Dliteratum%253Aachs%26aulast%3DMaas%26aufirst%3DW.%26aulast%3DJanssen%26aufirst%3DM.%2BJ.%26aulast%3DStamhuis%26aufirst%3DE.%2BJ.%26aulast%3DWynberg%26aufirst%3DH.%26atitle%3D%25281%2529Mechanism%2520of%2520enamine%2520reactions.%2520IV.%2520The%2520hydrolysis%2520of%2520tertiary%2520enamines%2520in%2520acidic%2520medium%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1965%26volume%3D30%26spage%3D1111%26epage%3D1115%26doi%3D10.1021%2Fjo01279a056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span> <span class="citation_source-book">Enamines: Synthesis, Structure and Reactions</span>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_contrib-group">Cook, A. G.</span>, Ed.; <span class="NLM_publisher-name">Marcel Dekker</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1988</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&author=A.+G.+Cook&title=Enamines%3A+Synthesis%2C+Structure+and+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DEnamines%253A%2520Synthesis%252C%2520Structure%2520and%2520Reactions%26aulast%3DCook%26aufirst%3DA.%2BG.%26pub%3DMarcel%2520Dekker%26date%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A<sub>3</sub> adenosine receptor agonist that protects against chronic neuropathic pain</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1007/s11302-015-9459-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1007%2Fs11302-015-9459-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=26111639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVyhsL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=371-387&author=D.+K.+Toshauthor=J.+Padiaauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=Efficient%2C+large-scale+synthesis+and+preclinical+studies+of+MRS5698%2C+a+highly+selective+A3+adenosine+receptor+agonist+that+protects+against+chronic+neuropathic+pain&doi=10.1007%2Fs11302-015-9459-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain</span></div><div class="casAuthors">Tosh, Dilip K.; Padia, Janak; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">371-387</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We reported that 2-(3,4-difluorophenylethynyl)-N6-3-chlorobenzyl (N)-methanocarba adenosine deriv. 1 (MRS5698) binds selectively to human and mouse A3 adenosine receptors (A3ARs, Ki 3 nM).  It is becoming an important pharmacol. tool for defining A3AR effects and is orally active in a chronic neuropathic pain model.  Here, we introduce a new synthetic route for MRS5698 from D-ribose, suitable for a scale-up on a multi-gram scale, and we measure in vitro and in vivo ADME-Tox parameters.  MRS5698 was very stable in vitro, failed to inhibit CYPs at <10 μM, and was largely bound to plasma proteins.  It was well tolerated in the rat at doses of ≤200 mg/kg i.p.  A 1 mg/kg i.p. dose in the mouse displayed t1/2 of 1.09 h and plasma Cmax of 204 nM at 1 h with an AUC of 213 ng × h/mL.  CACO-2 bidirectional transport studies suggested intestinal efflux of MRS5698 (efflux ratio 86).  Although the oral %F is only 5 %, the beneficial effect to reverse pain lasted for at least 2 h in the CCI model in rats, using the same vehicle for oral administration of a high dose.  The stability, low toxicity, lack of CYP interaction, pharmacokinetic half-life, and in vivo efficacy suggest that MRS5698 is a preferred compd. for further consideration as a treatment for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu82TREqapwLVg90H21EOLACvtfcHk0lj51J4tC8E_Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVyhsL7J&md5=0d810ff59dc5011f0ae25e7f8d6d24c4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs11302-015-9459-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-015-9459-2%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DPadia%26aufirst%3DJ.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DEfficient%252C%2520large-scale%2520synthesis%2520and%2520preclinical%2520studies%2520of%2520MRS5698%252C%2520a%2520highly%2520selective%2520A3%2520adenosine%2520receptor%2520agonist%2520that%2520protects%2520against%2520chronic%2520neuropathic%2520pain%26jtitle%3DPurinergic%2520Signalling%26date%3D2015%26volume%3D11%26spage%3D371%26epage%3D387%26doi%3D10.1007%2Fs11302-015-9459-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cheng, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between inhibition constant (K1) and concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic-reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span><span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+inhibition+constant+%28K1%29+and+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic-reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0liLCJsRy0Y-7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic-reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bradford, M. M.</span><span> </span><span class="NLM_article-title">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=942051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+rapid+and+sensitive+method+for+the+quantitation+of+microgram+quantities+of+protein+utilizing+the+principle+of+protein-dye+binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span></div><div class="casAuthors">Bradford, Marion M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">248-54</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A protein detn. method that involves the binding of coomassie Brilliant Blue G 250 to protein is described.  The binding of the dye to protein causes a shift in the absorption max. of the dye from 465 to 595 nm, and it is the increase in absorption at 595 nm that is monitored.  This assay is very reproducible and rapid with the dye binding process virtually complete in ∼ 2 min with good color stability for 1 hr.  There is little or no interference from cations such as Na+ or K+ nor from carbohydrates such as sucrose.  A small amt. of color is developed in the presence of strongly alk. buffering agents, but the assay may be run accurately by the use of proper buffer controls.  The only components found to give excessive interfering color in the assay are relatively large amts. of detergents such as Na dodecyl sulfate, Triton X 100, and commercial glassware detergents.  Interference by small amts. of detergent may be eliminated by the use of proper control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_T_d0trcNrVg90H21EOLACvtfcHk0liLCJsRy0Y-7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D&md5=43f388a493becc4193c7a49d9de0e1db</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520the%2520quantitation%2520of%2520microgram%2520quantities%2520of%2520protein%2520utilizing%2520the%2520principle%2520of%2520protein-dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Nordstedt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1016/0003-2697(90)90113-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2F0003-2697%2890%2990113-N" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=1990&pages=231-234&author=C.+Nordstedtauthor=B.+B.+Fredholm&title=A+modification+of+a+protein-binding+method+for+rapid+quantification+of+cAMP+in+cell-culture+supernatants+and+body+fluid&doi=10.1016%2F0003-2697%2890%2990113-N"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2890%2990113-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252890%252990113-N%26sid%3Dliteratum%253Aachs%26aulast%3DNordstedt%26aufirst%3DC.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DA%2520modification%2520of%2520a%2520protein-binding%2520method%2520for%2520rapid%2520quantification%2520of%2520cAMP%2520in%2520cell-culture%2520supernatants%2520and%2520body%2520fluid%26jtitle%3DAnal.%2520Biochem.%26date%3D1990%26volume%3D189%26spage%3D231%26epage%3D234%26doi%3D10.1016%2F0003-2697%2890%2990113-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Little, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">Central adenosine A<sub>3</sub> receptor (A<sub>3</sub>AR) activation reverses neuropathic pain</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">S50</span><span class="refDoi"> DOI: 10.1016/j.jpain.2014.01.207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2Fj.jpain.2014.01.207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=S50&author=J.+Littleauthor=Z.+Chenauthor=A.+Fordauthor=K.+Janesauthor=T.+Doyleauthor=D.+Toshauthor=K.+Jacobsonauthor=D.+Salvemini&title=Central+adenosine+A3+receptor+%28A3AR%29+activation+reverses+neuropathic+pain&doi=10.1016%2Fj.jpain.2014.01.207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2014.01.207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2014.01.207%26sid%3Dliteratum%253Aachs%26aulast%3DLittle%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DFord%26aufirst%3DA.%26aulast%3DJanes%26aufirst%3DK.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DTosh%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DCentral%2520adenosine%2520A3%2520receptor%2520%2528A3AR%2529%2520activation%2520reverses%2520neuropathic%2520pain%26jtitle%3DJ.%2520Pain%26date%3D2014%26volume%3D15%26spage%3DS50%26doi%3D10.1016%2Fj.jpain.2014.01.207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y. K.</span><span> </span><span class="NLM_article-title">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1016/0304-3959(88)90209-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2F0304-3959%2888%2990209-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=2837713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1988&pages=87-107&author=G.+J.+Bennettauthor=Y.+K.+Xie&title=A+peripheral+mononeuropathy+in+rat+that+produces+disorders+of+pain+sensation+like+those+seen+in+man&doi=10.1016%2F0304-3959%2888%2990209-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span></div><div class="casAuthors">Bennett Gary J; Xie Y-K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-107</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">A peripheral mononeuropathy was produced in adult rats by placing loosely constrictive ligatures around the common sciatic nerve.  The postoperative behavior of these rats indicated that hyperalgesia, allodynia and, possibly, spontaneous pain (or dysesthesia) were produced.  Hyperalgesic responses to noxious radiant heat were evident on the second postoperative day and lasted for over 2 months.  Hyperalgesic responses to chemogenic pain were also present.  The presence of allodynia was inferred from the nocifensive responses evoked by standing on an innocuous, chilled metal floor or by innocuous mechanical stimulation, and by the rats' persistence in holding the hind paw in a guarded position.  The presence of spontaneous pain was suggested by a suppression of appetite and by the frequent occurrence of apparently spontaneous nocifensive responses.  The affected hind paw was abnormally warm or cool in about one-third of the rats.  About one-half of the rats developed grossly overgrown claws on the affected side.  Experiments with this animal model may advance our understanding of the neural mechanisms of neuropathic pain disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvFbgQgoOLbwWRJ3OJdH_qfW6udTcc2eZkChukRVwNV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D&md5=b65eee81b7058ce686a014eee46ead80</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2888%2990209-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252888%252990209-6%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DXie%26aufirst%3DY.%2BK.%26atitle%3DA%2520peripheral%2520mononeuropathy%2520in%2520rat%2520that%2520produces%2520disorders%2520of%2520pain%2520sensation%2520like%2520those%2520seen%2520in%2520man%26jtitle%3DPain%26date%3D1988%26volume%3D33%26spage%3D87%26epage%3D107%26doi%3D10.1016%2F0304-3959%2888%2990209-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Besnard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruda, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecassis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguiz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidah, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constam, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickerton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">492</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.+P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0ljcB9uu3XOWQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Janowsky, A.; Eshleman, A.; Tosh, D. K.; Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Rigid adenine nucleoside derivatives as novel modulators of the human sodium symporters for dopamine and other neurotransmitters</span>.  <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1124/jpet.115.229666</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1124%2Fjpet.115.229666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=26813929" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Janowsky&author=A.+Eshleman&author=D.+K.+Tosh&author=K.+A.+Jacobson&title=Rigid+adenine+nucleoside+derivatives+as+novel+modulators+of+the+human+sodium+symporters+for+dopamine+and+other+neurotransmitters&doi=10.1124%2Fjpet.115.229666"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.229666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.229666%26sid%3Dliteratum%253Aachs%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DRigid%2520adenine%2520nucleoside%2520derivatives%2520as%2520novel%2520modulators%2520of%2520the%2520human%2520sodium%2520symporters%2520for%2520dopamine%2520and%2520other%2520neurotransmitters%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26doi%3D10.1124%2Fjpet.115.229666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Rational design of sulfonated A<sub>3</sub> adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5949</span><span class="NLM_x">–</span> <span class="NLM_lpage">5963</span><span class="refDoi"> DOI: 10.1021/jm4007966</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4007966" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvFamtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5949-5963&author=S.+Paolettaauthor=D.+K.+Toshauthor=A.+Finleyauthor=E.+Gizewskiauthor=S.+M.+Mossauthor=Z.+G.+Gaoauthor=J.+A.+Auchampachauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=Rational+design+of+sulfonated+A3+adenosine+receptor-selective+nucleosides+as+pharmacological+tools+to+study+chronic+neuropathic+pain&doi=10.1021%2Fjm4007966"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Sulfonated A3 Adenosine Receptor-Selective Nucleosides as Pharmacological Tools To Study Chronic Neuropathic Pain</span></div><div class="casAuthors">Paoletta, Silvia; Tosh, Dilip K.; Finley, Amanda; Gizewski, Elizabeth T.; Moss, Steven M.; Gao, Zhan-Guo; Auchampach, John A.; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5949-5963</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(N)-Methanocarba(bicyclo[3.1.0]hexane)adenosine derivs. were probed for sites of charged sulfonate substitution, which precludes diffusion across biol. membranes, e.g., blood-brain barrier.  Mol. modeling predicted that sulfonate groups on C2-phenylethynyl substituents would provide high affinity at both mouse (m) and human (h) A3 adenosine receptors (ARs), while a N6-p-sulfophenylethyl substituent would det. higher hA3AR vs mA3AR affinity.  These modeling predictions, based on steric fitting of the binding cavity and crucial interactions with key residues, were confirmed by binding/efficacy studies of synthesized sulfonates.  N6-3-Chlorobenzyl-2-(3-sulfophenylethynyl) deriv. I (R = 3-Cl-Bn, R1 = H, R2 = 3-SO3H) (MRS5841) bound selectively to h/m A3ARs (Ki(hA3AR) = 1.9 nM) as agonist, while corresponding p-sulfo isomer I (R = 3-Cl-Bn, R1 = H, R2 = 4-SO3H) (MRS5701) displayed mixed A1/A3AR agonism.  Both nucleosides administered i.p. reduced mouse chronic neuropathic pain that was ascribed to either A3AR or A1/A3AR using A3AR genetic deletion.  Thus, rational design methods based on A3AR homol. models successfully predicted sites for sulfonate incorporation, for delineating adenosine's CNS vs peripheral actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzqyBaxHNVQrVg90H21EOLACvtfcHk0lgA264wRABJDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvFamtbw%253D&md5=f00b54135a300a673b63e6550de78faf</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm4007966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4007966%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DFinley%26aufirst%3DA.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DMoss%26aufirst%3DS.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRational%2520design%2520of%2520sulfonated%2520A3%2520adenosine%2520receptor-selective%2520nucleosides%2520as%2520pharmacological%2520tools%2520to%2520study%2520chronic%2520neuropathic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5949%26epage%3D5963%26doi%3D10.1021%2Fjm4007966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kusachi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugni, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R. A.</span><span> </span><span class="NLM_article-title">Dog coronary artery adenosine receptor: structure of the N<sup>6</sup>-alkyl subregion</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1636</span><span class="NLM_x">–</span> <span class="NLM_lpage">1643</span><span class="refDoi"> DOI: 10.1021/jm00149a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00149a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=1636-1643&author=S.+Kusachiauthor=R.+D.+Thompsonauthor=W.+J.+Bugniauthor=N.+Yamadaauthor=R.+A.+Olsson&title=Dog+coronary+artery+adenosine+receptor%3A+structure+of+the+N6-alkyl+subregion&doi=10.1021%2Fjm00149a016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm00149a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00149a016%26sid%3Dliteratum%253Aachs%26aulast%3DKusachi%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DR.%2BD.%26aulast%3DBugni%26aufirst%3DW.%2BJ.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DOlsson%26aufirst%3DR.%2BA.%26atitle%3DDog%2520coronary%2520artery%2520adenosine%2520receptor%253A%2520structure%2520of%2520the%2520N6-alkyl%2520subregion%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D1636%26epage%3D1643%26doi%3D10.1021%2Fjm00149a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Gillerman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, B.</span><span> </span><span class="NLM_article-title">Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1021/jm101286g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101286g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=107-121&author=I.+Gillermanauthor=B.+Fischer&title=Investigations+into+the+origin+of+the+molecular+recognition+of+several+adenosine+deaminase+inhibitors&doi=10.1021%2Fjm101286g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm101286g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101286g%26sid%3Dliteratum%253Aachs%26aulast%3DGillerman%26aufirst%3DI.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DInvestigations%2520into%2520the%2520origin%2520of%2520the%2520molecular%2520recognition%2520of%2520several%2520adenosine%2520deaminase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D107%26epage%3D121%26doi%3D10.1021%2Fjm101286g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Hüttemann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukena, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenschow, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwabe, U.</span><span> </span><span class="NLM_article-title">R<sub>a</sub> adenosine receptors in human platelets. Characterization by 5′-N-ethylcarboxamido [<sup>3</sup>H]adenosine binding in relation to adenylate cyclase activity</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1007/BF00495948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1007%2FBF00495948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=6328333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADyaL2cXitVChsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=1984&pages=226-233&author=E.+H%C3%BCttemannauthor=D.+Ukenaauthor=V.+Lenschowauthor=U.+Schwabe&title=Ra+adenosine+receptors+in+human+platelets.+Characterization+by+5%E2%80%B2-N-ethylcarboxamido+%5B3H%5Dadenosine+binding+in+relation+to+adenylate+cyclase+activity&doi=10.1007%2FBF00495948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Ra adenosine receptors in human platelets.  Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity</span></div><div class="casAuthors">Huettemann, E.; Ukena, D.; Lenschow, V.; Schwabe, U.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">226-33</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">Adenosine  [58-61-7] receptors in human platelet membranes were characterized by radioligand binding and measurement of adenylate cyclase  [9012-42-4] activity.  Binding of 5'-N-ethyl-carboxamidoadenosine (NECA)  [35920-39-9] was rapid, reversible and dependent on protein concn., pH and temp.  Due to a rapid rate of dissocn. (half-life approx. 20 s) binding was highest at 0°.  Adenosine deaminase and GTP  [86-01-1] alone did not influence [3H]NECA binding, whereas several divalent cations decreased binding.  Satn. expts. revealed 2 different binding sites for [3H]NECA, with KD values of 0.16 and 2.9 μmol/L and Bmax values of 8.4 and 33.4 pmol/mg of protein.  In competition expts. NECA was the most potent adenosine agonist (IC50 0.5 μmol/L), followed by 2-chloroadenosine  [146-77-0] (IC50 6.3 μmol/L) and adenosine (IC50 12 μmol/L).  A similar rank order of potencies was obsd. for the stimulatory effect of adenosine analogs on platelet adenylate cyclase.  NECA stimulated adenylate cyclase activity with an EC50 value of 0.5 μmol/L and was approx. 4-fold more potent than (-)N6-phenylisopropyladenosine [(-)PIA]  [38594-96-6].  However, (-)PIA and N6-cyclohexyladenosine did not affect [3H]NECA binding, an observation not consistent with the stimulatory effect on adenylate cyclase.  The adenosine antagonists IBMX, theophylline, and caffeine showed IC50 values between 98 and 5600 μmol/L.  [3H]PIA bound to platelet membranes with very low affinity and was not displaced by NECA.  The [3H]NECA binding to human platelet membranes satisfies essential criteria for Ra adenosine receptors and, with some limitations, should be of value for the characterization of adenosine receptors in Ra subtype selective cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol8r_0XpfwabVg90H21EOLACvtfcHk0lgA264wRABJDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXitVChsLw%253D&md5=de1db21d0f341c1a2c5ee87a2408d040</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2FBF00495948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00495948%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCttemann%26aufirst%3DE.%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DLenschow%26aufirst%3DV.%26aulast%3DSchwabe%26aufirst%3DU.%26atitle%3DRa%2520adenosine%2520receptors%2520in%2520human%2520platelets.%2520Characterization%2520by%25205%25E2%2580%25B2-N-ethylcarboxamido%2520%255B3H%255Dadenosine%2520binding%2520in%2520relation%2520to%2520adenylate%2520cyclase%2520activity%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1984%26volume%3D325%26spage%3D226%26epage%3D233%26doi%3D10.1007%2FBF00495948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Recent developments in adenosine receptor ligands and their potential as novel drugs</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1808</span><span class="NLM_x">, </span> <span class="NLM_fpage">1290</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2010.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2Fj.bbamem.2010.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=21185259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1808&publication_year=2011&pages=1290-1308&author=C.+M%C3%BCllerauthor=K.+A.+Jacobson&title=Recent+developments+in+adenosine+receptor+ligands+and+their+potential+as+novel+drugs&doi=10.1016%2Fj.bbamem.2010.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in adenosine receptor ligands and their potential as novel drugs</span></div><div class="casAuthors">Mueller, Christa E.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1808</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1290-1308</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Medicinal chem. approaches have been applied to all four of the adenosine receptor (AR) subtypes (A1, A2A, A2B, and A3) to create selective agonists and antagonists for each.  The most recent class of selective AR ligands to be reported is the class of A2BAR agonists.  The availability of these selective ligands has facilitated research on therapeutic applications of modulating the ARs and in some cases has provided clin. candidates.  Prodrug approaches have been developed which improve the bioavailability of the drugs, reduce side-effects, and/or may lead to site-selective effects.  The A2A agonist regadenoson (Lexiscan), a diagnostic drug for myocardial perfusion imaging, is the first selective AR agonist to be approved.  Other selective agonists and antagonists are or were undergoing clin. trials for a broad range of indications, including capadenoson and tecadenoson (A1 agonists) for atrial fibrillation, or paroxysmal supraventricular tachycardia, resp., apadenoson and binodenoson (A2A agonists) for myocardial perfusion imaging, preladenant (A2A antagonist) for the treatment of Parkinson's disease, and CF101 and CF102 (A3 agonists) for inflammatory diseases and cancer, resp.  This article is part of a Special Issue entitled: "Adenosine Receptors".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8Cuch7XkT7Vg90H21EOLACvtfcHk0lgA264wRABJDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsr8%253D&md5=f143d2424c178c0a75e956ffb6b8320a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2010.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2010.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520developments%2520in%2520adenosine%2520receptor%2520ligands%2520and%2520their%2520potential%2520as%2520novel%2520drugs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2011%26volume%3D1808%26spage%3D1290%26epage%3D1308%26doi%3D10.1016%2Fj.bbamem.2010.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Hassan, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Elkhair, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riordan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khare, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waud, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, J. A.,  3rd.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of the substrate activity of C-6 substituted purine ribosides with E. coli purine nucleoside phosphorylase: palladium mediated cross-coupling of organozinc halides with 6-chloropurine nucleosides</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2Fj.ejmech.2011.10.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=167-174&author=A.+E.+Hassanauthor=R.+A.+Abou-Elkhairauthor=J.+M.+Riordanauthor=P.+W.+Allanauthor=W.+B.+Parkerauthor=R.+Khareauthor=W.+R.+Waudauthor=J.+A.+Montgomeryauthor=J.+A.+Secrist&title=Synthesis+and+evaluation+of+the+substrate+activity+of+C-6+substituted+purine+ribosides+with+E.+coli+purine+nucleoside+phosphorylase%3A+palladium+mediated+cross-coupling+of+organozinc+halides+with+6-chloropurine+nucleosides&doi=10.1016%2Fj.ejmech.2011.10.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DHassan%26aufirst%3DA.%2BE.%26aulast%3DAbou-Elkhair%26aufirst%3DR.%2BA.%26aulast%3DRiordan%26aufirst%3DJ.%2BM.%26aulast%3DAllan%26aufirst%3DP.%2BW.%26aulast%3DParker%26aufirst%3DW.%2BB.%26aulast%3DKhare%26aufirst%3DR.%26aulast%3DWaud%26aufirst%3DW.%2BR.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26aulast%3DSecrist%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520the%2520substrate%2520activity%2520of%2520C-6%2520substituted%2520purine%2520ribosides%2520with%2520E.%2520coli%2520purine%2520nucleoside%2520phosphorylase%253A%2520palladium%2520mediated%2520cross-coupling%2520of%2520organozinc%2520halides%2520with%25206-chloropurine%2520nucleosides%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D167%26epage%3D174%26doi%3D10.1016%2Fj.ejmech.2011.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Van Aerschot, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyns, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdewijn, P. A.</span><span> </span><span class="NLM_article-title">Antiviral activity of C-alkylated purine nucleosides obtained by cross-coupling with tetraalkyltin reagents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2938</span><span class="NLM_x">–</span> <span class="NLM_lpage">2942</span><span class="refDoi"> DOI: 10.1021/jm00072a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00072a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2938-2942&author=A.+A.+Van+Aerschotauthor=P.+Mamosauthor=N.+J.+Weynsauthor=S.+Ikedaauthor=E.+De+Clercqauthor=P.+A.+Herdewijn&title=Antiviral+activity+of+C-alkylated+purine+nucleosides+obtained+by+cross-coupling+with+tetraalkyltin+reagents&doi=10.1021%2Fjm00072a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm00072a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00072a013%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BAerschot%26aufirst%3DA.%2BA.%26aulast%3DMamos%26aufirst%3DP.%26aulast%3DWeyns%26aufirst%3DN.%2BJ.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DHerdewijn%26aufirst%3DP.%2BA.%26atitle%3DAntiviral%2520activity%2520of%2520C-alkylated%2520purine%2520nucleosides%2520obtained%2520by%2520cross-coupling%2520with%2520tetraalkyltin%2520reagents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2938%26epage%3D2942%26doi%3D10.1021%2Fjm00072a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Luongo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vita, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grifantini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Novellis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappellacci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maione, S.</span><span> </span><span class="NLM_article-title">5<b>′</b>-Chloro-5<b>′</b>-deoxy-(±)-ENBA, a potent and selective adenosine A<sub>1</sub> receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">13712</span><span class="NLM_x">–</span> <span class="NLM_lpage">13726</span><span class="refDoi"> DOI: 10.3390/molecules171213712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.3390%2Fmolecules171213712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=23174891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVequrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=13712-13726&author=L.+Luongoauthor=R.+Petrelliauthor=L.+Gattaauthor=C.+Giordanoauthor=F.+Guidaauthor=P.+Vitaauthor=P.+Franchettiauthor=M.+Grifantiniauthor=V.+de+Novellisauthor=L.+Cappellacciauthor=S.+Maione&title=5%E2%80%B2-Chloro-5%E2%80%B2-deoxy-%28%C2%B1%29-ENBA%2C+a+potent+and+selective+adenosine+A1+receptor+agonist%2C+alleviates+neuropathic+pain+in+mice+through+functional+glial+and+microglial+changes+without+affecting+motor+or+cardiovascular+functions&doi=10.3390%2Fmolecules171213712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">5'-Chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions</span></div><div class="casAuthors">Luongo, Livio; Petrelli, Riccardo; Gatta, Luisa; Giordano, Catia; Guida, Francesca; Vita, Patrizia; Franchetti, Palmarisa; Grifantini, Mario; de Novellis, Vito; Cappellacci, Loredana; Maione, Sabatino</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13712-13726</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">This study was undertaken in order to investigate the effect of chronic treatment with 5'-chloro-5'-deoxy-(±)-ENBA, a potent and highly selective agonist of human adenosine A1 receptor, on thermal hyperalgesia and mech. allodynia in a mouse model of neuropathic pain, the Spared Nerve Injury (SNI) of the sciatic nerve.  Chronic systemic administration of 5'-chloro-5'-deoxy-(±)-ENBA (0.5 mg/kg, i.p.) reduced both mech. allodynia and thermal hyperalgesia 3 and 7 days post-SNI, in a way prevented by DPCPX (3 mg/kg, i.p.), a selective A1 adenosine receptor antagonist, without exerting any significant change on the motor coordination or arterial blood pressure.  In addn., a single i.p. injection of 5'-chloro-5'-deoxy-(±)-ENBA (0.5 mg/kg, i.p.) 7 days post-SNI also reduced both symptoms for at least two hours.  SNI was assocd. with spinal changes in microglial activation ipsilaterally to the nerve injury.  Activated, hypertrophic microglia were significantly reduced by 5'-chloro-5'-deoxy-(±)-ENBA chronic treatment.  Our results demonstrated an involvement of adenosine A1 receptor in the amplified nociceptive thresholds and in spinal glial and microglial changes occurred in neuropathic pain, without affecting motor coordination or blood pressure.  Our data suggest a possible use of adenosine A1 receptor agonist in neuropathic pain symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZDTfzGFQbeLVg90H21EOLACvtfcHk0lg1ovND0GkN_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVequrjE&md5=c4bf495b0fb81de282fc9a192ba1b345</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3390%2Fmolecules171213712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules171213712%26sid%3Dliteratum%253Aachs%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DPetrelli%26aufirst%3DR.%26aulast%3DGatta%26aufirst%3DL.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DVita%26aufirst%3DP.%26aulast%3DFranchetti%26aufirst%3DP.%26aulast%3DGrifantini%26aufirst%3DM.%26aulast%3Dde%2BNovellis%26aufirst%3DV.%26aulast%3DCappellacci%26aufirst%3DL.%26aulast%3DMaione%26aufirst%3DS.%26atitle%3D5%25E2%2580%25B2-Chloro-5%25E2%2580%25B2-deoxy-%2528%25C2%25B1%2529-ENBA%252C%2520a%2520potent%2520and%2520selective%2520adenosine%2520A1%2520receptor%2520agonist%252C%2520alleviates%2520neuropathic%2520pain%2520in%2520mice%2520through%2520functional%2520glial%2520and%2520microglial%2520changes%2520without%2520affecting%2520motor%2520or%2520cardiovascular%2520functions%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26spage%3D13712%26epage%3D13726%26doi%3D10.3390%2Fmolecules171213712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Cavasotto, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palomba, D.</span><span> </span><span class="NLM_article-title">Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">13576</span><span class="NLM_x">–</span> <span class="NLM_lpage">13594</span><span class="refDoi"> DOI: 10.1039/C5CC05050B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1039%2FC5CC05050B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=26256645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Sqs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=13576-13594&author=C.+N.+Cavasottoauthor=D.+Palomba&title=Expanding+the+horizons+of+G+protein-coupled+receptor+structure-based+ligand+discovery+and+optimization+using+homology+models&doi=10.1039%2FC5CC05050B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models</span></div><div class="casAuthors">Cavasotto, Claudio N.; Palomba, Damian</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">71</span>),
    <span class="NLM_cas:pages">13576-13594</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  With >800 members in humans, the G protein-coupled receptor (GPCR) super-family is the target for more than 30% of the marketed drugs.  The recent boom in GPCR crystallog. has enabled the soln. of ∼30 different GPCR structures, which boosted the identification and optimization of novel modulators and new chem. entities through structure-based strategies.  However, the no. of available structures represents a small part of the human GPCR druggable target space, and its complete coverage in the near future seems unlikely.  Homol. modeling represents a reliable tool to fill this gap, and hence to vastly expand the horizons of structure-based drug discovery and design.  In this Feature Article, we show from a wealth of retrospective and prospective studies that in spite of the pitfalls of and standing challenges in homol. modeling, structural models have been crit. for the blossoming and success of GPCR structure-based lead discovery and optimization endeavours; in addn., they have also been instrumental in characterizing receptor-ligand interaction, guiding the design of site-directed mutagenesis and SAR studies, and assessing off-target effects.  Considering though their current limitations, we also discuss the most pressing issues to develop more accurate homol. modeling strategies, with a special focus on the integration of computational tools with biochem., biophys. and QSAR data, highlighting methodol. aspects and recent progress.  The teachings of the three GPCR Dock community-wide assessments and the fresh developments in GPCR classes B, C and F are commented.  This is a fast growing and highly promising field of research, and in the coming years, the use of high-quality models should enable the discovery of a growing no. of potent, selective and efficient GPCR drug leads with high therapeutic potential through receptor structure-based strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9LmkRKbR3hrVg90H21EOLACvtfcHk0lg1ovND0GkN_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Sqs7rL&md5=d8d899e555a3cc5c9830c5820e499841</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1039%2FC5CC05050B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC05050B%26sid%3Dliteratum%253Aachs%26aulast%3DCavasotto%26aufirst%3DC.%2BN.%26aulast%3DPalomba%26aufirst%3DD.%26atitle%3DExpanding%2520the%2520horizons%2520of%2520G%2520protein-coupled%2520receptor%2520structure-based%2520ligand%2520discovery%2520and%2520optimization%2520using%2520homology%2520models%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D13576%26epage%3D13594%26doi%3D10.1039%2FC5CC05050B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiselev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakraborty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayasekara, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span> </span><span class="NLM_article-title">John Daly Lecture: Structure-guided drug design for adenosine and P2Y receptors</span> <span class="citation_source-journal">Comput. Struct. Biotechnol. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1016/j.csbj.2014.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2Fj.csbj.2014.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=25973142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A280%3ADC%252BC2MfjvFGquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=286-298&author=K.+A.+Jacobsonauthor=Z.+G.+Gaoauthor=S.+Paolettaauthor=E.+Kiselevauthor=S.+Chakrabortyauthor=P.+S.+Jayasekaraauthor=R.+Balasubramanianauthor=D.+K.+Tosh&title=John+Daly+Lecture%3A+Structure-guided+drug+design+for+adenosine+and+P2Y+receptors&doi=10.1016%2Fj.csbj.2014.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors</span></div><div class="casAuthors">Jacobson Kenneth A; Gao Zhan-Guo; Paoletta Silvia; Kiselev Evgeny; Chakraborty Saibal; Jayasekara P Suresh; Balasubramanian Ramachandran; Tosh Dilip K</div><div class="citationInfo"><span class="NLM_cas:title">Computational and structural biotechnology journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">286-98</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We establish structure activity relationships of extracellular nucleosides and nucleotides at G protein-coupled receptors (GPCRs), e.g. adenosine receptors (ARs) and P2Y receptors (P2YRs), respectively.  We synthesize selective agents for use as pharmacological probes and potential therapeutic agents (e.g.  A3AR agonists for neuropathic pain).  Detailed structural information derived from the X-ray crystallographic structures within these families enables the design of novel ligands, guides modification of known agonists and antagonists, and helps predict polypharmacology.  Structures were recently reported for the P2Y12 receptor (P2Y12R), an anti-thrombotic target.  Comparison of agonist-bound and antagonist-bound P2Y12R indicates unprecedented structural plasticity in the outer portions of the transmembrane (TM) domains and the extracellular loops.  Nonphosphate-containing ligands of the P2YRs, such as the selective P2Y14R antagonist PPTN, are desired for bioavailability and increased stability.  Also, A2AAR structures are effectively applied to homology modeling of closely related A1AR and A3AR, which are not yet crystallized.  Conformational constraint of normally flexible ribose with bicyclic analogues increased the ligand selectivity.  Comparison of rigid A3AR agonist congeners allows the exploration of interaction of specific regions of the nucleoside analogues with the target and off-target GPCRs, such as biogenic amine receptors.  Molecular modeling predicts plasticity of the A3AR at TM2 to accommodate highly rigidified ligands.  Novel fluorescent derivatives of high affinity GPCR ligands are useful tool compounds for characterization of receptors and their oligomeric assemblies.  Fluorescent probes are useful for characterization of GPCRs in living cells by flow cytometry and other methods.  Thus, 3D knowledge of receptor binding and activation facilitates drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTp_cjf_vxkV5w7prLlxLOzfW6udTcc2eZr7cZKnNrKebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfjvFGquw%253D%253D&md5=045ec3300bf51cac43082e09bc2a72e0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.csbj.2014.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.csbj.2014.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DKiselev%26aufirst%3DE.%26aulast%3DChakraborty%26aufirst%3DS.%26aulast%3DJayasekara%26aufirst%3DP.%2BS.%26aulast%3DBalasubramanian%26aufirst%3DR.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26atitle%3DJohn%2520Daly%2520Lecture%253A%2520Structure-guided%2520drug%2520design%2520for%2520adenosine%2520and%2520P2Y%2520receptors%26jtitle%3DComput.%2520Struct.%2520Biotechnol.%2520J.%26date%3D2015%26volume%3D13%26spage%3D286%26epage%3D298%26doi%3D10.1016%2Fj.csbj.2014.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span>Molecular Operating Environment (MOE), <span class="NLM_edition">version 2012.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>; <span class="NLM_publisher-loc">1255 University St., Suite 1600, Montreal, QC H3B 3X3, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+version+2012.10%3B+Chemical+Computing+Group+Inc.%3B+1255+University+St.%2C+Suite+1600%2C+Montreal%2C+QC+H3B+3X3%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Rasmussen, S. G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVree, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calinski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathiesen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skiniotis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunahara, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">Crystal structure of the β<sub>2</sub> adrenergic receptor–Gs protein complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">477</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1038/nature10361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1038%2Fnature10361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=21772288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1equrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=477&publication_year=2011&pages=549-555&author=S.+G.+F.+Rasmussenauthor=B.+T.+DeVreeauthor=Y.+Zouauthor=A.+C.+Kruseauthor=K.+Y.+Chungauthor=T.+S.+Kobilkaauthor=F.+S.+Thianauthor=P.+S.+Chaeauthor=E.+Pardonauthor=D.+Calinskiauthor=J.+M.+Mathiesenauthor=S.+T.+A.+Shahauthor=J.+A.+Lyonsauthor=M.+Caffreyauthor=S.+H.+Gellmanauthor=J.+Steyaertauthor=G.+Skiniotisauthor=W.+I.+Weisauthor=R.+K.+Sunaharaauthor=B.+K.+Kobilka&title=Crystal+structure+of+the+%CE%B22+adrenergic+receptor%E2%80%93Gs+protein+complex&doi=10.1038%2Fnature10361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the β2 adrenergic receptor-Gs protein complex</span></div><div class="casAuthors">Rasmussen, Soren G. F.; DeVree, Brian T.; Zou, Yao-Zhong; Kruse, Andrew C.; Chung, Ka-Young; Kobilka, Tong-Sun; Thian, Foon-Sun; Chae, Pil-Seok; Pardon, Els; Calinski, Diane; Mathiesen, Jesper M.; Shah, Syed T. A.; Lyons, Joseph A.; Caffrey, Martin; Gellman, Samuel H.; Steyaert, Jan; Skiniotis, Georgios; Weis, William I.; Sunahara, Roger K.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">477</span>
        (<span class="NLM_cas:issue">7366</span>),
    <span class="NLM_cas:pages">549-555</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are responsible for the majority of cellular responses to hormones and neurotransmitters as well as the senses of sight, olfaction and taste.  The paradigm of GPCR signalling is the activation of a heterotrimeric GTP binding protein (G protein) by an agonist-occupied receptor.  The β2 adrenergic receptor (β2AR) activation of Gs, the stimulatory G protein for adenylyl cyclase, has long been a model system for GPCR signalling.  Here we present the crystal structure of the active state ternary complex composed of agonist-occupied monomeric β2AR and nucleotide-free Gs heterotrimer.  The principal interactions between the β2AR and Gs involve the amino- and carboxy-terminal α-helixes of Gs, with conformational changes propagating to the nucleotide-binding pocket.  The largest conformational changes in the β2AR include a 14 Å outward movement at the cytoplasmic end of transmembrane segment 6 (TM6) and an α-helical extension of the cytoplasmic end of TM5.  The most surprising observation is a major displacement of the α-helical domain of Gαs relative to the Ras-like GTPase domain.  This crystal structure represents the first high-resoln. view of transmembrane signalling by a GPCR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-PdYRDvolqrVg90H21EOLACvtfcHk0lhr4xV_JzvAEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1equrrL&md5=d22a43dd677ac255d138b1aedff357d3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature10361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10361%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%2BF.%26aulast%3DDeVree%26aufirst%3DB.%2BT.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DChung%26aufirst%3DK.%2BY.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DChae%26aufirst%3DP.%2BS.%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DCalinski%26aufirst%3DD.%26aulast%3DMathiesen%26aufirst%3DJ.%2BM.%26aulast%3DShah%26aufirst%3DS.%2BT.%2BA.%26aulast%3DLyons%26aufirst%3DJ.%2BA.%26aulast%3DCaffrey%26aufirst%3DM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DSkiniotis%26aufirst%3DG.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DCrystal%2520structure%2520of%2520the%2520%25CE%25B22%2520adrenergic%2520receptor%25E2%2580%2593Gs%2520protein%2520complex%26jtitle%3DNature%26date%3D2011%26volume%3D477%26spage%3D549%26epage%3D555%26doi%3D10.1038%2Fnature10361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span>Schrödinger Suite 2015; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2015%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Suite%25202015%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span>LigPrep, <span class="NLM_edition">version 3.5</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+3.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span>Glide, <span class="NLM_edition">version 6.8</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+6.8%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23a','cit23b'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref38':['cit38'],'ref36':['cit36'],'ref37':['cit37'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabetta  Coppi</span>, <span class="hlFld-ContribAuthor ">Federica  Cherchi</span>, <span class="hlFld-ContribAuthor ">Elena  Lucarini</span>, <span class="hlFld-ContribAuthor ">Carla  Ghelardini</span>, <span class="hlFld-ContribAuthor ">Felicita  Pedata</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Di Cesare Mannelli</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Pugliese</span>, <span class="hlFld-ContribAuthor ">Daniela  Salvemini</span>. </span><span class="cited-content_cbyCitation_article-title">Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A3 Receptor Subtype. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (15)
                                     , 7952. <a href="https://doi.org/10.3390/ijms22157952" title="DOI URL">https://doi.org/10.3390/ijms22157952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22157952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22157952%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DUncovering%252Bthe%252BMechanisms%252Bof%252BAdenosine%252BReceptor-Mediated%252BPain%252BControl%25253A%252BFocus%252Bon%252Bthe%252BA3%252BReceptor%252BSubtype%26aulast%3DCoppi%26aufirst%3DElisabetta%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D15%26spage%3D7952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Pd
              ‐Catalyzed
              C
              
              C
              Bond‐Forming Reactions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 323-361. <a href="https://doi.org/10.1002/9783527828166.ch6" title="DOI URL">https://doi.org/10.1002/9783527828166.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527828166.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527828166.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DPd%252B%2525E2%252580%252590Catalyzed%252BC%252B%2525EF%2525A3%2525BF%252BC%252BBond%2525E2%252580%252590Forming%252BReactions%26date%3D2021%26date%3D2020%26spage%3D323%26epage%3D361%26pub%3DWiley%26atitle%3DApplied%252BOrganic%252BChemistry%26aulast%3DDe%26aufirst%3DSurya%2BK.%26date%3D2021%26date%3D2020%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aaron  Tan</span>, <span class="hlFld-ContribAuthor ">Maria V.  Babak</span>, <span class="hlFld-ContribAuthor ">Gopalakrishnan  Venkatesan</span>, <span class="hlFld-ContribAuthor ">Clarissa  Lim</span>, <span class="hlFld-ContribAuthor ">Karl-Norbert  Klotz</span>, <span class="hlFld-ContribAuthor ">Deron Raymond  Herr</span>, <span class="hlFld-ContribAuthor ">Siew Lee  Cheong</span>, <span class="hlFld-ContribAuthor ">Stephanie  Federico</span>, <span class="hlFld-ContribAuthor ">Giampiero  Spalluto</span>, <span class="hlFld-ContribAuthor ">Wei-Yi  Ong</span>, <span class="hlFld-ContribAuthor ">Yu Zong  Chen</span>, <span class="hlFld-ContribAuthor ">Jason Siau Ee  Loo</span>, <span class="hlFld-ContribAuthor ">Giorgia  Pastorin</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (20)
                                     , 3661. <a href="https://doi.org/10.3390/molecules24203661" title="DOI URL">https://doi.org/10.3390/molecules24203661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24203661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24203661%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BEvaluation%252Bof%252BNew%252BIndolylpyrimidylpiperazines%252Bfor%252BGastrointestinal%252BCancer%252BTherapy%26aulast%3DTan%26aufirst%3DAaron%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D20%26spage%3D3661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biebele  Abel</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Stewart R.  Durell</span>, <span class="hlFld-ContribAuthor ">Megumi  Murakami</span>, <span class="hlFld-ContribAuthor ">Shahrooz  Vahedi</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Suresh V.  Ambudkar</span>. </span><span class="cited-content_cbyCitation_article-title">Evidence for the Interaction of A
              3
              Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1). </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2019,</strong> <em>96 </em>
                                    (2)
                                     , 180-192. <a href="https://doi.org/10.1124/mol.118.115295" title="DOI URL">https://doi.org/10.1124/mol.118.115295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.118.115295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.118.115295%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DEvidence%252Bfor%252Bthe%252BInteraction%252Bof%252BA%252B3%252BAdenosine%252BReceptor%252BAgonists%252Bat%252Bthe%252BDrug-Binding%252BSite%252528s%252529%252Bof%252BHuman%252BP-glycoprotein%252B%252528ABCB1%252529%26aulast%3DAbel%26aufirst%3DBiebele%26date%3D2019%26date%3D2019%26volume%3D96%26issue%3D2%26spage%3D180%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jolien  Storme</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Christophe P.  Stove</span>. </span><span class="cited-content_cbyCitation_article-title">Probing structure-activity relationship in β-arrestin2 recruitment of diversely substituted adenosine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>158 </em>, 103-113. <a href="https://doi.org/10.1016/j.bcp.2018.10.003" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DProbing%252Bstructure-activity%252Brelationship%252Bin%252B%2525CE%2525B2-arrestin2%252Brecruitment%252Bof%252Bdiversely%252Bsubstituted%252Badenosine%252Bderivatives%26aulast%3DStorme%26aufirst%3DJolien%26date%3D2018%26volume%3D158%26spage%3D103%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Stefania  Merighi</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>, <span class="hlFld-ContribAuthor ">Pier Andrea  Borea</span>, <span class="hlFld-ContribAuthor ">Stefania  Baraldi</span>, <span class="hlFld-ContribAuthor ">Mojgan  Aghazadeh Tabrizi</span>, <span class="hlFld-ContribAuthor ">Romeo  Romagnoli</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Stefania  Gessi</span>. </span><span class="cited-content_cbyCitation_article-title">A
              3
              Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (4)
                                     , 1031-1072. <a href="https://doi.org/10.1002/med.21456" title="DOI URL">https://doi.org/10.1002/med.21456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21456%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DA%252B3%252BAdenosine%252BReceptors%252Bas%252BModulators%252Bof%252BInflammation%25253A%252BFrom%252BMedicinal%252BChemistry%252Bto%252BTherapy%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2018%26date%3D2017%26volume%3D38%26issue%3D4%26spage%3D1031%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 45-72. <a href="https://doi.org/10.1007/978-1-4939-7465-8_3" title="DOI URL">https://doi.org/10.1007/978-1-4939-7465-8_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7465-8_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7465-8_3%26sid%3Dliteratum%253Aachs%26atitle%3DBreakthrough%252Bin%252BGPCR%252BCrystallography%252Band%252BIts%252BImpact%252Bon%252BComputer-Aided%252BDrug%252BDesign%26aulast%3DCiancetta%26aufirst%3DAntonella%26date%3D2018%26date%3D2017%26spage%3D45%26epage%3D72%26pub%3DSpringer%2520New%2520York%26atitle%3DComputational%252BMethods%252Bfor%252BGPCR%252BDrug%252BDiscovery%26aulast%3DHeifetz%26aufirst%3DAlexander%26date%3D2018%26volume%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Jinha  Yu</span>, <span class="hlFld-ContribAuthor ">Rama R.  Suresh</span>, <span class="hlFld-ContribAuthor ">Harsha  Rao</span>, <span class="hlFld-ContribAuthor ">Romeo  Romagnoli</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Mojgan  Aghazadeh Tabrizi</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of the A3 Adenosine Receptor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 169-198. <a href="https://doi.org/10.1007/978-3-319-90808-3_7" title="DOI URL">https://doi.org/10.1007/978-3-319-90808-3_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-90808-3_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-90808-3_7%26sid%3Dliteratum%253Aachs%26atitle%3DMedicinal%252BChemistry%252Bof%252Bthe%252BA3%252BAdenosine%252BReceptor%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2018%26date%3D2018%26spage%3D169%26epage%3D198%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BAdenosine%252BReceptors%26aulast%3DBorea%26aufirst%3DPier%2BAndrea%26date%3D2018%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Kenneth  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Probing and Molecular Modeling of the A3 Adenosine Receptor: A Focus on Agonist Binding. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (3)
                                     , 449. <a href="https://doi.org/10.3390/molecules22030449" title="DOI URL">https://doi.org/10.3390/molecules22030449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22030449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22030449%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructural%252BProbing%252Band%252BMolecular%252BModeling%252Bof%252Bthe%252BA3%252BAdenosine%252BReceptor%25253A%252BA%252BFocus%252Bon%252BAgonist%252BBinding%26aulast%3DCiancetta%26aufirst%3DAntonella%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D3%26spage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Reported Examples of C6-Modified Ribose-Containing (<b>1</b>–<b>3</b>)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and (<i>N</i>)-Methanocarba (<b>4</b>–<b>6</b>) Nucleosides<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> as AR Ligands<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>The binding <i>K</i><sub>i</sub> values (μM) at the rat (r) A<sub>3</sub>AR or hA<sub>3</sub>AR are shown in parentheses. Values for <b>4</b> and <b>6</b> were measured for the present study using the same methods as in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></p></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Attempted Synthesis of 6-Chloro (<i>N</i>)-Methanocarba Intermediate <b>30</b> as a Possible Precursor of Selective A<sub>3</sub>AR Agonists and the Redirected Route to A<sub>3</sub>AR Agonist Series Containing at the C6 Position Either a Substituted Styryl <b>12</b>–<b>14</b> or a Methyl Group <b>15</b>, <b>17</b> (Affinities in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, rt; (ii) 40% MeNH<sub>2</sub>, MeOH, rt; (iii) 10% TFA, MeOH, 70 °C.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Application of the Redirected Route from <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> to the Preparation of C6-Substituted 2-Cl (<i>N</i>)-Methanocarba Derivative <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Although many 2-Cl derivatives are potent A<sub>3</sub>AR agonists,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> this compound only weakly bound to the receptor (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). (i) phenylacetylene, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, rt; (ii) 40% MeNH<sub>2</sub>, MeOH, rt; (iii) 10% TFA, MeOH, 70 °C.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of C6-CH<sub>3</sub> (<i>N</i>)-Methanocarba Derivatives <b>16</b>, <b>18</b>, and <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2-iodo-6-methyl purine <b>54</b>, Ph<sub>3</sub>P, DIAD, THF, rt; (ii) 40% MeNH<sub>2</sub>, MeOH, rt; (iii) aryl alkynes, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF; (iv) 10% TFA, MeOH, H<sub>2</sub>O, 70 °C.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of C6-H (<i>N</i>)-Methanocarba Derivatives <b>20</b>, <b>21</b>, <b>23</b>, and <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2-iodo-purine, Ph<sub>3</sub>P, DIAD, THF, rt; (ii) 40% MeNH<sub>2</sub>, MeOH, rt; (iii) 10% TFA, MeOH, H<sub>2</sub>O, 70 °C; (iv) aryl alkynes, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Unproductive Synthetic Route to (<i>N</i>)-Methanocarba-inosine Derivative <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) MeONa, MeOH, rt; rt; (ii) 40% MeNH<sub>2</sub>, MeOH, rt.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0011.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of (<i>N</i>)-Methanocarba-inosine Derivative <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) MeONa, MeOH, rt; (ii) TBAF, THF, rt; (iii) PDC, DMF, 40 °C; (iv) MeNH<sub>2</sub>, HATU, DIPEA, DMF; (v) 2-chloro-5-ethynylthiophene, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF; (vi) Dowex50, MeOH, H<sub>2</sub>O, 70 °C.</p></p></figure><figure data-id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Functional agonism at the hA<sub>3</sub>AR (A) and the mA<sub>3</sub>AR (B) of nucleosides lacking an exocyclic NH, which remain selective A<sub>3</sub>AR ligands. (A) Compounds <b>15</b>, <b>19</b>, and <b>21</b> proved to be potent, full agonists at the hA<sub>3</sub>AR (% values relative to inhibition of forskolin-stimulated cyclic AMP accumulation by adenosine-5′-<i>N</i>-methyluronamide <b>1</b> at 10 μM). Compounds <b>12</b> (B) and <b>15</b> (C) in an assay of inhibition of forskolin-stimulated cyclic AMP accumulation with HEK293 cells expressing the mA<sub>3</sub>AR, as described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Concentration–effect curves with reference full agonist 2-chloro-<i>N</i><sup>6</sup>-(3-iodobenzyl)-5′-<i>N</i>-methylcarboxamidoadenosine <b>55</b> are included. Data are the mean ± SEM, <i>n</i> = 4–7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time course of protection hind paw mechanoallodynia of the sciatic nerve in the CCI mouse model (po administration on day 7, 3 μmol/kg). The vehicle was 10% DMSO in 0.5% methylcellulose, which when administered alone had no effect on PWT. There was no effect on the contralateral paw. (A) CCI results (<i>n</i> = 3) for compounds <b>12</b> (●) and <b>15</b> (■). Data are the mean ± SEM. For comparison, compound <b>8</b> at the same dose provided 100% and 23.7 ± 10.8% protection against mechanoallodynia in the same model at 1 and 3 h, respectively.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (B) CCI results (<i>n</i> = 2) for compounds <b>19</b> (●) and <b>21</b> (■).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/medium/jm-2015-019989_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hypothetical binding mode of C6-methyl (<i>N</i>)-methanocarba derivative <b>15</b> (orange carbon atoms, ball and stick representation), a potent and selective agonist, obtained after docking simulations at the hA<sub>3</sub>AR. Side chains of residues important for ligand recognition are reported as sticks (gray carbon atoms). H-bonds are pictured as green solid lines, whereas π–π stacking interactions as cyan dashed lines with the centroids of the aromatic rings displayed as cyan spheres. Nonpolar hydrogen atoms are omitted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01998/20170218/images/large/jm-2015-019989_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01998&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor: History and perspectives</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span><span class="refDoi"> DOI: 10.1124/pr.113.008540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1124%2Fpr.113.008540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=25387804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=74-102&author=P.+A.+Boreaauthor=K.+Varaniauthor=F.+Vincenziauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Merighiauthor=S.+Gessi&title=The+A3+adenosine+receptor%3A+History+and+perspectives&doi=10.1124%2Fpr.113.008540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor: history and perspectives</span></div><div class="casAuthors">Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Merighi, Stefania; Gessi, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-102, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  By general consensus, the omnipresent purine nucleoside adenosine is considered a major regulator of local tissue function, esp. when energy supply fails to meet cellular energy demand.  Adenosine mediation involves activation of a family of four G protein-coupled adenosine receptors (ARs): A1, A2A, A2B, and A3.  The A3 adenosine receptor (A3AR) is the only adenosine subtype to be overexpressed in inflammatory and cancer cells, thus making it a potential target for therapy.  Originally isolated as an orphan receptor, A3AR presented a twofold nature under different pathophysiol. conditions: it appeared to be protective/harmful under ischemic conditions, pro/anti-inflammatory, and pro/antitumoral depending on the systems investigated.  Until recently, the greatest and most intriguing challenge has been to understand whether, and in which cases, selective A3 agonists or antagonists would be the best choice.  Today, the choice has been made and A3AR agonists are now under clin. development for some disorders including rheumatoid arthritis, psoriasis, glaucoma, and hepatocellular carcinoma.  More specifically, the interest and relevance of these new agents derives from clin. data demonstrating that A3AR agonists are both effective and safe.  Thus, it will become apparent in the present review that purine scientists do seem to be getting closer to their goal: the incorporation of adenosine ligands into drugs with the ability to save lives and improve human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNTebUcia2x7Vg90H21EOLACvtfcHk0lg-fDgerJChZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D&md5=152673d44c951624ccb2ef090ffc670c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.113.008540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.113.008540%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DGessi%26aufirst%3DS.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%253A%2520History%2520and%2520perspectives%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26spage%3D74%26epage%3D102%26doi%3D10.1124%2Fpr.113.008540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Stoilov, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licheva, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihaylova, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitblat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrov, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimbova, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pispati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurman- Balbir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagaria, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oparanov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpaz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farbstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Therapeutic effect of oral CF101 in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled Phase II study</span> <span class="citation_source-journal">Immunome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">087</span><span class="refDoi"> DOI: 10.4172/1745-7580.1000087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.4172%2F1745-7580.1000087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=087&author=R.+M.+Stoilovauthor=R.+N.+Lichevaauthor=M.+K.+Mihaylovaauthor=T.+Reitblatauthor=E.+A.+Dimitrovauthor=K.+M.+Shimbovaauthor=G.+Bhatiaauthor=A.+Pispatiauthor=A.+Gurman-+Balbirauthor=B.+R.+Bagariaauthor=B.+A.+Oparanovauthor=S.+Fishmanauthor=Z.+Harpazauthor=M.+Farbsteinauthor=S.+Cohenauthor=D.+Bristolauthor=M.+H.+Silvermanauthor=P.+Fishman&title=Therapeutic+effect+of+oral+CF101+in+patients+with+rheumatoid+arthritis%3A+A+randomized%2C+double-blind%2C+placebo-controlled+Phase+II+study&doi=10.4172%2F1745-7580.1000087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4172%2F1745-7580.1000087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F1745-7580.1000087%26sid%3Dliteratum%253Aachs%26aulast%3DStoilov%26aufirst%3DR.%2BM.%26aulast%3DLicheva%26aufirst%3DR.%2BN.%26aulast%3DMihaylova%26aufirst%3DM.%2BK.%26aulast%3DReitblat%26aufirst%3DT.%26aulast%3DDimitrov%26aufirst%3DE.%2BA.%26aulast%3DShimbova%26aufirst%3DK.%2BM.%26aulast%3DBhatia%26aufirst%3DG.%26aulast%3DPispati%26aufirst%3DA.%26aulast%3DGurman-%2BBalbir%26aufirst%3DA.%26aulast%3DBagaria%26aufirst%3DB.%2BR.%26aulast%3DOparanov%26aufirst%3DB.%2BA.%26aulast%3DFishman%26aufirst%3DS.%26aulast%3DHarpaz%26aufirst%3DZ.%26aulast%3DFarbstein%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DBristol%26aufirst%3DD.%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DTherapeutic%2520effect%2520of%2520oral%2520CF101%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%253A%2520A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520Phase%2520II%2520study%26jtitle%3DImmunome%2520Res.%26date%3D2014%26volume%3D11%26spage%3D087%26doi%3D10.4172%2F1745-7580.1000087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Little, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons-Liguori, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luongo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maione, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickenson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">Endogenous adenosine A<sub>3</sub> receptor activation selectively alleviates persistent pain states</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1093/brain/awu330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1093%2Fbrain%2Fawu330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=25414036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A280%3ADC%252BC2M3pvFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2015&pages=28-35&author=J.+W.+Littleauthor=A.+Fordauthor=A.+M.+Symons-Liguoriauthor=Z.+Chenauthor=K.+Janesauthor=T.+Doyleauthor=J.+Xieauthor=L.+Luongoauthor=D.+K.+Toshauthor=S.+Maioneauthor=K.+Bannisterauthor=A.+Dickensonauthor=T.+W.+Vanderahauthor=F.+Porrecaauthor=K.+A.+Jacobsonauthor=D.+Salvemini&title=Endogenous+adenosine+A3+receptor+activation+selectively+alleviates+persistent+pain+states&doi=10.1093%2Fbrain%2Fawu330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states</span></div><div class="casAuthors">Little Joshua W; Ford Amanda; Chen Zhoumou; Janes Kali; Doyle Timothy; Salvemini Daniela; Symons-Liguori Ashley M; Xie Jennifer; Vanderah Todd W; Porreca Frank; Luongo Livio; Maione Sabatino; Tosh Dillip K; Jacobson Kenneth A; Bannister Kirsty; Dickenson Anthony H</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">Pt 1</span>),
    <span class="NLM_cas:pages">28-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic pain is a global burden that promotes disability and unnecessary suffering.  To date, efficacious treatment of chronic pain has not been achieved.  Thus, new therapeutic targets are needed.  Here, we demonstrate that increasing endogenous adenosine levels through selective adenosine kinase inhibition produces powerful analgesic effects in rodent models of experimental neuropathic pain through the A3 adenosine receptor (A3AR, now known as ADORA3) signalling pathway.  Similar results were obtained by the administration of a novel and highly selective A3AR agonist.  These effects were prevented by blockade of spinal and supraspinal A3AR, lost in A3AR knock-out mice, and independent of opioid and endocannabinoid mechanisms.  A3AR activation also relieved non-evoked spontaneous pain behaviours without promoting analgesic tolerance or inherent reward.  Further examination revealed that A3AR activation reduced spinal cord pain processing by decreasing the excitability of spinal wide dynamic range neurons and producing supraspinal inhibition of spinal nociception through activation of serotonergic and noradrenergic bulbospinal circuits.  Critically, engaging the A3AR mechanism did not alter nociceptive thresholds in non-neuropathy animals and therefore produced selective alleviation of persistent neuropathic pain states.  These studies reveal A3AR activation by adenosine as an endogenous anti-nociceptive pathway and support the development of A3AR agonists as novel therapeutics to treat chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTV_nDN4yfcy0Q0lWbKiCflfW6udTcc2eYLJPG4PCDY57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3pvFersw%253D%253D&md5=85411b662ffef21c0fc58f0549845716</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawu330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawu330%26sid%3Dliteratum%253Aachs%26aulast%3DLittle%26aufirst%3DJ.%2BW.%26aulast%3DFord%26aufirst%3DA.%26aulast%3DSymons-Liguori%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJanes%26aufirst%3DK.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DBannister%26aufirst%3DK.%26aulast%3DDickenson%26aufirst%3DA.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DEndogenous%2520adenosine%2520A3%2520receptor%2520activation%2520selectively%2520alleviates%2520persistent%2520pain%2520states%26jtitle%3DBrain%26date%3D2015%26volume%3D138%26spage%3D28%26epage%3D35%26doi%3D10.1093%2Fbrain%2Fawu330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doré, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurrell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhukov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span> </span><span class="NLM_article-title">Discovery of 1,2,4-triazine derivatives as adenosine A<sub>2A</sub> antagonists using structure based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1898</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span><span class="refDoi"> DOI: 10.1021/jm201376w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201376w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1898-1903&author=M.+Congreveauthor=S.+P.+Andrewsauthor=A.+S.+Dor%C3%A9author=K.+Hollensteinauthor=E.+Hurrellauthor=C.+J.+Langmeadauthor=J.+S.+Masonauthor=I.+W.+Ngauthor=B.+Tehanauthor=A.+Zhukovauthor=M.+P.+Weirauthor=F.+H.+Marshall&title=Discovery+of+1%2C2%2C4-triazine+derivatives+as+adenosine+A2A+antagonists+using+structure+based+drug+design&doi=10.1021%2Fjm201376w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design</span></div><div class="casAuthors">Congreve, Miles; Andrews, Stephen P.; Dore, Andrew S.; Hollenstein, Kaspar; Hurrell, Edward; Langmead, Christopher J.; Mason, Jonathan S.; Ng, Irene W.; Tehan, Benjamin; Zhukov, Andrei; Weir, Malcolm; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1898-1903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, ligand efficient, selective, and orally efficacious 1,2,4-triazine derivs. have been identified using structure based drug design approaches as antagonists of the adenosine A2A receptor.  The X-ray crystal structures of compds. 4e and 4g (I) bound to the GPCR illustrate that the mols. bind deeply inside the orthosteric binding cavity.  In vivo pharmacokinetic and efficacy data for compd. 4k are presented, demonstrating the potential of this series of compds. for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpddydZvtRPv7Vg90H21EOLACvtfcHk0lg-fDgerJChZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D&md5=71d76db8a22bf82f11d3632d2917e155</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm201376w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201376w%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3DHurrell%26aufirst%3DE.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DNg%26aufirst%3DI.%2BW.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DWeir%26aufirst%3DM.%2BP.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DDiscovery%2520of%25201%252C2%252C4-triazine%2520derivatives%2520as%2520adenosine%2520A2A%2520antagonists%2520using%2520structure%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1898%26epage%3D1903%26doi%3D10.1021%2Fjm201376w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heitman, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegal, G.</span><span> </span><span class="NLM_article-title">Fragment screening of GPCRs using biophysical methods: identification of ligands of the adenosine A<sub>2A</sub> Receptor with novel biological activity</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2064</span><span class="NLM_x">–</span> <span class="NLM_lpage">2073</span><span class="refDoi"> DOI: 10.1021/cb300436c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300436c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWhtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=2064-2073&author=D.+Chenauthor=J.+C.+Erreyauthor=L.+H.+Heitmanauthor=F.+H.+Marshallauthor=A.+P.+IJzermanauthor=G.+Siegal&title=Fragment+screening+of+GPCRs+using+biophysical+methods%3A+identification+of+ligands+of+the+adenosine+A2A+Receptor+with+novel+biological+activity&doi=10.1021%2Fcb300436c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment Screening of GPCRs Using Biophysical Methods: Identification of Ligands of the Adenosine A2A Receptor with Novel Biological Activity</span></div><div class="casAuthors">Chen, Dan; Errey, James C.; Heitman, Laura H.; Marshall, Fiona H.; IJzerman, Adriaan P.; Siegal, Gregg</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2064-2073</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery (FBDD) has proven a powerful method to develop novel drugs with excellent oral bioavailability against challenging pharmaceutical targets such as protein-protein interaction targets.  Very recently the underlying biophys. techniques have begun to be successfully applied to membrane proteins.  Here we show that novel, ligand efficient small mols. with a variety of biol. activities can be found by screening a small fragment library using thermostabilized (StaR) G protein-coupled receptors (GPCRs) and target immobilized NMR screening (TINS).  Detergent-solubilized StaR adenosine A2A receptor was immobilized with retention of functionality, and a screen of 531 fragments was performed.  Hits from the screen were thoroughly characterized for biochem. activity using the wild-type receptor.  Both orthosteric and allosteric modulatory activity has been demonstrated in biochem. validation assays.  Allosteric activity was confirmed in cell-based functional assays.  The validated fragment hits make excellent starting points for a subsequent hit-to-lead elaboration program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1XViW7Pwl9bVg90H21EOLACvtfcHk0lhWLeZ9l9nbMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWhtbbL&md5=100b470e43c452b4fef8b9cf1637cfcd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fcb300436c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300436c%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DSiegal%26aufirst%3DG.%26atitle%3DFragment%2520screening%2520of%2520GPCRs%2520using%2520biophysical%2520methods%253A%2520identification%2520of%2520ligands%2520of%2520the%2520adenosine%2520A2A%2520Receptor%2520with%2520novel%2520biological%2520activity%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D2064%26epage%3D2073%26doi%3D10.1021%2Fcb300436c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">In vivo phenotypic screening for treating chronic neuropathic pain: Modification of C2-arylethynyl group of conformationally constrained A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9901</span><span class="NLM_x">–</span> <span class="NLM_lpage">9914</span><span class="refDoi"> DOI: 10.1021/jm501021n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501021n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9901-9914&author=D.+K.+Toshauthor=A.+Finleyauthor=S.+Paolettaauthor=S.+M.+Mossauthor=Z.+G.+Gaoauthor=E.+Gizewskiauthor=J.+Auchampachauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=In+vivo+phenotypic+screening+for+treating+chronic+neuropathic+pain%3A+Modification+of+C2-arylethynyl+group+of+conformationally+constrained+A3+adenosine+receptor+agonists&doi=10.1021%2Fjm501021n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Phenotypic Screening for Treating Chronic Neuropathic Pain: Modification of C2-Arylethynyl Group of Conformationally Constrained A3 Adenosine Receptor Agonists</span></div><div class="casAuthors">Tosh, Dilip K.; Finley, Amanda; Paoletta, Silvia; Moss, Steven M.; Gao, Zhan-Guo; Gizewski, Elizabeth T.; Auchampach, John A.; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9901-9914</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(N)-Methanocarba adenosine 5'-methyluronamides contg. 2-arylethynyl groups were synthesized as A3 adenosine receptor (AR) agonists and screened in vivo (po) for redn. of neuropathic pain.  A small N6-Me group maintained binding affinity, with human > mouse A3AR and MW < 500 and other favorable physicochem. properties.  Emax (maximal efficacy in a mouse chronic constriction injury pain model) of previously characterized A3AR agonist, 2-(3,4-difluorophenylethynyl)-N6-(3-chlorobenzyl) deriv. 6a, MRS5698, was surpassed.  More efficacious analogs (in vivo) contained the following C2-arylethynyl groups: pyrazin-2-yl 23 (binding Ki, hA3AR, nM 1.8), fur-2-yl 27 (0.6), thien-2-yl 32 (0.6) and its 5-chloro 33, MRS5980 (0.7) and 5-bromo 34 (0.4) equiv., and physiol. unstable ferrocene 36, MRS5979 (2.7). 33 and 36 displayed particularly long in vivo duration (>3 h).  Selected analogs were docked to an A3AR homol. model to explore the environment of receptor-bound C2 and N6 groups.  Various analogs bound with μM affinity at off-target biogenic amine (M2, 5HT2A, β3, 5HT2B, 5HT2C, and α2C) or other receptors.  Thus, we have expanded the structural range of orally active A3AR agonists for chronic pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQCo4JjAXTTLVg90H21EOLACvtfcHk0lhWLeZ9l9nbMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrjF&md5=d9f3f36c4c107a289cef7f4deb9b70ce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm501021n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501021n%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DFinley%26aufirst%3DA.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DMoss%26aufirst%3DS.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DIn%2520vivo%2520phenotypic%2520screening%2520for%2520treating%2520chronic%2520neuropathic%2520pain%253A%2520Modification%2520of%2520C2-arylethynyl%2520group%2520of%2520conformationally%2520constrained%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9901%26epage%3D9914%26doi%3D10.1021%2Fjm501021n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure-guided design of A<sub>3</sub> adenosine receptor-selective nucleosides: Combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4847</span><span class="NLM_x">–</span> <span class="NLM_lpage">4860</span><span class="refDoi"> DOI: 10.1021/jm300396n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300396n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4847-4860&author=D.+K.+Toshauthor=F.+Deflorianauthor=K.+Phanauthor=Z.+G.+Gaoauthor=T.+C.+Wanauthor=E.+Gizewskiauthor=J.+A.+Auchampachauthor=K.+A.+Jacobson&title=Structure-guided+design+of+A3+adenosine+receptor-selective+nucleosides%3A+Combination+of+2-arylethynyl+and+bicyclo%5B3.1.0%5Dhexane+substitutions&doi=10.1021%2Fjm300396n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of A3 Adenosine Receptor-Selective Nucleosides: Combination of 2-Arylethynyl and Bicyclo[3.1.0]hexane Substitutions</span></div><div class="casAuthors">Tosh, Dilip K.; Deflorian, Francesca; Phan, Khai; Gao, Zhan-Guo; Wan, Tina C.; Gizewski, Elizabeth; Auchampach, John A.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4847-4860</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(N)-Methanocarba adenosine 5'-methyluronamides contg. known A3 AR (adenosine receptor)-enhancing modifications, i.e., 2-(arylethynyl)adenine and N6-Me or N6-(3-substituted-benzyl), were nanomolar full agonists of human (h) A3AR and highly selective (Ki ∼0.6 nM, N6-Me 2-(halophenylethynyl) analogs).  Combined 2-arylethynyl-N6-3-chlorobenzyl substitutions preserved A3AR affinity/selectivity in the (N)-methanocarba series (e.g., 3,4-difluoro full agonist MRS5698, Ki 3 nM, human and mouse A3) better than that for ribosides.  Polyarom. 2-ethynyl N6-3-chlorobenzyl analogs, such as potent linearly extended 2-p-biphenylethynyl MRS5679 (Ki hA3 3.1 nM; A1, A2A, inactive) and fluorescent 1-pyrene adduct MRS5704 (Ki hA3 68.3 nM), were conformationally rigid; receptor docking identified a large, mainly hydrophobic binding region.  The vicinity of receptor-bound C2 groups was probed by homol. modeling based on recent x-ray structure of an agonist-bound A2AAR, with a predicted helical rearrangement requiring an agonist-specific outward displacement of TM2 resembling opsin.  Thus, the x-ray structure of related A2AAR is useful in guiding the design of new A3AR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMpTThMrry7bVg90H21EOLACvtfcHk0lhWLeZ9l9nbMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFygu74%253D&md5=e01c27247742c9d20ee7ff753a2de88c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm300396n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300396n%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DWan%26aufirst%3DT.%2BC.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-guided%2520design%2520of%2520A3%2520adenosine%2520receptor-selective%2520nucleosides%253A%2520Combination%2520of%25202-arylethynyl%2520and%2520bicyclo%255B3.1.0%255Dhexane%2520substitutions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4847%26epage%3D4860%26doi%3D10.1021%2Fjm300396n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chubukov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heitman, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structural basis for allosteric regulation of GPCRs by sodium ions</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span><span class="refDoi"> DOI: 10.1126/science.1219218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1126%2Fscience.1219218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=22798613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVKqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2012&pages=232-236&author=W.+Liuauthor=E.+Chunauthor=A.+A.+Thompsonauthor=P.+Chubukovauthor=F.+Xuauthor=V.+Katritchauthor=G.+W.+Hanauthor=C.+B.+Rothauthor=L.+H.+Heitmanauthor=A.+P.+IJzermanauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structural+basis+for+allosteric+regulation+of+GPCRs+by+sodium+ions&doi=10.1126%2Fscience.1219218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions</span></div><div class="casAuthors">Liu, Wei; Chun, Eugene; Thompson, Aaron A.; Chubukov, Pavel; Xu, Fei; Katritch, Vsevolod; Han, Gye Won; Roth, Christopher B.; Heitman, Laura H.; IJzerman, Adriaan P.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">6091</span>),
    <span class="NLM_cas:pages">232-236</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Pharmacol. responses of G protein-coupled receptors (GPCRs) can be fine-tuned by allosteric modulators.  Structural studies of such effects have been limited due to the medium resoln. of GPCR structures.  We reengineered the human A2A adenosine receptor by replacing its third intracellular loop with apocytochrome b562RIL and solved the structure at 1.8 angstrom resoln.  The high-resoln. structure allowed us to identify 57 ordered water mols. inside the receptor comprising three major clusters.  The central cluster harbors a putative sodium ion bound to the highly conserved aspartate residue Asp2.50.  Addnl., two cholesterols stabilize the conformation of helix VI, and one of 23 ordered lipids intercalates inside the ligand-binding pocket.  These high-resoln. details shed light on the potential role of structured water mols., sodium ions, and lipids/cholesterol in GPCR stabilization and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvcjQimGnIMLVg90H21EOLACvtfcHk0lgBadvSXwjy6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVKqtbs%253D&md5=782b2235b76ef77b11b6456f8e4485e1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1219218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1219218%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DChubukov%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DRoth%26aufirst%3DC.%2BB.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520basis%2520for%2520allosteric%2520regulation%2520of%2520GPCRs%2520by%2520sodium%2520ions%26jtitle%3DScience%26date%3D2012%26volume%3D337%26spage%3D232%26epage%3D236%26doi%3D10.1126%2Fscience.1219218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R.</span><span> </span><span class="NLM_article-title">Agonist bound structure of the human adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1126/science.1202793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1126%2Fscience.1202793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=21393508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFWjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2011&pages=322-327&author=F.+Xuauthor=H.+Wuauthor=V.+Katritchauthor=G.+W.+Hanauthor=K.+A.+Jacobsonauthor=Z.+G.+Gaoauthor=V.+Cherezovauthor=R.+Stevens&title=Agonist+bound+structure+of+the+human+adenosine+A2A+receptor&doi=10.1126%2Fscience.1202793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of an Agonist-Bound Human A2A Adenosine Receptor</span></div><div class="casAuthors">Xu, Fei; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Jacobson, Kenneth A.; Gao, Zhan-Guo; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">6027</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Activation of G protein-coupled receptors upon agonist binding is a crit. step in the signaling cascade for this family of cell surface proteins.  We report the crystal structure of the A2A adenosine receptor (A2AAR) bound to an agonist UK-432097 at 2.7 angstrom resoln.  Relative to inactive, antagonist-bound A2AAR, the agonist-bound structure displays an outward tilt and rotation of the cytoplasmic half of helix VI, a movement of helix V, and an axial shift of helix III, resembling the changes assocd. with the active-state opsin structure.  Addnl., a seesaw movement of helix VII and a shift of extracellular loop 3 are likely specific to A2AAR and its ligand.  The results define the mol. UK-432097 as a "conformationally selective agonist" capable of receptor stabilization in a specific active-state configuration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMkD1ni9m9GrVg90H21EOLACvtfcHk0lgBadvSXwjy6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFWjt7s%253D&md5=b1e074f38f45c95d4cc3b40378b24923</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1202793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1202793%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%26atitle%3DAgonist%2520bound%2520structure%2520of%2520the%2520human%2520adenosine%2520A2A%2520receptor%26jtitle%3DScience%26date%3D2011%26volume%3D332%26spage%3D322%26epage%3D327%26doi%3D10.1126%2Fscience.1202793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lebon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, C. G.</span><span> </span><span class="NLM_article-title">Agonist-bound adenosine A<sub>2A</sub> receptor structures reveal common features of GPCR activation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">474</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span><span class="refDoi"> DOI: 10.1038/nature10136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1038%2Fnature10136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=21593763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFyqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=474&publication_year=2011&pages=521-525&author=G.+Lebonauthor=T.+Warneauthor=P.+C.+Edwardsauthor=K.+Bennettauthor=C.+J.+Langmeadauthor=A.+G.+Leslieauthor=C.+G.+Tate&title=Agonist-bound+adenosine+A2A+receptor+structures+reveal+common+features+of+GPCR+activation&doi=10.1038%2Fnature10136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation</span></div><div class="casAuthors">Lebon, Guillaume; Warne, Tony; Edwards, Patricia C.; Bennett, Kirstie; Langmead, Christopher J.; Leslie, Andrew G. W.; Tate, Christopher G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">474</span>
        (<span class="NLM_cas:issue">7352</span>),
    <span class="NLM_cas:pages">521-525</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adenosine receptors and β-adrenoceptors are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins on binding the agonists adenosine or noradrenaline, resp.  GPCRs have similar structures consisting of seven transmembrane helixes that contain well-conserved sequence motifs, indicating that they are probably activated by a common mechanism.  Recent structures of β-adrenoceptors highlight residues in transmembrane region 5 that initially bind specifically to agonists rather than to antagonists, indicating that these residues have an important role in agonist-induced activation of receptors.  Here we present two crystal structures of the thermostabilized human adenosine A2A receptor (A2AR-GL31) bound to its endogenous agonist adenosine and the synthetic agonist NECA.  The structures represent an intermediate conformation between the inactive and active states, because they share all the features of GPCRs that are thought to be in a fully activated state, except that the cytoplasmic end of transmembrane helix 6 partially occludes the G-protein-binding site.  The adenine substituent of the agonists binds in a similar fashion to the chem. related region of the inverse agonist ZM241385 (ref. 8).  Both agonists contain a ribose group, not found in ZM241385, which extends deep into the ligand-binding pocket where it makes polar interactions with conserved residues in H7 (Ser 2777.42 and His 2787.43; superscripts refer to Ballesteros-Weinstein numbering) and non-polar interactions with residues in H3.  In contrast, the inverse agonist ZM241385 does not interact with any of these residues and comparison with the agonist-bound structures indicates that ZM241385 sterically prevents the conformational change in H5 and therefore it acts as an inverse agonist.  Comparison of the agonist-bound structures of A2AR with the agonist-bound structures of β-adrenoceptors indicates that the contraction of the ligand-binding pocket caused by the inward motion of helixes 3, 5 and 7 may be a common feature in the activation of all GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1rCKkCsE9CrVg90H21EOLACvtfcHk0lgBadvSXwjy6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFyqsrg%253D&md5=1b8161216b878db48ad33d7e8e007dc7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature10136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10136%26sid%3Dliteratum%253Aachs%26aulast%3DLebon%26aufirst%3DG.%26aulast%3DWarne%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DBennett%26aufirst%3DK.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DTate%26aufirst%3DC.%2BG.%26atitle%3DAgonist-bound%2520adenosine%2520A2A%2520receptor%2520structures%2520reveal%2520common%2520features%2520of%2520GPCR%2520activation%26jtitle%3DNature%26date%3D2011%26volume%3D474%26spage%3D521%26epage%3D525%26doi%3D10.1038%2Fnature10136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaakola, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span> </span><span class="NLM_article-title">Structure-based discovery of novel chemotypes for adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1799</span><span class="NLM_x">–</span> <span class="NLM_lpage">1809</span><span class="refDoi"> DOI: 10.1021/jm901647p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901647p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlKqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1799-1809&author=V.+Katritchauthor=V.+P.+Jaakolaauthor=J.+R.+Laneauthor=J.+Linauthor=A.+P.+IJzermanauthor=M.+Yeagerauthor=I.+Kufarevaauthor=R.+C.+Stevensauthor=R.+Abagyan&title=Structure-based+discovery+of+novel+chemotypes+for+adenosine+A2A+receptor+antagonists&doi=10.1021%2Fjm901647p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Novel Chemotypes for Adenosine A2A Receptor Antagonists</span></div><div class="casAuthors">Katritch, Vsevolod; Jaakola, Veli-Pekka; Lane, J. Robert; Lin, Judy; IJzerman, Adriaan P.; Yeager, Mark; Kufareva, Irina; Stevens, Raymond C.; Abagyan, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1799-1809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent progress in crystallog. of G-protein coupled receptors opens an unprecedented venue for structure-based GPCR drug discovery.  To test efficiency of the structure-based approach, we performed mol. docking and virtual ligand screening (VLS) of more than 4 million com. available "drug-like" and "lead-like" compds. against the A2AAR 2.6 Å resoln. crystal structure.  Out of 56 high ranking compds. tested in A2AAR binding assays, 23 showed affinities under 10 μM, 11 of those had sub-μM affinities and two compds. had affinities under 60 nM.  The identified hits represent at least 9 different chem. scaffolds and are characterized by very high ligand efficiency (0.3-0.5 kcal/mol per heavy atom).  Significant A2AAR antagonist activities were confirmed for 10 out of 13 ligands tested in functional assays.  High success rate, novelty, and diversity of the chem. scaffolds and strong ligand efficiency of the A2AAR antagonists identified in this study suggest practical applicability of receptor-based VLS in GPCR drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX-YAwoEVzEbVg90H21EOLACvtfcHk0lhkv8ypfTus0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlKqsw%253D%253D&md5=5a54df43f6edd20d83e7e5942e2f9811</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm901647p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901647p%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DJaakola%26aufirst%3DV.%2BP.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DYeager%26aufirst%3DM.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DStructure-based%2520discovery%2520of%2520novel%2520chemotypes%2520for%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1799%26epage%3D1809%26doi%3D10.1021%2Fjm901647p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Integrated methods for the construction of three dimensional models and computational probing of structure-function relationships in G-protein coupled receptors</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1016/S1043-9471(05)80049-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=366-428&author=J.+A.+Ballesterosauthor=H.+Weinstein&title=Integrated+methods+for+the+construction+of+three+dimensional+models+and+computational+probing+of+structure-function+relationships+in+G-protein+coupled+receptors&doi=10.1016%2FS1043-9471%2805%2980049-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span></div><div class="casAuthors">Ballesteros, Juan A.; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">366-428</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review, with 135 refs., on approaches that can be used to resolve the apparent ambiguities that burden the pharmacol. testing of G protein-coupled receptor (GPCR) models, based on the integration of structural information about the receptor, about mutants, and about the changes induced by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfENoRspqa7LVg90H21EOLACvtfcHk0lhkv8ypfTus0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D&md5=d3f99e9d07cea245a770f3f099bc8cc7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three%2520dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure-function%2520relationships%2520in%2520G-protein%2520coupled%2520receptors%26jtitle%3DMethods%2520Neurosci.%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428%26doi%3D10.1016%2FS1043-9471%2805%2980049-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bruns, R. F.</span><span> </span><span class="NLM_article-title">Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists</span> <span class="citation_source-journal">Can. J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1139/y80-110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1139%2Fy80-110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=6253037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADyaL3cXls1Sqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1980&pages=673-691&author=R.+F.+Bruns&title=Adenosine+receptor+activation+in+human+fibroblasts%3A+nucleoside+agonists+and+antagonists&doi=10.1139%2Fy80-110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor activation in human fibroblasts:  nucleoside agonists and antagonists</span></div><div class="casAuthors">Bruns, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">673-91</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    </div><div class="casAbstract">Adenosine  [58-61-7] (ED50 15 μM) causes a 50-fold increase in intracellular cyclic AMP in the VA13 human fibroblast line.  A total of 128 nucleosides was tested as agonists and antagonists.  Eight classes of compds. were found: full agonists (14 compds.), weak agonists (20), high-efficacy partial agonists (16), low-efficacy partial agonists (7), competitive inhibitors (11), noncompetitive inhibitors (3), partial agonist - noncompetitive inhibitors (3), and inactive compds. (54).  The noncompetitive inhibitors antagonized the responses to adenosine, isoproterenol, and prostaglandin E1 and thus may have been adenylate cyclase inhibitors.  The most potent noncompetitive inhibitor, 2',5'-dideoxyadenosine  [6698-26-6] was a partial inhibitor, reducing the response to isoproterenol by only 77% even at very high concns.  The most potent agonists, partial agonists, and pure antagonists had apparent affinities of about 5 μM.  Although all positions were important for affinity at the adenosine receptor, only the 3'- and 5'-positions and to a much lesser extent the 6- and 8-positions had an effect on efficacy.  The receptor tolerated bulky groups at the 6-position of adenosine, had an Et-sized pocket near the 5'-position, and had little bulk tolerance towards modifications at other positions.  Among the full agonists, only one 5'-deriv. and one 2-position deriv. had higher apparent affinity than adenosine.  Studies with conformationally restricted agonists and antagonists showed that adenosine must be in the anti conformation in order to bind to the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKRAqZBkQJY7Vg90H21EOLACvtfcHk0lhkv8ypfTus0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXls1Sqtb4%253D&md5=1851e7bb2c11b84bddafc934515169fb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1139%2Fy80-110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fy80-110%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26atitle%3DAdenosine%2520receptor%2520activation%2520in%2520human%2520fibroblasts%253A%2520nucleoside%2520agonists%2520and%2520antagonists%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D1980%26volume%3D58%26spage%3D673%26epage%3D691%26doi%3D10.1139%2Fy80-110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span><span class="refDoi"> DOI: 10.2174/138161208784480081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.2174%2F138161208784480081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=18537675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1525-1552&author=G.+Cristalliauthor=C.+Lambertucciauthor=G.+Marucciauthor=R.+Volpiniauthor=D.+Dal+Ben&title=A2A+adenosine+receptor+and+its+modulators%3A+overview+on+a+druggable+GPCR+and+on+structure-activity+relationship+analysis+and+binding+requirements+of+agonists+and+antagonists&doi=10.2174%2F138161208784480081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists</span></div><div class="casAuthors">Cristalli, G.; Lambertucci, C.; Marucci, G.; Volpini, R.; Dal Ben, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1525-1552</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the biol. effects of adenosine, the development of potent and selective agonists and antagonists of adenosine receptors has been the subject of medicinal chem. research for several decades, even if their clin. evaluation has been discontinued.  Main problems include side effects due to the ubiquity of the receptors and the possibility of side effects, or to low brain penetration (in particular for the targeting of CNS diseases), short half-life of compds., lack of effects.  Furthermore, species differences in the affinity of ligands make difficult preclin. testing in animal models.  Nevertheless, adenosine receptors continue to represent promising drug targets.  A2A receptor has proved to be a promising pharmacol. target for small synthetic ligands, and while A2A agonists are undergoing clin. trials for myocardial perfusion imaging and as anti-inflammatory agents, A2A antagonists represent an attractive field of research to discover new drugs for the treatment of neurodegenerative disorders, such as Parkinson's disease.  Furthermore, the information coming from bioinformatics and mol. modeling studies for the A2A receptor has made easier the understanding of ligand-target interaction and the rational design of agonists and antagonists for this subtype.  The aim of this review is to show an overview of the most significant steps and progresses in developing A2A adenosine receptor agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLD7b3gsaCZrVg90H21EOLACvtfcHk0ljRBXudafYGYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D&md5=3b8c004d9a1fbff02c0a0ee1b476fcea</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F138161208784480081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208784480081%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DDal%2BBen%26aufirst%3DD.%26atitle%3DA2A%2520adenosine%2520receptor%2520and%2520its%2520modulators%253A%2520overview%2520on%2520a%2520druggable%2520GPCR%2520and%2520on%2520structure-activity%2520relationship%2520analysis%2520and%2520binding%2520requirements%2520of%2520agonists%2520and%2520antagonists%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D1525%26epage%3D1552%26doi%3D10.2174%2F138161208784480081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Siddiqi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esker, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, J. A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneller, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span> </span><span class="NLM_article-title">Search for new purine- and ribose- modified adenosine analogues as selective agonists and antagonists at adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1174</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span><span class="refDoi"> DOI: 10.1021/jm00007a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00007a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1174-1188&author=S.+M.+Siddiqiauthor=K.+A.+Jacobsonauthor=J.+L.+Eskerauthor=M.+E.+Olahauthor=X.-D.+Jiauthor=N.+Melmanauthor=K.+N.+Tiwariauthor=J.+A.+Secristauthor=S.+W.+Schnellerauthor=G.+Cristalliauthor=G.+L.+Stilesauthor=C.+R.+Johnsonauthor=A.+P.+IJzerman&title=Search+for+new+purine-+and+ribose-+modified+adenosine+analogues+as+selective+agonists+and+antagonists+at+adenosine+receptors&doi=10.1021%2Fjm00007a014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00007a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00007a014%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqi%26aufirst%3DS.%2BM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DEsker%26aufirst%3DJ.%2BL.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DJi%26aufirst%3DX.-D.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DTiwari%26aufirst%3DK.%2BN.%26aulast%3DSecrist%26aufirst%3DJ.%2BA.%26aulast%3DSchneller%26aufirst%3DS.%2BW.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJohnson%26aufirst%3DC.%2BR.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26atitle%3DSearch%2520for%2520new%2520purine-%2520and%2520ribose-%2520modified%2520adenosine%2520analogues%2520as%2520selective%2520agonists%2520and%2520antagonists%2520at%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1174%26epage%3D1188%26doi%3D10.1021%2Fjm00007a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chang, L. C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanjersberg, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe Künzel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder-Krieger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span> </span><span class="NLM_article-title">2,6-Disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2861</span><span class="NLM_x">–</span> <span class="NLM_lpage">2867</span><span class="refDoi"> DOI: 10.1021/jm050640i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050640i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVajtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2861-2867&author=L.+C.+W.+Changauthor=R.+F.+Spanjersbergauthor=J.+K.+von+Frijtag+Drabbe+K%C3%BCnzelauthor=T.+Mulder-Kriegerauthor=J.+Brusseeauthor=A.+P.+IJzerman&title=2%2C6-Disubstituted+and+2%2C6%2C8-trisubstituted+purines+as+adenosine+receptor+antagonists&doi=10.1021%2Fjm050640i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">2,6-Disubstituted and 2,6,8-Trisubstituted Purines as Adenosine Receptor Antagonists</span></div><div class="casAuthors">Chang, Lisa C. W.; Spanjersberg, Ronald F.; Von Kuenzel, Jacobien K.; Mulder-Krieger, Thea; Brussee, Johannes; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2861-2867</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Purines have long been exploited as adenosine receptor antagonists.  The substitution pattern about the purine ring has been well investigated, and certain criteria have become almost a prerequisite for good affinity at the adenosine A1 receptor.  The adaptation of the pharmacophore and the initial series of pyrimidines developed in an earlier publication resulted in a series of purines with an entirely new substitution pattern.  One compd. in particular, 8-cyclopentyl-2,6-diphenylpurine (31, LUF 5962) has been shown to be very promising with an affinity of 0.29 nM at the human adenosine A1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgkii9-PAkabVg90H21EOLACvtfcHk0ljRBXudafYGYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVajtLc%253D&md5=f13f0250833a4575bdd74a5f26a51e26</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm050640i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050640i%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%2BC.%2BW.%26aulast%3DSpanjersberg%26aufirst%3DR.%2BF.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BK%25C3%25BCnzel%26aufirst%3DJ.%2BK.%26aulast%3DMulder-Krieger%26aufirst%3DT.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26atitle%3D2%252C6-Disubstituted%2520and%25202%252C6%252C8-trisubstituted%2520purines%2520as%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2861%26epage%3D2867%26doi%3D10.1021%2Fjm050640i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">van Galen, P. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Bergen, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">A binding site model and structure-activity relationships for the rat A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=1101-1111&author=P.+J.+M.+van+Galenauthor=A.+H.+van+Bergenauthor=C.+Gallo-Rodriguezauthor=N.+Melmanauthor=M.+E.+Olahauthor=A.+P.+IJzermanauthor=G.+L.+Stilesauthor=K.+A.+Jacobson&title=A+binding+site+model+and+structure-activity+relationships+for+the+rat+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BGalen%26aufirst%3DP.%2BJ.%2BM.%26aulast%3Dvan%2BBergen%26aufirst%3DA.%2BH.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA%2520binding%2520site%2520model%2520and%2520structure-activity%2520relationships%2520for%2520the%2520rat%2520A3%2520adenosine%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D1101%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ravi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltysiak, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2295</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span><span class="refDoi"> DOI: 10.1016/S0960-894X(01)00450-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2FS0960-894X%2801%2900450-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=2295-2300&author=G.+Raviauthor=K.+Leeauthor=X.+D.+Jiauthor=H.+S.+Kimauthor=K.+A.+Soltysiakauthor=V.+E.+Marquezauthor=K.+A.+Jacobson&title=Synthesis+and+purine+receptor+affinity+of+6-oxopurine+nucleosides+and+nucleotides+containing+%28N%29-methanocarba-pseudoribose+rings&doi=10.1016%2FS0960-894X%2801%2900450-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900450-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900450-4%26sid%3Dliteratum%253Aachs%26aulast%3DRavi%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DSoltysiak%26aufirst%3DK.%2BA.%26aulast%3DMarquez%26aufirst%3DV.%2BE.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520purine%2520receptor%2520affinity%2520of%25206-oxopurine%2520nucleosides%2520and%2520nucleotides%2520containing%2520%2528N%2529-methanocarba-pseudoribose%2520rings%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D2295%26epage%3D2300%26doi%3D10.1016%2FS0960-894X%2801%2900450-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis using ring closure metathesis and effect on nucleoside transport of a (N)-methanocarba <i>S</i>-(4-nitrobenzyl)thioinosine derivative</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1021/ol006999c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol006999c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=597-599&author=K.+Leeauthor=C.+Cassauthor=K.+A.+Jacobson&title=Synthesis+using+ring+closure+metathesis+and+effect+on+nucleoside+transport+of+a+%28N%29-methanocarba+S-%284-nitrobenzyl%29thioinosine+derivative&doi=10.1021%2Fol006999c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fol006999c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006999c%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DCass%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520using%2520ring%2520closure%2520metathesis%2520and%2520effect%2520on%2520nucleoside%2520transport%2520of%2520a%2520%2528N%2529-methanocarba%2520S-%25284-nitrobenzyl%2529thioinosine%2520derivative%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26spage%3D597%26epage%3D599%26doi%3D10.1021%2Fol006999c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure-guided design of A<sub>3</sub> adenosine receptor-selective nucleosides: Combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7580</span><span class="NLM_x">–</span> <span class="NLM_lpage">7592</span><span class="refDoi"> DOI: 10.1021/jm900426g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900426g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7580-7592&author=D.+K.+Toshauthor=M.+Chinnauthor=A.+A.+Ivanovauthor=A.+M.+Klutzauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=Structure-guided+design+of+A3+adenosine+receptor-selective+nucleosides%3A+Combination+of+2-arylethynyl+and+bicyclo%5B3.1.0%5Dhexane+substitutions&doi=10.1021%2Fjm900426g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm900426g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900426g%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DChinn%26aufirst%3DM.%26aulast%3DIvanov%26aufirst%3DA.%2BA.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-guided%2520design%2520of%2520A3%2520adenosine%2520receptor-selective%2520nucleosides%253A%2520Combination%2520of%25202-arylethynyl%2520and%2520bicyclo%255B3.1.0%255Dhexane%2520substitutions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7580%26epage%3D7592%26doi%3D10.1021%2Fjm900426g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Joshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, A. K.</span><span> </span><span class="NLM_article-title">Base-mediated selective synthesis of diversely substituted <i>N</i>-heterocyclic enamines and enaminones by the hydroamination of alkynes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">5633</span><span class="NLM_x">–</span> <span class="NLM_lpage">5645</span><span class="refDoi"> DOI: 10.1021/jo300782n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo300782n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslGjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=5633-5645&author=M.+Joshiauthor=M.+Patelauthor=R.+Tiwariauthor=A.+K.+Verma&title=Base-mediated+selective+synthesis+of+diversely+substituted+N-heterocyclic+enamines+and+enaminones+by+the+hydroamination+of+alkynes&doi=10.1021%2Fjo300782n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Base-Mediated Selective Synthesis of Diversely Substituted N-Heterocyclic Enamines and Enaminones by the Hydroamination of Alkynes</span></div><div class="casAuthors">Joshi, Megha; Patel, Monika; Tiwari, Rakesh; Verma, Akhilesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5633-5645</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Regio- and stereoselective alkynylation of various N-heterocycles using potassium and cesium salts in DMSO is described.  Terminal alkynes and internal alkynes provided the kinetically stable Z-enamines in good to excellent yields using KOH at 120 °C.  E.g., in presence of KOH in DMSO, alkynylation of pyrrole by 4-EtC6H4C≡CH gave 82% (Z)-I.  Addn. of heterocyclic amines to 1,3- and 1,4-diethynylbenzene provided a mixt. of E/Z isomers with KOH; however, with Cs2CO3 Z-isomers were obtained by the hydroamination at one triple bond.  This methodol. also provides an easy and novel access for the synthesis of enaminones.  The detailed work also supports the formation of the cis-isomer by preferential addn. of o-haloarylalkynes followed by intramol. C2 arylation in the copper-catalyzed tandem synthesis of indolo and pyrrolo[2,1-a]isoquinolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0e2DuhUB1e7Vg90H21EOLACvtfcHk0lhwoHcLqjQ0MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslGjs78%253D&md5=1235fbc7459a052acd70c63b798ed5b2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjo300782n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo300782n%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DVerma%26aufirst%3DA.%2BK.%26atitle%3DBase-mediated%2520selective%2520synthesis%2520of%2520diversely%2520substituted%2520N-heterocyclic%2520enamines%2520and%2520enaminones%2520by%2520the%2520hydroamination%2520of%2520alkynes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2012%26volume%3D77%26spage%3D5633%26epage%3D5645%26doi%3D10.1021%2Fjo300782n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Muller, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultzsch, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foubelo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, M.</span><span> </span><span class="NLM_article-title">Hydroamination: Direct addition of amines to alkenes and alkynes</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">3795</span><span class="NLM_x">–</span> <span class="NLM_lpage">3892</span><span class="refDoi"> DOI: 10.1021/cr0306788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0306788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A280%3ADC%252BD1crptleisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=3795-3892&author=T.+E.+Mullerauthor=K.+C.+Hultzschauthor=M.+Yusauthor=F.+Foubeloauthor=M.+Tada&title=Hydroamination%3A+Direct+addition+of+amines+to+alkenes+and+alkynes&doi=10.1021%2Fcr0306788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroamination: direct addition of amines to alkenes and alkynes</span></div><div class="casAuthors">Muller Thomas E; Hultzsch Kai C; Yus Miguel; Foubelo Francisco; Tada Mizuki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3795-892</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSV453Tu8yN5ntlzo9xastyfW6udTcc2ea57Mzv38Efgrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crptleisg%253D%253D&md5=56894f42f4e5b51472b69eecddb81b89</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fcr0306788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0306788%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DT.%2BE.%26aulast%3DHultzsch%26aufirst%3DK.%2BC.%26aulast%3DYus%26aufirst%3DM.%26aulast%3DFoubelo%26aufirst%3DF.%26aulast%3DTada%26aufirst%3DM.%26atitle%3DHydroamination%253A%2520Direct%2520addition%2520of%2520amines%2520to%2520alkenes%2520and%2520alkynes%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D3795%26epage%3D3892%26doi%3D10.1021%2Fcr0306788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Severin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doye, S.</span><span> </span><span class="NLM_article-title">The catalytic hydroamination of alkynes</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1407</span><span class="refDoi"> DOI: 10.1039/b600981f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1039%2Fb600981f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=17660874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1ygtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=1407&author=R.+Severinauthor=S.+Doye&title=The+catalytic+hydroamination+of+alkynes&doi=10.1039%2Fb600981f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">The catalytic hydroamination of alkynes</span></div><div class="casAuthors">Severin, Rene; Doye, Sven</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1407-1420</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The review focus on recent developments in intermol. hydroamination of alkynes and developments in catalysts that appeared in the literature between the end of 2002 and Oct. 31, 2006.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLf6UnNZGoU7Vg90H21EOLACvtfcHk0lhwoHcLqjQ0MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1ygtbw%253D&md5=451aee5c9a59c6ba8aa25f7fc39bac5b</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1039%2Fb600981f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb600981f%26sid%3Dliteratum%253Aachs%26aulast%3DSeverin%26aufirst%3DR.%26aulast%3DDoye%26aufirst%3DS.%26atitle%3DThe%2520catalytic%2520hydroamination%2520of%2520alkynes%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2007%26volume%3D36%26spage%3D1407%26doi%3D10.1039%2Fb600981f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maas, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamhuis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynberg, H.</span><span> </span><span class="NLM_article-title"><a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a>Mechanism of enamine reactions. IV. The hydrolysis of tertiary enamines in acidic medium</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1111</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span><span class="refDoi"> DOI: 10.1021/jo01279a056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01279a056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1965&pages=1111-1115&author=W.+Maasauthor=M.+J.+Janssenauthor=E.+J.+Stamhuisauthor=H.+Wynberg&title=%281%29Mechanism+of+enamine+reactions.+IV.+The+hydrolysis+of+tertiary+enamines+in+acidic+medium&doi=10.1021%2Fjo01279a056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fjo01279a056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01279a056%26sid%3Dliteratum%253Aachs%26aulast%3DMaas%26aufirst%3DW.%26aulast%3DJanssen%26aufirst%3DM.%2BJ.%26aulast%3DStamhuis%26aufirst%3DE.%2BJ.%26aulast%3DWynberg%26aufirst%3DH.%26atitle%3D%25281%2529Mechanism%2520of%2520enamine%2520reactions.%2520IV.%2520The%2520hydrolysis%2520of%2520tertiary%2520enamines%2520in%2520acidic%2520medium%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1965%26volume%3D30%26spage%3D1111%26epage%3D1115%26doi%3D10.1021%2Fjo01279a056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span> <span class="citation_source-book">Enamines: Synthesis, Structure and Reactions</span>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_contrib-group">Cook, A. G.</span>, Ed.; <span class="NLM_publisher-name">Marcel Dekker</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1988</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&author=A.+G.+Cook&title=Enamines%3A+Synthesis%2C+Structure+and+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DEnamines%253A%2520Synthesis%252C%2520Structure%2520and%2520Reactions%26aulast%3DCook%26aufirst%3DA.%2BG.%26pub%3DMarcel%2520Dekker%26date%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A<sub>3</sub> adenosine receptor agonist that protects against chronic neuropathic pain</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1007/s11302-015-9459-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1007%2Fs11302-015-9459-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=26111639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVyhsL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=371-387&author=D.+K.+Toshauthor=J.+Padiaauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=Efficient%2C+large-scale+synthesis+and+preclinical+studies+of+MRS5698%2C+a+highly+selective+A3+adenosine+receptor+agonist+that+protects+against+chronic+neuropathic+pain&doi=10.1007%2Fs11302-015-9459-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain</span></div><div class="casAuthors">Tosh, Dilip K.; Padia, Janak; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">371-387</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We reported that 2-(3,4-difluorophenylethynyl)-N6-3-chlorobenzyl (N)-methanocarba adenosine deriv. 1 (MRS5698) binds selectively to human and mouse A3 adenosine receptors (A3ARs, Ki 3 nM).  It is becoming an important pharmacol. tool for defining A3AR effects and is orally active in a chronic neuropathic pain model.  Here, we introduce a new synthetic route for MRS5698 from D-ribose, suitable for a scale-up on a multi-gram scale, and we measure in vitro and in vivo ADME-Tox parameters.  MRS5698 was very stable in vitro, failed to inhibit CYPs at <10 μM, and was largely bound to plasma proteins.  It was well tolerated in the rat at doses of ≤200 mg/kg i.p.  A 1 mg/kg i.p. dose in the mouse displayed t1/2 of 1.09 h and plasma Cmax of 204 nM at 1 h with an AUC of 213 ng × h/mL.  CACO-2 bidirectional transport studies suggested intestinal efflux of MRS5698 (efflux ratio 86).  Although the oral %F is only 5 %, the beneficial effect to reverse pain lasted for at least 2 h in the CCI model in rats, using the same vehicle for oral administration of a high dose.  The stability, low toxicity, lack of CYP interaction, pharmacokinetic half-life, and in vivo efficacy suggest that MRS5698 is a preferred compd. for further consideration as a treatment for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu82TREqapwLVg90H21EOLACvtfcHk0ljas44TUBIwJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVyhsL7J&md5=0d810ff59dc5011f0ae25e7f8d6d24c4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs11302-015-9459-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-015-9459-2%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DPadia%26aufirst%3DJ.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DEfficient%252C%2520large-scale%2520synthesis%2520and%2520preclinical%2520studies%2520of%2520MRS5698%252C%2520a%2520highly%2520selective%2520A3%2520adenosine%2520receptor%2520agonist%2520that%2520protects%2520against%2520chronic%2520neuropathic%2520pain%26jtitle%3DPurinergic%2520Signalling%26date%3D2015%26volume%3D11%26spage%3D371%26epage%3D387%26doi%3D10.1007%2Fs11302-015-9459-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cheng, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between inhibition constant (K1) and concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic-reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span><span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+inhibition+constant+%28K1%29+and+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic-reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0ljas44TUBIwJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic-reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bradford, M. M.</span><span> </span><span class="NLM_article-title">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=942051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+rapid+and+sensitive+method+for+the+quantitation+of+microgram+quantities+of+protein+utilizing+the+principle+of+protein-dye+binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span></div><div class="casAuthors">Bradford, Marion M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">248-54</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A protein detn. method that involves the binding of coomassie Brilliant Blue G 250 to protein is described.  The binding of the dye to protein causes a shift in the absorption max. of the dye from 465 to 595 nm, and it is the increase in absorption at 595 nm that is monitored.  This assay is very reproducible and rapid with the dye binding process virtually complete in ∼ 2 min with good color stability for 1 hr.  There is little or no interference from cations such as Na+ or K+ nor from carbohydrates such as sucrose.  A small amt. of color is developed in the presence of strongly alk. buffering agents, but the assay may be run accurately by the use of proper buffer controls.  The only components found to give excessive interfering color in the assay are relatively large amts. of detergents such as Na dodecyl sulfate, Triton X 100, and commercial glassware detergents.  Interference by small amts. of detergent may be eliminated by the use of proper control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_T_d0trcNrVg90H21EOLACvtfcHk0ljas44TUBIwJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D&md5=43f388a493becc4193c7a49d9de0e1db</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520the%2520quantitation%2520of%2520microgram%2520quantities%2520of%2520protein%2520utilizing%2520the%2520principle%2520of%2520protein-dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Nordstedt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1016/0003-2697(90)90113-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2F0003-2697%2890%2990113-N" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=1990&pages=231-234&author=C.+Nordstedtauthor=B.+B.+Fredholm&title=A+modification+of+a+protein-binding+method+for+rapid+quantification+of+cAMP+in+cell-culture+supernatants+and+body+fluid&doi=10.1016%2F0003-2697%2890%2990113-N"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2890%2990113-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252890%252990113-N%26sid%3Dliteratum%253Aachs%26aulast%3DNordstedt%26aufirst%3DC.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DA%2520modification%2520of%2520a%2520protein-binding%2520method%2520for%2520rapid%2520quantification%2520of%2520cAMP%2520in%2520cell-culture%2520supernatants%2520and%2520body%2520fluid%26jtitle%3DAnal.%2520Biochem.%26date%3D1990%26volume%3D189%26spage%3D231%26epage%3D234%26doi%3D10.1016%2F0003-2697%2890%2990113-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Little, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">Central adenosine A<sub>3</sub> receptor (A<sub>3</sub>AR) activation reverses neuropathic pain</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">S50</span><span class="refDoi"> DOI: 10.1016/j.jpain.2014.01.207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2Fj.jpain.2014.01.207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=S50&author=J.+Littleauthor=Z.+Chenauthor=A.+Fordauthor=K.+Janesauthor=T.+Doyleauthor=D.+Toshauthor=K.+Jacobsonauthor=D.+Salvemini&title=Central+adenosine+A3+receptor+%28A3AR%29+activation+reverses+neuropathic+pain&doi=10.1016%2Fj.jpain.2014.01.207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2014.01.207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2014.01.207%26sid%3Dliteratum%253Aachs%26aulast%3DLittle%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DFord%26aufirst%3DA.%26aulast%3DJanes%26aufirst%3DK.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DTosh%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DCentral%2520adenosine%2520A3%2520receptor%2520%2528A3AR%2529%2520activation%2520reverses%2520neuropathic%2520pain%26jtitle%3DJ.%2520Pain%26date%3D2014%26volume%3D15%26spage%3DS50%26doi%3D10.1016%2Fj.jpain.2014.01.207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y. K.</span><span> </span><span class="NLM_article-title">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1016/0304-3959(88)90209-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2F0304-3959%2888%2990209-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=2837713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1988&pages=87-107&author=G.+J.+Bennettauthor=Y.+K.+Xie&title=A+peripheral+mononeuropathy+in+rat+that+produces+disorders+of+pain+sensation+like+those+seen+in+man&doi=10.1016%2F0304-3959%2888%2990209-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span></div><div class="casAuthors">Bennett Gary J; Xie Y-K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-107</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">A peripheral mononeuropathy was produced in adult rats by placing loosely constrictive ligatures around the common sciatic nerve.  The postoperative behavior of these rats indicated that hyperalgesia, allodynia and, possibly, spontaneous pain (or dysesthesia) were produced.  Hyperalgesic responses to noxious radiant heat were evident on the second postoperative day and lasted for over 2 months.  Hyperalgesic responses to chemogenic pain were also present.  The presence of allodynia was inferred from the nocifensive responses evoked by standing on an innocuous, chilled metal floor or by innocuous mechanical stimulation, and by the rats' persistence in holding the hind paw in a guarded position.  The presence of spontaneous pain was suggested by a suppression of appetite and by the frequent occurrence of apparently spontaneous nocifensive responses.  The affected hind paw was abnormally warm or cool in about one-third of the rats.  About one-half of the rats developed grossly overgrown claws on the affected side.  Experiments with this animal model may advance our understanding of the neural mechanisms of neuropathic pain disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvFbgQgoOLbwWRJ3OJdH_qfW6udTcc2eY6YmSjliCWubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D&md5=b65eee81b7058ce686a014eee46ead80</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2888%2990209-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252888%252990209-6%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DXie%26aufirst%3DY.%2BK.%26atitle%3DA%2520peripheral%2520mononeuropathy%2520in%2520rat%2520that%2520produces%2520disorders%2520of%2520pain%2520sensation%2520like%2520those%2520seen%2520in%2520man%26jtitle%3DPain%26date%3D1988%26volume%3D33%26spage%3D87%26epage%3D107%26doi%3D10.1016%2F0304-3959%2888%2990209-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Besnard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruda, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecassis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguiz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidah, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constam, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickerton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">492</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.+P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lgdVHGnXzb80w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Janowsky, A.; Eshleman, A.; Tosh, D. K.; Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Rigid adenine nucleoside derivatives as novel modulators of the human sodium symporters for dopamine and other neurotransmitters</span>.  <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1124/jpet.115.229666</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1124%2Fjpet.115.229666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=26813929" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Janowsky&author=A.+Eshleman&author=D.+K.+Tosh&author=K.+A.+Jacobson&title=Rigid+adenine+nucleoside+derivatives+as+novel+modulators+of+the+human+sodium+symporters+for+dopamine+and+other+neurotransmitters&doi=10.1124%2Fjpet.115.229666"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.229666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.229666%26sid%3Dliteratum%253Aachs%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DRigid%2520adenine%2520nucleoside%2520derivatives%2520as%2520novel%2520modulators%2520of%2520the%2520human%2520sodium%2520symporters%2520for%2520dopamine%2520and%2520other%2520neurotransmitters%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26doi%3D10.1124%2Fjpet.115.229666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Rational design of sulfonated A<sub>3</sub> adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5949</span><span class="NLM_x">–</span> <span class="NLM_lpage">5963</span><span class="refDoi"> DOI: 10.1021/jm4007966</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4007966" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvFamtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5949-5963&author=S.+Paolettaauthor=D.+K.+Toshauthor=A.+Finleyauthor=E.+Gizewskiauthor=S.+M.+Mossauthor=Z.+G.+Gaoauthor=J.+A.+Auchampachauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=Rational+design+of+sulfonated+A3+adenosine+receptor-selective+nucleosides+as+pharmacological+tools+to+study+chronic+neuropathic+pain&doi=10.1021%2Fjm4007966"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Sulfonated A3 Adenosine Receptor-Selective Nucleosides as Pharmacological Tools To Study Chronic Neuropathic Pain</span></div><div class="casAuthors">Paoletta, Silvia; Tosh, Dilip K.; Finley, Amanda; Gizewski, Elizabeth T.; Moss, Steven M.; Gao, Zhan-Guo; Auchampach, John A.; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5949-5963</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(N)-Methanocarba(bicyclo[3.1.0]hexane)adenosine derivs. were probed for sites of charged sulfonate substitution, which precludes diffusion across biol. membranes, e.g., blood-brain barrier.  Mol. modeling predicted that sulfonate groups on C2-phenylethynyl substituents would provide high affinity at both mouse (m) and human (h) A3 adenosine receptors (ARs), while a N6-p-sulfophenylethyl substituent would det. higher hA3AR vs mA3AR affinity.  These modeling predictions, based on steric fitting of the binding cavity and crucial interactions with key residues, were confirmed by binding/efficacy studies of synthesized sulfonates.  N6-3-Chlorobenzyl-2-(3-sulfophenylethynyl) deriv. I (R = 3-Cl-Bn, R1 = H, R2 = 3-SO3H) (MRS5841) bound selectively to h/m A3ARs (Ki(hA3AR) = 1.9 nM) as agonist, while corresponding p-sulfo isomer I (R = 3-Cl-Bn, R1 = H, R2 = 4-SO3H) (MRS5701) displayed mixed A1/A3AR agonism.  Both nucleosides administered i.p. reduced mouse chronic neuropathic pain that was ascribed to either A3AR or A1/A3AR using A3AR genetic deletion.  Thus, rational design methods based on A3AR homol. models successfully predicted sites for sulfonate incorporation, for delineating adenosine's CNS vs peripheral actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzqyBaxHNVQrVg90H21EOLACvtfcHk0lgdVHGnXzb80w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvFamtbw%253D&md5=f00b54135a300a673b63e6550de78faf</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm4007966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4007966%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DFinley%26aufirst%3DA.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DMoss%26aufirst%3DS.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRational%2520design%2520of%2520sulfonated%2520A3%2520adenosine%2520receptor-selective%2520nucleosides%2520as%2520pharmacological%2520tools%2520to%2520study%2520chronic%2520neuropathic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5949%26epage%3D5963%26doi%3D10.1021%2Fjm4007966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kusachi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugni, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R. A.</span><span> </span><span class="NLM_article-title">Dog coronary artery adenosine receptor: structure of the N<sup>6</sup>-alkyl subregion</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1636</span><span class="NLM_x">–</span> <span class="NLM_lpage">1643</span><span class="refDoi"> DOI: 10.1021/jm00149a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00149a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=1636-1643&author=S.+Kusachiauthor=R.+D.+Thompsonauthor=W.+J.+Bugniauthor=N.+Yamadaauthor=R.+A.+Olsson&title=Dog+coronary+artery+adenosine+receptor%3A+structure+of+the+N6-alkyl+subregion&doi=10.1021%2Fjm00149a016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm00149a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00149a016%26sid%3Dliteratum%253Aachs%26aulast%3DKusachi%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DR.%2BD.%26aulast%3DBugni%26aufirst%3DW.%2BJ.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DOlsson%26aufirst%3DR.%2BA.%26atitle%3DDog%2520coronary%2520artery%2520adenosine%2520receptor%253A%2520structure%2520of%2520the%2520N6-alkyl%2520subregion%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D1636%26epage%3D1643%26doi%3D10.1021%2Fjm00149a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Gillerman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, B.</span><span> </span><span class="NLM_article-title">Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1021/jm101286g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101286g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=107-121&author=I.+Gillermanauthor=B.+Fischer&title=Investigations+into+the+origin+of+the+molecular+recognition+of+several+adenosine+deaminase+inhibitors&doi=10.1021%2Fjm101286g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm101286g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101286g%26sid%3Dliteratum%253Aachs%26aulast%3DGillerman%26aufirst%3DI.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DInvestigations%2520into%2520the%2520origin%2520of%2520the%2520molecular%2520recognition%2520of%2520several%2520adenosine%2520deaminase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D107%26epage%3D121%26doi%3D10.1021%2Fjm101286g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Hüttemann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukena, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenschow, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwabe, U.</span><span> </span><span class="NLM_article-title">R<sub>a</sub> adenosine receptors in human platelets. Characterization by 5′-N-ethylcarboxamido [<sup>3</sup>H]adenosine binding in relation to adenylate cyclase activity</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1007/BF00495948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1007%2FBF00495948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=6328333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADyaL2cXitVChsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=1984&pages=226-233&author=E.+H%C3%BCttemannauthor=D.+Ukenaauthor=V.+Lenschowauthor=U.+Schwabe&title=Ra+adenosine+receptors+in+human+platelets.+Characterization+by+5%E2%80%B2-N-ethylcarboxamido+%5B3H%5Dadenosine+binding+in+relation+to+adenylate+cyclase+activity&doi=10.1007%2FBF00495948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Ra adenosine receptors in human platelets.  Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity</span></div><div class="casAuthors">Huettemann, E.; Ukena, D.; Lenschow, V.; Schwabe, U.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">226-33</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">Adenosine  [58-61-7] receptors in human platelet membranes were characterized by radioligand binding and measurement of adenylate cyclase  [9012-42-4] activity.  Binding of 5'-N-ethyl-carboxamidoadenosine (NECA)  [35920-39-9] was rapid, reversible and dependent on protein concn., pH and temp.  Due to a rapid rate of dissocn. (half-life approx. 20 s) binding was highest at 0°.  Adenosine deaminase and GTP  [86-01-1] alone did not influence [3H]NECA binding, whereas several divalent cations decreased binding.  Satn. expts. revealed 2 different binding sites for [3H]NECA, with KD values of 0.16 and 2.9 μmol/L and Bmax values of 8.4 and 33.4 pmol/mg of protein.  In competition expts. NECA was the most potent adenosine agonist (IC50 0.5 μmol/L), followed by 2-chloroadenosine  [146-77-0] (IC50 6.3 μmol/L) and adenosine (IC50 12 μmol/L).  A similar rank order of potencies was obsd. for the stimulatory effect of adenosine analogs on platelet adenylate cyclase.  NECA stimulated adenylate cyclase activity with an EC50 value of 0.5 μmol/L and was approx. 4-fold more potent than (-)N6-phenylisopropyladenosine [(-)PIA]  [38594-96-6].  However, (-)PIA and N6-cyclohexyladenosine did not affect [3H]NECA binding, an observation not consistent with the stimulatory effect on adenylate cyclase.  The adenosine antagonists IBMX, theophylline, and caffeine showed IC50 values between 98 and 5600 μmol/L.  [3H]PIA bound to platelet membranes with very low affinity and was not displaced by NECA.  The [3H]NECA binding to human platelet membranes satisfies essential criteria for Ra adenosine receptors and, with some limitations, should be of value for the characterization of adenosine receptors in Ra subtype selective cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol8r_0XpfwabVg90H21EOLACvtfcHk0lheyXuP_tHrUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXitVChsLw%253D&md5=de1db21d0f341c1a2c5ee87a2408d040</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2FBF00495948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00495948%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCttemann%26aufirst%3DE.%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DLenschow%26aufirst%3DV.%26aulast%3DSchwabe%26aufirst%3DU.%26atitle%3DRa%2520adenosine%2520receptors%2520in%2520human%2520platelets.%2520Characterization%2520by%25205%25E2%2580%25B2-N-ethylcarboxamido%2520%255B3H%255Dadenosine%2520binding%2520in%2520relation%2520to%2520adenylate%2520cyclase%2520activity%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1984%26volume%3D325%26spage%3D226%26epage%3D233%26doi%3D10.1007%2FBF00495948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Recent developments in adenosine receptor ligands and their potential as novel drugs</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1808</span><span class="NLM_x">, </span> <span class="NLM_fpage">1290</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2010.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2Fj.bbamem.2010.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=21185259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1808&publication_year=2011&pages=1290-1308&author=C.+M%C3%BCllerauthor=K.+A.+Jacobson&title=Recent+developments+in+adenosine+receptor+ligands+and+their+potential+as+novel+drugs&doi=10.1016%2Fj.bbamem.2010.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in adenosine receptor ligands and their potential as novel drugs</span></div><div class="casAuthors">Mueller, Christa E.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1808</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1290-1308</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Medicinal chem. approaches have been applied to all four of the adenosine receptor (AR) subtypes (A1, A2A, A2B, and A3) to create selective agonists and antagonists for each.  The most recent class of selective AR ligands to be reported is the class of A2BAR agonists.  The availability of these selective ligands has facilitated research on therapeutic applications of modulating the ARs and in some cases has provided clin. candidates.  Prodrug approaches have been developed which improve the bioavailability of the drugs, reduce side-effects, and/or may lead to site-selective effects.  The A2A agonist regadenoson (Lexiscan), a diagnostic drug for myocardial perfusion imaging, is the first selective AR agonist to be approved.  Other selective agonists and antagonists are or were undergoing clin. trials for a broad range of indications, including capadenoson and tecadenoson (A1 agonists) for atrial fibrillation, or paroxysmal supraventricular tachycardia, resp., apadenoson and binodenoson (A2A agonists) for myocardial perfusion imaging, preladenant (A2A antagonist) for the treatment of Parkinson's disease, and CF101 and CF102 (A3 agonists) for inflammatory diseases and cancer, resp.  This article is part of a Special Issue entitled: "Adenosine Receptors".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8Cuch7XkT7Vg90H21EOLACvtfcHk0lheyXuP_tHrUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsr8%253D&md5=f143d2424c178c0a75e956ffb6b8320a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2010.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2010.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520developments%2520in%2520adenosine%2520receptor%2520ligands%2520and%2520their%2520potential%2520as%2520novel%2520drugs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2011%26volume%3D1808%26spage%3D1290%26epage%3D1308%26doi%3D10.1016%2Fj.bbamem.2010.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Hassan, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Elkhair, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riordan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khare, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waud, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, J. A.,  3rd.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of the substrate activity of C-6 substituted purine ribosides with E. coli purine nucleoside phosphorylase: palladium mediated cross-coupling of organozinc halides with 6-chloropurine nucleosides</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2Fj.ejmech.2011.10.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=167-174&author=A.+E.+Hassanauthor=R.+A.+Abou-Elkhairauthor=J.+M.+Riordanauthor=P.+W.+Allanauthor=W.+B.+Parkerauthor=R.+Khareauthor=W.+R.+Waudauthor=J.+A.+Montgomeryauthor=J.+A.+Secrist&title=Synthesis+and+evaluation+of+the+substrate+activity+of+C-6+substituted+purine+ribosides+with+E.+coli+purine+nucleoside+phosphorylase%3A+palladium+mediated+cross-coupling+of+organozinc+halides+with+6-chloropurine+nucleosides&doi=10.1016%2Fj.ejmech.2011.10.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DHassan%26aufirst%3DA.%2BE.%26aulast%3DAbou-Elkhair%26aufirst%3DR.%2BA.%26aulast%3DRiordan%26aufirst%3DJ.%2BM.%26aulast%3DAllan%26aufirst%3DP.%2BW.%26aulast%3DParker%26aufirst%3DW.%2BB.%26aulast%3DKhare%26aufirst%3DR.%26aulast%3DWaud%26aufirst%3DW.%2BR.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26aulast%3DSecrist%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520the%2520substrate%2520activity%2520of%2520C-6%2520substituted%2520purine%2520ribosides%2520with%2520E.%2520coli%2520purine%2520nucleoside%2520phosphorylase%253A%2520palladium%2520mediated%2520cross-coupling%2520of%2520organozinc%2520halides%2520with%25206-chloropurine%2520nucleosides%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D167%26epage%3D174%26doi%3D10.1016%2Fj.ejmech.2011.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Van Aerschot, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyns, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdewijn, P. A.</span><span> </span><span class="NLM_article-title">Antiviral activity of C-alkylated purine nucleosides obtained by cross-coupling with tetraalkyltin reagents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2938</span><span class="NLM_x">–</span> <span class="NLM_lpage">2942</span><span class="refDoi"> DOI: 10.1021/jm00072a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00072a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2938-2942&author=A.+A.+Van+Aerschotauthor=P.+Mamosauthor=N.+J.+Weynsauthor=S.+Ikedaauthor=E.+De+Clercqauthor=P.+A.+Herdewijn&title=Antiviral+activity+of+C-alkylated+purine+nucleosides+obtained+by+cross-coupling+with+tetraalkyltin+reagents&doi=10.1021%2Fjm00072a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm00072a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00072a013%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BAerschot%26aufirst%3DA.%2BA.%26aulast%3DMamos%26aufirst%3DP.%26aulast%3DWeyns%26aufirst%3DN.%2BJ.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DHerdewijn%26aufirst%3DP.%2BA.%26atitle%3DAntiviral%2520activity%2520of%2520C-alkylated%2520purine%2520nucleosides%2520obtained%2520by%2520cross-coupling%2520with%2520tetraalkyltin%2520reagents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2938%26epage%3D2942%26doi%3D10.1021%2Fjm00072a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Luongo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vita, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grifantini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Novellis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappellacci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maione, S.</span><span> </span><span class="NLM_article-title">5<b>′</b>-Chloro-5<b>′</b>-deoxy-(±)-ENBA, a potent and selective adenosine A<sub>1</sub> receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">13712</span><span class="NLM_x">–</span> <span class="NLM_lpage">13726</span><span class="refDoi"> DOI: 10.3390/molecules171213712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.3390%2Fmolecules171213712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=23174891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVequrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=13712-13726&author=L.+Luongoauthor=R.+Petrelliauthor=L.+Gattaauthor=C.+Giordanoauthor=F.+Guidaauthor=P.+Vitaauthor=P.+Franchettiauthor=M.+Grifantiniauthor=V.+de+Novellisauthor=L.+Cappellacciauthor=S.+Maione&title=5%E2%80%B2-Chloro-5%E2%80%B2-deoxy-%28%C2%B1%29-ENBA%2C+a+potent+and+selective+adenosine+A1+receptor+agonist%2C+alleviates+neuropathic+pain+in+mice+through+functional+glial+and+microglial+changes+without+affecting+motor+or+cardiovascular+functions&doi=10.3390%2Fmolecules171213712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">5'-Chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions</span></div><div class="casAuthors">Luongo, Livio; Petrelli, Riccardo; Gatta, Luisa; Giordano, Catia; Guida, Francesca; Vita, Patrizia; Franchetti, Palmarisa; Grifantini, Mario; de Novellis, Vito; Cappellacci, Loredana; Maione, Sabatino</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13712-13726</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">This study was undertaken in order to investigate the effect of chronic treatment with 5'-chloro-5'-deoxy-(±)-ENBA, a potent and highly selective agonist of human adenosine A1 receptor, on thermal hyperalgesia and mech. allodynia in a mouse model of neuropathic pain, the Spared Nerve Injury (SNI) of the sciatic nerve.  Chronic systemic administration of 5'-chloro-5'-deoxy-(±)-ENBA (0.5 mg/kg, i.p.) reduced both mech. allodynia and thermal hyperalgesia 3 and 7 days post-SNI, in a way prevented by DPCPX (3 mg/kg, i.p.), a selective A1 adenosine receptor antagonist, without exerting any significant change on the motor coordination or arterial blood pressure.  In addn., a single i.p. injection of 5'-chloro-5'-deoxy-(±)-ENBA (0.5 mg/kg, i.p.) 7 days post-SNI also reduced both symptoms for at least two hours.  SNI was assocd. with spinal changes in microglial activation ipsilaterally to the nerve injury.  Activated, hypertrophic microglia were significantly reduced by 5'-chloro-5'-deoxy-(±)-ENBA chronic treatment.  Our results demonstrated an involvement of adenosine A1 receptor in the amplified nociceptive thresholds and in spinal glial and microglial changes occurred in neuropathic pain, without affecting motor coordination or blood pressure.  Our data suggest a possible use of adenosine A1 receptor agonist in neuropathic pain symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZDTfzGFQbeLVg90H21EOLACvtfcHk0lhqNDBlHjA-Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVequrjE&md5=c4bf495b0fb81de282fc9a192ba1b345</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3390%2Fmolecules171213712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules171213712%26sid%3Dliteratum%253Aachs%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DPetrelli%26aufirst%3DR.%26aulast%3DGatta%26aufirst%3DL.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DVita%26aufirst%3DP.%26aulast%3DFranchetti%26aufirst%3DP.%26aulast%3DGrifantini%26aufirst%3DM.%26aulast%3Dde%2BNovellis%26aufirst%3DV.%26aulast%3DCappellacci%26aufirst%3DL.%26aulast%3DMaione%26aufirst%3DS.%26atitle%3D5%25E2%2580%25B2-Chloro-5%25E2%2580%25B2-deoxy-%2528%25C2%25B1%2529-ENBA%252C%2520a%2520potent%2520and%2520selective%2520adenosine%2520A1%2520receptor%2520agonist%252C%2520alleviates%2520neuropathic%2520pain%2520in%2520mice%2520through%2520functional%2520glial%2520and%2520microglial%2520changes%2520without%2520affecting%2520motor%2520or%2520cardiovascular%2520functions%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26spage%3D13712%26epage%3D13726%26doi%3D10.3390%2Fmolecules171213712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Cavasotto, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palomba, D.</span><span> </span><span class="NLM_article-title">Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">13576</span><span class="NLM_x">–</span> <span class="NLM_lpage">13594</span><span class="refDoi"> DOI: 10.1039/C5CC05050B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1039%2FC5CC05050B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=26256645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Sqs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=13576-13594&author=C.+N.+Cavasottoauthor=D.+Palomba&title=Expanding+the+horizons+of+G+protein-coupled+receptor+structure-based+ligand+discovery+and+optimization+using+homology+models&doi=10.1039%2FC5CC05050B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models</span></div><div class="casAuthors">Cavasotto, Claudio N.; Palomba, Damian</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">71</span>),
    <span class="NLM_cas:pages">13576-13594</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  With >800 members in humans, the G protein-coupled receptor (GPCR) super-family is the target for more than 30% of the marketed drugs.  The recent boom in GPCR crystallog. has enabled the soln. of ∼30 different GPCR structures, which boosted the identification and optimization of novel modulators and new chem. entities through structure-based strategies.  However, the no. of available structures represents a small part of the human GPCR druggable target space, and its complete coverage in the near future seems unlikely.  Homol. modeling represents a reliable tool to fill this gap, and hence to vastly expand the horizons of structure-based drug discovery and design.  In this Feature Article, we show from a wealth of retrospective and prospective studies that in spite of the pitfalls of and standing challenges in homol. modeling, structural models have been crit. for the blossoming and success of GPCR structure-based lead discovery and optimization endeavours; in addn., they have also been instrumental in characterizing receptor-ligand interaction, guiding the design of site-directed mutagenesis and SAR studies, and assessing off-target effects.  Considering though their current limitations, we also discuss the most pressing issues to develop more accurate homol. modeling strategies, with a special focus on the integration of computational tools with biochem., biophys. and QSAR data, highlighting methodol. aspects and recent progress.  The teachings of the three GPCR Dock community-wide assessments and the fresh developments in GPCR classes B, C and F are commented.  This is a fast growing and highly promising field of research, and in the coming years, the use of high-quality models should enable the discovery of a growing no. of potent, selective and efficient GPCR drug leads with high therapeutic potential through receptor structure-based strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9LmkRKbR3hrVg90H21EOLACvtfcHk0lia2z0okygYVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Sqs7rL&md5=d8d899e555a3cc5c9830c5820e499841</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1039%2FC5CC05050B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC05050B%26sid%3Dliteratum%253Aachs%26aulast%3DCavasotto%26aufirst%3DC.%2BN.%26aulast%3DPalomba%26aufirst%3DD.%26atitle%3DExpanding%2520the%2520horizons%2520of%2520G%2520protein-coupled%2520receptor%2520structure-based%2520ligand%2520discovery%2520and%2520optimization%2520using%2520homology%2520models%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D13576%26epage%3D13594%26doi%3D10.1039%2FC5CC05050B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiselev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakraborty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayasekara, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span> </span><span class="NLM_article-title">John Daly Lecture: Structure-guided drug design for adenosine and P2Y receptors</span> <span class="citation_source-journal">Comput. Struct. Biotechnol. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1016/j.csbj.2014.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1016%2Fj.csbj.2014.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=25973142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A280%3ADC%252BC2MfjvFGquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=286-298&author=K.+A.+Jacobsonauthor=Z.+G.+Gaoauthor=S.+Paolettaauthor=E.+Kiselevauthor=S.+Chakrabortyauthor=P.+S.+Jayasekaraauthor=R.+Balasubramanianauthor=D.+K.+Tosh&title=John+Daly+Lecture%3A+Structure-guided+drug+design+for+adenosine+and+P2Y+receptors&doi=10.1016%2Fj.csbj.2014.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors</span></div><div class="casAuthors">Jacobson Kenneth A; Gao Zhan-Guo; Paoletta Silvia; Kiselev Evgeny; Chakraborty Saibal; Jayasekara P Suresh; Balasubramanian Ramachandran; Tosh Dilip K</div><div class="citationInfo"><span class="NLM_cas:title">Computational and structural biotechnology journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">286-98</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We establish structure activity relationships of extracellular nucleosides and nucleotides at G protein-coupled receptors (GPCRs), e.g. adenosine receptors (ARs) and P2Y receptors (P2YRs), respectively.  We synthesize selective agents for use as pharmacological probes and potential therapeutic agents (e.g.  A3AR agonists for neuropathic pain).  Detailed structural information derived from the X-ray crystallographic structures within these families enables the design of novel ligands, guides modification of known agonists and antagonists, and helps predict polypharmacology.  Structures were recently reported for the P2Y12 receptor (P2Y12R), an anti-thrombotic target.  Comparison of agonist-bound and antagonist-bound P2Y12R indicates unprecedented structural plasticity in the outer portions of the transmembrane (TM) domains and the extracellular loops.  Nonphosphate-containing ligands of the P2YRs, such as the selective P2Y14R antagonist PPTN, are desired for bioavailability and increased stability.  Also, A2AAR structures are effectively applied to homology modeling of closely related A1AR and A3AR, which are not yet crystallized.  Conformational constraint of normally flexible ribose with bicyclic analogues increased the ligand selectivity.  Comparison of rigid A3AR agonist congeners allows the exploration of interaction of specific regions of the nucleoside analogues with the target and off-target GPCRs, such as biogenic amine receptors.  Molecular modeling predicts plasticity of the A3AR at TM2 to accommodate highly rigidified ligands.  Novel fluorescent derivatives of high affinity GPCR ligands are useful tool compounds for characterization of receptors and their oligomeric assemblies.  Fluorescent probes are useful for characterization of GPCRs in living cells by flow cytometry and other methods.  Thus, 3D knowledge of receptor binding and activation facilitates drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTp_cjf_vxkV5w7prLlxLOzfW6udTcc2eYebGurm5C1rrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfjvFGquw%253D%253D&md5=045ec3300bf51cac43082e09bc2a72e0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.csbj.2014.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.csbj.2014.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DKiselev%26aufirst%3DE.%26aulast%3DChakraborty%26aufirst%3DS.%26aulast%3DJayasekara%26aufirst%3DP.%2BS.%26aulast%3DBalasubramanian%26aufirst%3DR.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26atitle%3DJohn%2520Daly%2520Lecture%253A%2520Structure-guided%2520drug%2520design%2520for%2520adenosine%2520and%2520P2Y%2520receptors%26jtitle%3DComput.%2520Struct.%2520Biotechnol.%2520J.%26date%3D2015%26volume%3D13%26spage%3D286%26epage%3D298%26doi%3D10.1016%2Fj.csbj.2014.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span>Molecular Operating Environment (MOE), <span class="NLM_edition">version 2012.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>; <span class="NLM_publisher-loc">1255 University St., Suite 1600, Montreal, QC H3B 3X3, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+version+2012.10%3B+Chemical+Computing+Group+Inc.%3B+1255+University+St.%2C+Suite+1600%2C+Montreal%2C+QC+H3B+3X3%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Rasmussen, S. G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVree, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calinski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathiesen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skiniotis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunahara, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">Crystal structure of the β<sub>2</sub> adrenergic receptor–Gs protein complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">477</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1038/nature10361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=10.1038%2Fnature10361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=21772288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1equrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=477&publication_year=2011&pages=549-555&author=S.+G.+F.+Rasmussenauthor=B.+T.+DeVreeauthor=Y.+Zouauthor=A.+C.+Kruseauthor=K.+Y.+Chungauthor=T.+S.+Kobilkaauthor=F.+S.+Thianauthor=P.+S.+Chaeauthor=E.+Pardonauthor=D.+Calinskiauthor=J.+M.+Mathiesenauthor=S.+T.+A.+Shahauthor=J.+A.+Lyonsauthor=M.+Caffreyauthor=S.+H.+Gellmanauthor=J.+Steyaertauthor=G.+Skiniotisauthor=W.+I.+Weisauthor=R.+K.+Sunaharaauthor=B.+K.+Kobilka&title=Crystal+structure+of+the+%CE%B22+adrenergic+receptor%E2%80%93Gs+protein+complex&doi=10.1038%2Fnature10361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the β2 adrenergic receptor-Gs protein complex</span></div><div class="casAuthors">Rasmussen, Soren G. F.; DeVree, Brian T.; Zou, Yao-Zhong; Kruse, Andrew C.; Chung, Ka-Young; Kobilka, Tong-Sun; Thian, Foon-Sun; Chae, Pil-Seok; Pardon, Els; Calinski, Diane; Mathiesen, Jesper M.; Shah, Syed T. A.; Lyons, Joseph A.; Caffrey, Martin; Gellman, Samuel H.; Steyaert, Jan; Skiniotis, Georgios; Weis, William I.; Sunahara, Roger K.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">477</span>
        (<span class="NLM_cas:issue">7366</span>),
    <span class="NLM_cas:pages">549-555</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are responsible for the majority of cellular responses to hormones and neurotransmitters as well as the senses of sight, olfaction and taste.  The paradigm of GPCR signalling is the activation of a heterotrimeric GTP binding protein (G protein) by an agonist-occupied receptor.  The β2 adrenergic receptor (β2AR) activation of Gs, the stimulatory G protein for adenylyl cyclase, has long been a model system for GPCR signalling.  Here we present the crystal structure of the active state ternary complex composed of agonist-occupied monomeric β2AR and nucleotide-free Gs heterotrimer.  The principal interactions between the β2AR and Gs involve the amino- and carboxy-terminal α-helixes of Gs, with conformational changes propagating to the nucleotide-binding pocket.  The largest conformational changes in the β2AR include a 14 Å outward movement at the cytoplasmic end of transmembrane segment 6 (TM6) and an α-helical extension of the cytoplasmic end of TM5.  The most surprising observation is a major displacement of the α-helical domain of Gαs relative to the Ras-like GTPase domain.  This crystal structure represents the first high-resoln. view of transmembrane signalling by a GPCR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-PdYRDvolqrVg90H21EOLACvtfcHk0lia2z0okygYVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1equrrL&md5=d22a43dd677ac255d138b1aedff357d3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature10361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10361%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%2BF.%26aulast%3DDeVree%26aufirst%3DB.%2BT.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DChung%26aufirst%3DK.%2BY.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DChae%26aufirst%3DP.%2BS.%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DCalinski%26aufirst%3DD.%26aulast%3DMathiesen%26aufirst%3DJ.%2BM.%26aulast%3DShah%26aufirst%3DS.%2BT.%2BA.%26aulast%3DLyons%26aufirst%3DJ.%2BA.%26aulast%3DCaffrey%26aufirst%3DM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DSkiniotis%26aufirst%3DG.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DCrystal%2520structure%2520of%2520the%2520%25CE%25B22%2520adrenergic%2520receptor%25E2%2580%2593Gs%2520protein%2520complex%26jtitle%3DNature%26date%3D2011%26volume%3D477%26spage%3D549%26epage%3D555%26doi%3D10.1038%2Fnature10361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span>Schrödinger Suite 2015; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2015%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Suite%25202015%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span>LigPrep, <span class="NLM_edition">version 3.5</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+3.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span>Glide, <span class="NLM_edition">version 6.8</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+6.8%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAK','PDB','3QAK'); return false;">PDB: 3QAK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SN6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SN6','PDB','3SN6'); return false;">PDB: 3SN6</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01998">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82688"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01998">10.1021/acs.jmedchem.5b01998</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">NMR analysis and mass spectra of selected synthesized compounds, results of PDSP screening, and supplementary chemical schemes (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_002.csv">CSV</a>)</p></li><li><p class="inline">Video related to <a class="ref internalNav" href="#fig3">Figure 3</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_004.avi">AVI</a>)</p></li><li><p class="inline">3D coordinates of the modeled hA<sub>3</sub>AR complex with <b>15</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_005.pdb">PDB</a>)</p></li><li><p class="inline">3D coordinates of the modeled hA<sub>3</sub>AR complex with <b>21</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_006.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_001.pdf">jm5b01998_si_001.pdf (4.7 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_002.csv">jm5b01998_si_002.csv (1.92 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_004.avi">jm5b01998_si_004.avi (6.38 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_005.pdb">jm5b01998_si_005.pdb (188.45 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01998/suppl_file/jm5b01998_si_006.pdb">jm5b01998_si_006.pdb (188.37 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01998&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01998%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01998" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995b4f8cd4238c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
